The detection of Coxiella burnetii (Q fever) in clinical and environmental samples by Lockhart, Michelle
Title page 
   
   
   
   
   
T Th he e   D De et te ec ct ti io on n   o of f   C Co ox xi ie el ll la a   b bu ur rn ne et ti ii i   ( (Q Q   f fe ev ve er r) )   i in n   
C Cl li in ni ic ca al l   a an nd d   E En nv vi ir ro on nm me en nt ta al l   S Sa am mp pl le es s   
   
   
   
M Mi ic ch he el ll le e   L Lo oc ck kh ha ar rt t   
B BS Sc c   ( (H Ho on no ou ur rs s) )   U Un ni iv ve er rs si it ty y   o of f   N Ne ew wc ca as st tl le e   2 20 00 04 4   
   
   
T Th hi is s   T Th he es si is s   i is s   p pr re es se en nt te ed d   f fo or r   t th he e   d de eg gr re ee e   o of f   D Do oc ct to or r   o of f   P Ph hi il lo os so op ph hy y, ,   
M Mu ur rd do oc ch h   U Un ni iv ve er rs si it ty y   2 20 01 10 0   
   
   
   ii 
D De ec cl la ar ra at ti io on n   
 
I I   d de ec cl la ar re e   t th ha at t   t th hi is s   t th he es si is s   i is s   m my y   o ow wn n   a ac cc co ou un nt t   o of f   m my y   r re es se ea ar rc ch h   a an nd d   c co on nt ta ai in ns s   a as s   
i it ts s   m ma ai in n   c co on nt te en nt t   w wo or rk k   w wh hi ic ch h   h ha as s   n no ot t   p pr re ev vi io ou us sl ly y   b be ee en n   s su ub bm mi it tt te ed d   f fo or r   a a   d de eg gr re ee e   
a at t   a an ny y   t te er rt ti ia ar ry y   e ed du uc ca at ti io on n   i in ns st ti it tu ut ti io on n. .   
M Mi ic ch he el ll le e   L Lo oc ck kh ha ar rt t   
   iii 
A Ab bs st tr ra ac ct t   
The zoonotic intracellular bacterium Coxiella burnetii is the cause of the human disease 
Q  fever.  Coxiella  burnetii  can  be  shed  by  infected  animals,  can  survive  harsh 
environments and has been shown to persist within the human host. The detection and 
isolation of this bacterium is difficult due to its intracellular nature. In order to detect 
minimal  concentrations  of  this  bacterium  in  various  clinical  and  environmental 
samples, highly sensitive assays were needed. A duplex real-time polymerase chain 
reaction (qPCR) assay was developed to detect C. burnetii DNA (targeting the Com1 
gene and the IS1111a gene). This assay was then tested on a variety of environmental 
and clinical sample types. 
 
Samples  (such  as  water,  soil,  aerosols,  blood  and  bone  marrow)  were  spiked  with 
C. burnetii (either living cell cultures or formalin killed cells) to determine the optimal 
method  for  extracting  and  detecting  C. burnetii  DNA.  The  silica  column  method 
followed  by  qPCR  assay  of  the  Com1  gene  was  shown  to  have  a  sensitivity  of 
approximately 1100 copies/litre in water, 1900 copies/kg in soil, 870 copies/litre in 
milk, and seven copies/litre of air. When the same technique was applied to clinical 
samples the silica column method proved to be the most effective in purifying DNA 
from  the  small  cell  variant  of  C. burnetii  and  effectively  removed  potential  PCR 
inhibitors  from  mock  clinical  samples  of  blood,  plasma,  serum  and  bone  marrow. 
However,  because  the  qPCR  cannot  differentiate  between  viable  and  non-viable 
C. burnetii DNA it was important to establish a sensitive assay for the detection of 
viable C. burnetii in order to investigate persistent infections and to obtain isolates of 
the bacteria from cases of Q fever for further studies. iv 
 
As isolation of Coxiella can be achieved using cell culture or animal inoculation these 
methods were compared for their sensitivity for C. burnetii detection. Vero and DH82 
cell  lines  were  the  most  sensitive  for  cell  culture  isolation  of  the  Arandale  and 
Henzerling  isolates  of  C. burnetii  respectively.  When  cell  culture  was  compared  to 
PCR and inoculation of severely combined immunodeficient (SCID) mice it was found 
that inoculation of SCID mice followed by euthanasia (at day 42) and removal and 
analysis  of  the  spleen  was  the  most  sensitive  method  for  the  detection  of  viable 
C. burnetii. 
 
It  has  recently  been  hypothesised  that  genetic  differences  between  isolates  of 
C. burnetii  are  responsible  for  differences  in  pathogenicity  and  disease  outcomes. 
Hence  the  differences  between  Australian  isolates  were  investigated.  Seven  new 
Australian isolates of C. burnetii were genetically analysed by conventional PCR of 
insertion  sequences  and  detection  of  the  acute  disease  antigen  A  (adaA)  gene.  Six 
Australian isolates of C. burnetii were placed in geno-group III but were negative for 
the adaA gene. One new Australian isolate (Poowong) was placed in geno-group II and 
was  positive  for  the  adaA  gene.  The  Poowong  isolate  was  from  a  seronegative 
asymptomatic patient, with bacteraemia detected by PCR in four initial samples as well 
as all 12 blood samples taken over a one month period. Through sequencing of 468bp 
of the ankyrin gene (ankH sequenced in triplicate) it was shown that the Poowong 
isolate had two base pair differences compared to the Henzerling isolate (also geno-
group II) and the Nine Mile isolate (geno-group I). This demonstrates that the Poowong 
isolate can be distinguished from the other isolates within the laboratory.  
 v 
The optimal methods of detection as determined in this study were used to analyse and 
evaluate  clinical  specimens.  Blood  samples  (serum,  plasma  and  peripheral  blood 
mononuclear cells) from 12 patients infected during an outbreak of Q fever in Newport 
UK in 2002 were examined. Cell culture of the peripheral blood mononuclear cells 
(PBMC) demonstrated that no viable C. burnetii cells were present. In contrast, six of 
the spleens from SCID mice inoculated with the PBMCs were positive for C. burnetii 
DNA  (by  Com1  qPCR)  and  six  were  positive  for  C. burnetii  antigen  (by  IFA). 
However, only two were positive for both. This suggests that in some patients low 
numbers  of  viable  C. burnetii  cells  persist  and  in  others  C. burnetii  persist  as  non-
viable antigen. 
 
In conclusion, this study demonstrated sensitive and specific optimal methods for the 
detection of C. burnetii in clinical and environmental samples, the optimal method for 
isolation  of  C. burnetii,  the  application  of  these  methods  on  a  number  of  clinical 
samples and the characterisation of seven new  isolates, including an isolate from a 
highly unusual asymptomatic case that is genetically unique from the others. This study 
has also shown that the pathogenesis of C. burnetii infection in humans and the effect 
of genetic differences in isolates on pathogenesis are far from adequately understood. 
The optimal methods of detection, isolation and grouping determined in this study will 
have an effect on future studies and will allow a greater understanding of C. burnetii 
and its persistence, both in the environment and in Q fever infections. vi 
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C Ch ha ap pt te er r   1 1. .    I In nt tr ro od du uc ct ti io on n   
1.1 Q Fever 
1.1.1  History 
The  disease  Q  fever  was  first  described  by  Edward  H.  Derrick
31.  Derrick  was 
investigating an outbreak of undiagnosed febrile illness in abattoir workers in Brisbane. 
After failed attempts to visualize or isolate the causative agent, the disease was named 
Q (Query) fever, due to its unknown aetiology. In a study by Macfarlane Burnet and 
Mavis Freeman the agent was cultured in guinea pigs and other animals and inclusions 
in vacuoles were visualized
20. In 1939 the agent was named Rickettsia burnetii after 
Burnet
32.  Around  the  same  time  in  the  Rocky  Mountain  Laboratory  in  Hamilton, 
Montana  (USA),  Herald  Cox  and  Gordon  Davis  isolated  an  agent  responsible  for 
human infections from ticks
26. They named it the “nine-mile fever” agent and this was 
later  found  to  be  immunologically  identical  to  Q  fever
21.  The  causative  agent  was 
originally  thought  to  be  a  Rickettsia,  belonging  to  the  alpha  subgroup  of  the 
proteobacteria,  however  genetic  comparisons  demonstrated  that  it  belonged  to  the 
gamma subgroup
123 and the agent was renamed Coxiella burnetii. 
 
1.1.2  The disease 
Q  fever  is  a  zoonosis  infecting  animals  such  as  cattle,  sheep,  goats,  rodents  and 
kangaroos. The infected animals are carriers and usually show no symptoms of the 
disease with the exception of abortions or under developed young. Originally known as 
“abattoir  fever”,  Q  fever  predominantly  affects  people  in  the  livestock  industry 
including; animal handlers, veterinarians, truck and train drivers, office staff, shearers,  
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meat inspectors, sale yard staff, farmers and their families. While many tick and other 
arthropod  species  have  been  shown  to  carry  C. burnetii,  human  infections  nearly 
always  occur  from  inhalation  of  infected  aerosols
112  and  possibly  from  ingestion
16. 
C. burnetii is highly infectious as disease can be initiated from as little as a single 
bacterium
112.  It  is  possible  to  acquire  an  infection  without  direct  animal  contact  as 
C. burnetii  is  air-borne  and  can  travel  in  the  wind  over  long  distances
113.  Thus  an 
outbreak can occur some distance from the source. 
1.1.2.1  Symptoms 
The clinical manifestations of Q fever are highly variable among cases. It is unknown 
whether different strains of the bacteria cause the different clinical manifestations, or if 
they are due to a different route of infection or host immune response
71. Around 60% of 
infected people do not display symptoms
72. When symptoms do appear they can be 
polymorphic and non-specific. Q fever can also manifest as acute disease or can persist 
as chronic Q fever for several years. 
1.1.2.2  Acute 
The majority of patients with symptoms will experience acute Q fever. This is self-
limiting and clinically presents as “flu-like” with pneumonia, headache, chills, sweats, 
fever and fatigue. With an abrupt onset acute Q fever generally lasts 2-3 weeks
72. 
1.1.2.3  Chronic 
Some infections can last longer and those persisting over six months or recrudescing 
are defined as chronic. Chronic Q fever infections represent only a small proportion of 
infections. Chronic Q fever has more severe complications and infection can last for 
many  years.  Chronic  Q  fever  generally  produces  endocarditis  and  other  vascular 
infections
72 which can be fatal if untreated.  
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1.1.2.4  Post Q fever Fatigue Syndrome (QFS) 
Following infection with acute Q fever, post Q fever fatigue syndrome (QFS) manifests 
in 10-15% of patients
44, 69. QFS may be considered to be one of the manifestations of 
chronic Q fever. QFS presents as fatigue, sweating, breathlessness and blurred vision 
and can also persist for several years and can be a debilitating illness. It is thought that 
this condition is caused by high levels of certain cytokines, including interleukin 10, 
that are stimulated by the persisting infection
84 or persisting antigen
70. 
 
Chronic Fatigue Syndrome (CFS) has been recognised as a symptom following acute 
infection
10,  72  and  indeed  the  similar  presentation  of  CFS  makes  it  difficult  to 
distinguish clinically from QFS. CFS is a disease for which many infectious agents 
have been thought to be responsible, but none has been confirmed as a cause
87. 
1.1.2.5  Treatment and Vaccination 
Q fever, including chronic Q fever, is treatable with tetracycline antibiotics such as 
doxycycline. For those at increased risk of infection a vaccine, Qvax®, is available in 
Australia. This vaccine contains a whole-cell formalin fixed suspension of C. burnetii. 
The producer of the vaccine, Commonwealth Serum Laboratories (CSL) estimated that 
around 50,000 Australians were vaccinated in 2003, but more recently that number has 
declined to 5,000 per annum
35. 
1.1.2.6  Q fever in Australia 
Around 400 people are diagnosed with Q fever annually in Australia (see Figure 1). It 
is believed that many more are misdiagnosed, as the symptoms are highly variable and 
can be similar to those due to other infections. In addition, medical professionals may 
not consider the disease in their diagnosis, particularly if animal contact is not apparent.  
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Figure 1 Notified Cases of Q Fever in Australia 1991-2009 
The figure shows the cases of Q fever in Australia as noted by Communicable Diseases 
Australia on the National Notifiable Disease Surveillance System. There is a slight 
decline  in  notified  cases  since  1994  with  a  possible  plateau  of  around  400  cases 
annually  since  2004.  This  data  is  collected  by  the  Australian  Government,  by  the 
Department  of  Health  and  Ageing,  and  is  available  online 
(http://www9.health.gov.au/cda/Source/CDA-index.cfm)  and  was  accessed  on  the 
18/01/2010. 
 
 
 
Endemic areas of Q fever are northern NSW and southern Queensland (see Figure 2). 
However it is present Australia-wide and outbreaks have occurred recently in South 
Australia
115 and Victoria
121.  
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Figure 2 Distribution of notified Q Fever Cases in Australia 2005-2009 
The figure shows the average (and standard deviation) of cases of Q fever in Australian 
states as noted by Communicable Diseases Australia on the National Notifiable Disease 
Surveillance System 2005-2009. From 2005-2009 there were no cases of Q Fever in 
Tasmania and only two were notified in the Australian Capital Territory in 2008. There 
is  a  clear  endemic  area  in  NSW  and  Queensland.  This  data  is  collected  by  the 
Department  of  Health  and  Ageing  of  the  Australian  Government,  and  is  available 
online  (http://www9.health.gov.au/cda/Source/CDA-index.cfm)  and  was  accessed  on 
the 18/01/10. 
 
1.2 Coxiella burnetii 
Q fever is caused by the intracellular bacterium Coxiella burnetii. In the human host it 
infects monocytes and macrophages. It varies in size from 0.4 to 1m long and 0.2 to 
0.4m wide. It has a membrane similar to Gram-negative bacteria however it is usually 
not stainable by the Gram technique
72. The genome size is highly variable between 
strains ranging from 1.5 to 2.4Mb
125. Coxiella burnetii enters the host cell by inducing 
endocytosis  in  phagocytes.  Unlike  other  intracellular  bacteria  that  either  escape  the 
phagosome  into  the  cytoplasm  or  prevent  the  binding  of  the  lysosomes  to  the 
phagosome,  C. burnetii  survives  the  highly  acidic  environment  within  the 
phagolysosome (Figure 3). The intracellular environment gives the bacteria access to  
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the  host  cell’s  nutrients  and  molecular  building  blocks.  Coxiella  actively  transports 
glucose, glutamate
43, proline
48 and other substrates from the intracellular environment. 
These transportation systems and the metabolism of nucleic acids and amino acids have 
been shown to be pH dependent
43, 48, 74. Original visualisation of C. burnetii showed 
that most were intracellular but always with an extracellular proportion
20. This is most 
likely attributed to C. burnetii that have been released and are about to infect other 
cells. 
 
 
 
Figure 3 Mouse L cell with phagolysosome filled with C. burnetii
22 
The arrow shows the thin layer of cytoplasm at one pole while the nucleus (N) is at the 
other. The figure also shows the similar size of the mitochondria (M) to the C. burnetii 
cells within the phagolysosome (V) (magnification x7600). 
 
1.2.1  Coxiella burnetii phases 
Coxiella burnetii exists in two distinct antigenic phases named I and II. Phase I is the 
natural or wild type found in animals and is capable of causing infection. Phase II is 
may result from serial passages in cell culture or embryonated eggs. Animal infection is  
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the only way to maintain the organism in the infectious Phase I. The key difference 
between the phases is the lipopolysaccharide (LPS). Phase I has long or smooth LPS 
which is responsible for its highly virulent nature. Phase II has truncated or rough LPS 
is  non-infectious,  more  easily  phagocytosed,  very  susceptible  to  host  defences,  is 
rapidly killed via the phagolysosomal pathway and is considered avirulent. This was 
demonstrated  by  inoculation  of  guinea  pigs  with  10
8  Phase  II  organisms.  No 
seroconversion was observed, while inoculation of guinea pigs with as few as two to 
four Phase I organisms resulted in seroconversion
76. This demonstrated the antigenic 
qualities of the smooth type LPS. It has been shown that Phase I organisms encode a 
complete LPS with an O antigen side chain, whereas some Phase II cells have major 
deletions of genes involved in LPS synthesis and are missing the O antigen side chain 
or several terminal sugars
51. The production of antibodies to these antigens is discussed 
further in section 1.3.1 
 
1.2.2  Coxiella burnetii Forms 
In addition to the different phases, Coxiella naturally exist in different forms. These 
forms include the large cell variant (LCV) the small cell variant (SCV) (see Figure 4) 
and a “spore like” form. This form is not considered a true spore because (based on 
current knowledge) only Gram-positive bacteria produce true spores and C. burnetii is 
a  Gram-negative  bacterium.  Several  developmental  cycles  have  been  proposed 
including one shown in Figure 5. In this example the “spore like” form is produced 
inside the large cell variant, and remains an endospore until released by the large cell
74. 
There seems to be some confusion surrounding the life cycle of C. burnetii, as the 
“spore like” form has not been visualised outside the LCV. It has been hypothesised 
that  during  release  of  the  endospore  it  undergoes  modifications  and  becomes  the  
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SCV
74. Hence to eliminate confusion the small extracellular form, released endospore, 
resistant form or “spore like form” will hereafter be referred to as the SCV. It is thought 
that all forms can exist in both phases. 
 
Figure 4 Forms of Coxiella burnetii
24 
The figure shows the SCV (left image) and the LCV (right image) as separated by 32% 
cesium  chloride  density  gradient  centrifugation  and  photographed  by  transmission 
electron microscopy. The bars represent 2m. 
 
 
Figure 5 Developmental cycle of C. burnetii (adapted from 
9). 
In the life cycle the small cell variant enters the host cell by endocytosis (1), then it 
multiplies by transverse binary fission and differentiates into the large cell variant (2), 
the lysosomes then bind to the phagosome (3) and the phagolysosome is acidified to a 
pH of 4.5. The large cell variant also multiplies by transverse binary fission, there is 
some  differentiation  back  to  the  small  cell  variant,  in  this  proposed  life  cycle, 
endospores are formed within the large cell variants (4). Finally the “spore like” forms 
are released from the host cell and become the SCV
9.  
9 
1.2.3  The Large Cell Variant 
The  LCV  is  pleomorphic,  can  be  larger  than  1m  in  length  and  is  considered  the 
replicative form. The LCV is more metabolically active and has ways of protecting 
itself  from  the  oxidative  stress  caused  by  the  lysosomes.  However,  it  is  more 
susceptible  to  adverse  conditions  such  as  osmotic  stress
73.  There  are  antigenic 
variations  between  the  cell  types  and  this  may  aid  in  evasion  of  the  host  immune 
defenses leading to persistent infection
24. 
 
1.2.4  The Small Cell Variant 
The  SCV  is  rod  shaped  and  ranges  from  0.2  to  0.5m  long
74.  The  SCV  may  be 
produced in adverse conditions, as it is very resistant to heat and drying and can survive 
long periods outside the host cell. The SCV has been shown to be the resistant form and 
it  remains  metabolically  active  and  infective  following  osmotic  stress,  elevated 
temperatures,  sonication  and  centrifugation  through  sucrose  density  gradients
73.  For 
this reason it is considered “spore like”. As the SCV can survive long periods outside 
the host in the environment, it may also survive the immunological defences of the host 
and  persist  leading  to  chronic  infections
73.  The  SCV  has  increased  transcription  of 
genes that down regulate metabolism and condense chromatin
24. It also produces form 
specific proteins such  as the DNA binding ScvA protein that is not found in  LCV 
fractions
47. These form specific proteins such as ScvA may aid in the condensing of 
chromatin and the resistance of the SCV. 
 
1.2.5  Pathogenesis 
Infection with C. burnetii affects the host cell in many ways and the different phases 
work in different ways. Phase  II  cells enter human macrophages by binding to the  
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leukocyte response intergrin (3) and the CR3 receptor. The LPS of Phase I however 
interferes with the engagement of the CR3 receptor, reducing phagocytic activity and 
binds by both the leukocyte response intergrin (3) and intergrin-associated protein 
complex
75. Because of this phagocytosis of Phase II organisms occurs at a much higher 
rate than for Phase I in non-phagocytic cells
119. Once the bacteria have entered the host 
they differentiate into the replicating form. This differentiation of SCV to LCV takes 1-
2 days to occur
25. Coxiella burnetii is capable of preventing apoptosis, as shown by 
persistently infected macrophages which have very little cytopathic effect
90. 
 
1.3 Diagnosis 
1.3.1  Serology 
The gold standard and most widely used technique for diagnosis of Q fever is serology. 
This involves the detection of antibodies to the bacteria in serum by methods such as 
immunofluorescence  (IFA),  which  may  represent  a  current  or  previous  infection. 
Diagnosis of a current infection requires two samples to show a seroconversion (two 
fold increase in 1-2 weeks). Antibodies detected can be to either Phase I or Phase II. 
The differences in the antigenic properties of the two LPS’s are due to differences in 
the structure (Phase II LPS is truncated). The first antibody to appear in acute Q fever 
infection is Phase II immunoglobulin M (IgM) (see Figure 6). The high titre in IgM 
peaks quickly and dies down and is followed by a peak in Phase II immunoglobulin G 
(IgG). The detection of IgG and immunoglobulin A (IgA) to Phase I antigens is used 
for diagnosis of chronic Q fever
66. 
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Figure 6 IgM and IgG antibody responses and bacteraemia in Acute Q Fever 
The figure shows an idealised representation of acute Q fever based on the clinical and 
laboratory experience of the Adelaide Q Fever Research Group and Infectious Diseases 
Laboratories, IMVS. Image adapted from
67. 
 
1.3.2  Culture 
Culture of C. burnetii is achievable but rarely considered as a method for diagnosis. 
Due to the bacteria’s intracellular nature it cannot be easily grown on agar plates and 
must be grown in cell culture, embryonated eggs or by animal inoculation. Cell culture 
lines for Coxiella include Vero cells (African green monkey kidney cells)
22, and mouse 
L cells, including L929 (House mouse fibroblast cells)
11, 
22. Amoeba (Acanthamoeba 
castellanii)  have  also  been  shown  to  maintain  C. burnetii  infection
60. The  infection 
does not generally destroy the host cells and infected cells have the same cell cycle 
progression as uninfected cells. This is a result of asymmetric division of infected cells 
producing one infected and one uninfected daughter cell. This ability of C. burnetii has  
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allowed it to persistently infect cell cultures for over two years without the addition of 
uninfected  cells
90.  The  infected  cell  monolayer  exhibits  CPE  at  the  same  rate  as 
uninfected cultures. Thus infection of the culture must be observed through the use of 
other methods such as IF or polymerase chain reaction (PCR).  Coxiella burnetii was 
traditionally cultured in embryonated eggs or laboratory animals such as guinea pigs 
and  mice.  Culture  of  infectious  Coxiella  burnetii  must  be  done  in  a  physical 
containment level three (PC3) laboratory, with the exception of the plaque purified 
Nine Mile Phase II, RSA 439 clone 4, which has genetic deletions that render it non-
infectious
29, 51. 
 
Since it has been shown that one organism can initiate infection in guinea pigs
96 and 
following  infection  large  numbers  of  bacterial  cells  can  be  recovered  from  their 
spleens
120 it is thought that animal inoculation may be more sensitive than cell culture. 
This was investigated in Chapter 6. 
 
1.3.3  Polymerase Chain Reaction (PCR) 
To detect the presence of the bacteria in any sample type including serum and blood 
buffy coats, PCR is extremely useful. This, like culture, is less subjective than serology 
however it does not differentiate between viable and non-viable organisms. While it 
would seem logical to sample the buffy coat (white blood cell fraction of blood) for the 
detection of these intracellular bacteria, PCR tests using serum have been successful in 
detecting circulating C. burnetii
39, 115. PCR has been shown to be very helpful in the 
early diagnosis of Q fever
115. There is a correlation between the increase in antibody 
titres and a decrease in PCR sensitivity
36. 
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It is thought that the SCV may be difficult to open up during the DNA extraction 
process  and  therefore  samples  may  be  falsely  negative.  Different  methods  of  DNA 
extraction for C. burnetii have been investigated
106. 
 
1.4 Genetics 
Genetic  analysis  of  Coxiella  burnetii  has  placed  this  bacterium  within  the  gamma 
subgroup of the Proteobacteria. Historically it was placed with the Rickettsia in the 
alpha subgroup, however this was changed following sequencing of the 16S gene
106, 123. 
Other studies have showed strong homology between strains of Coxiella burnetii
106. 
 
1.4.1  The Com1 gene 
The  Com1  gene  codes  for  a  27-kDa  outer  membrane  protein  occuring  once  in  the 
genome and is highly conserved
132. This gene is used as a PCR target for detection of 
C. burnetii by many diagnostic laboratories. Differences in the sequence of this gene 
may be used to differentiate groups of C. burnetii isolates
132 (see section 1.5). 
 
1.4.2  The Insertion Sequence 
The  C. burnetii  genome  contains  many  repetitive  bacterial  insertion  sequence  (IS) 
elements
52. The insertion sequence or IS1111a gene has been found in 20 copies in the 
Nine Mile Phase I strain
103, while in other isolates the number of IS1111 elements has 
been shown to vary from seven to 110
57. 
 
There is some speculation about the IS1111a gene as it may not be present in all strains 
of  the  bacteria.  This  was  due  to  one  study  which  demonstrated  22  acute  Q  fever  
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patients and eight QFS patients all from one outbreak of the disease (hence presumably 
the one strain) that were all Com1 positive but IS1111a negative
69. Furthermore it has 
been  suggested  that  a  study  of  a  French  outbreak
39  experienced  low  numbers  of 
positives  because  this  also  involved  a  strain  that  did  not  contain  the  insertion 
sequence
89. Indeed recently it has been suggested that there may be animal strains that 
do not contain the IS1111a
102. 
 
1.5 Classification and grouping 
Due  to  the  differences  in  disease  outcome  several  studies  have  been  undertaken  to 
group C. burnetii isolates. There have been several studies to identify a difference in 
C. burnetii strains responsible for the differences in disease outcomes
42, 97, 130. However 
there is much speculation about this
110.  If a difference between chronic isolates, acute 
isolates and possibly asymptomatic isolates was found perhaps we would understand 
the disease better and uncover the reason behind the different disease states. 
 
Methods that have attempted to group isolates include RFLP analysis
5, 54, 77, 78, 104 via 
SDS-polyacrylamide
50 and pulse field gel electrophoresis
46, 111 genetic sequences
101, 106, 
132 or genetic comparison
30 and microarray
14. Some of these were used or adapted to 
classify Australian isolates obtained during the course of this study. 
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C Ch ha ap pt te er r   2 2. .    M Me et th ho od ds s   
2.1 Laboratory conditions 
The majority of the laboratory work was carried out in a physical containment level 
two (PC2) laboratory in the Australian Rickettsial Reference Laboratory in Geelong, 
Victoria. Some work (including culture of isolates other than C. burnetii Nine Mile 
strain  Clone  4)  was  performed  in  a  PC3  laboratory  situated  in  the  Hunter  Area 
Pathology  Service  (HAPS)  in  Newcastle,  New  South  Wales.  C.  burnetii  was 
deactivated prior to removal from the PC3 lab by incubating at  70°C for 30 minutes. 
All  experiments  were  performed  using  aseptic  techniques  inside  class-2  biological 
safety  cabinets.  The  cabinets  used  were  manufactured  Clyde-Apac  Australia  (for 
culture and DNA extraction, in the PC2 lab) and Bio-Cabinets Australia (for PCR set 
up, in the physical containment level one or PC1 lab). Three geographically isolated 
rooms were used for a) DNA extraction, b) PCR set up and c) the running of the PCR 
so as to minimise contamination and false positive results. Where not stated, samples 
were incubated or spun at room temperature. 
 
2.2 Immunological Methods 
Serology  was  performed  by  micro  immunofluorescence  assay  (IFA).  This  method 
allowed  for  the  detection  of  antibodies  in  patient  serum.  Isolates  (including  cell 
cultures) were screened using IFA that detected C. burnetii antigens. 
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2.2.1  IFA for detecting antibodies in serum 
Antibodies are synthesised in response to antigens that are molecular components of 
the  infectious  bacterium  C. burnetii.  Serum  was  analysed  for  the  presence  of 
C. burnetii antibodies by IFA. This assay can detect IgA, IgG and IgM antibodies to 
Phase I or Phase II and results are used to support a diagnosis as described in the 
introduction section 1.3.1. Titration of the serum was made on samples that screened 
positive to determine the end point/concentration of antibodies. Positive controls used 
in this assay were positive human sera for Phase I and II standardised to give an end 
point titre of approximately 1:600. Positive and negative controls were obtained from 
routine diagnostics conducted by the ARRL. 
2.2.1.1  Screening 
Positive  antigen  (Sirion  Virion,  Thermo  trace,  Australia)  was  spotted  using  sterile 
transfer pipettes (Samco, USA) onto 40 well slides (Path Tech, Australia). The top two 
rows were spotted with Phase II and the bottom two rows were spotted with Phase I 
C. burnetii. Antigen was fixed to the slide by incubation for five minutes in 100% 
acetone (BioLab, Australia). The serum was first diluted (1:25 and 1:400 see below) in 
2% casein buffer (Phosphate buffered saline or PBS; Oxoid, England with 2% milk 
powder; Diploma, Australia) then spotted onto the wells (the first column was spotted 
with positive control serum, and the last column was spotted with negative control 
serum, the rest were available for screening unknown sera) and incubated for 30-45 
minutes in a humid environment at 35°C (Sanyo, Japan). The slides were then washed 
in 10% PBS (Oxoid, England) for 3-5 minutes and air-dried. The conjugate fluorescent 
labelled anti-human (FITC) for total antibodies (IgA, IgG and IgM) (FITC, Siemens, 
Bio Mediq, Australia) diluted 1:100 in 2% casein buffer was then spotted onto all wells 
of the slides and incubated for 30-45 minutes in a humid environment at 35°C. Slides  
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were  once  again  washed  in  1:10  PBS,  air-dried  and  then  were  mounted  using  a 
fluorescent  mounting  media  (Dako,  USA)  and  coverslipped  (Biolab  Scientific, 
Australia) before being viewed under an illuminator-equipped UV microscope (Leica, 
Germany). Positive results were indicated where fluorescence was evident in serum 
that  had  been  diluted  to  1:25  or  greater.    Negative  results  were  reported  where  no 
fluorescence was apparent at a dilution of 1:25.  Due to the observed prozone effect of 
some  serum  samples  (Stenos  and  Nguyen,  personal  communication  2007)  samples 
were screened at 1:25 as stated above and also at 1:400. Positive sera were titrated out 
in order to determine the end point. 
2.2.1.2  Titration 
Titrations were performed on serum samples that were positive by screening. The level 
of antibodies titres could be useful in the diagnosis of previous or current, acute or 
chronic  disease
66.  Slides  were  prepared  similar  to  the  screening  test  with  positive 
antigen, however all 40 wells were spotted with the sample antigen, hence two slides 
were  required one  with Phase  I and one with  Phase  II C. burnetii. The spotting of 
positive and negative controls was performed as described in the screening method. 
Samples were titrated in 2% casein buffer (PBS; Oxoid, England with 2% milk powder; 
Diploma, Australia) at  dilutions 1:25, 1:50, 1:100, 1:200, 1:400, 1:800, 1:1600 and 
1:3200.  Slides  were  incubated,  washed,  spotted  with  conjugate,  incubated,  washed 
again, coverslipped and viewed as for the screening slides. The titre of positive sera 
was determined as the final positive dilution. 
 
2.2.2  IFA for detecting antigen in samples 
The IFA was also used to detect antigen in samples such as cell culture. Small sections 
of the monolayer (1cm
2) were scraped and collected with the media in a 10ml tube  
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(Interpath  Services,  Australia)  from  a  flask,  or  in  a  1.5ml  tube  (Interpath  Services, 
Australia)  that  was  then  spun  at  4,500g  for  10  minutes  in  a  centrifuge  (Sigma 
Laboratory  Centrifuges,  Germany).  Pellets  were  then  resuspended  in  1ml  of  PBS 
(Oxoid, England) to be used for IFA and/or DNA extraction and PCR. Using a transfer 
pipette (Samco, USA) aliquots of the resuspended cultures were spotted onto 12 well 
slides  (Menzel  Gläsier,  Germany)  and  acetone  fixed  slides  (BioLab,  Australia). 
Samples were spotted onto two wells, one thick (a small dome of solution could be 
seen) and one thin (almost all solution removed off the slide). Known positive human 
serum  containing  antibodies  against  C. burnetii  was  used  as  the  source  of  primary 
antibodies (the same as that used for the positive control in the screening and titration 
section  2.2.1)  and  was  spotted,  incubated  and  washed  as  described  in  the  previous 
section. The conjugate (as per section 2.2.1.1) was then spotted, incubated and washed. 
Slides  were  then  mounted  and  coverslipped  before  viewing  under  a  fluorescence 
microscope. 
  
2.3 Cell Culture 
Coxiella burnetii was isolated and kept viable in cell culture. This method induces the 
formation of Phase II and, with the exception of Clone 4, all cultures were kept in a 
PC3 laboratory. 
 
2.3.1  Cell culture types 
The  cell  culture  cell  types  used  were  Vero,  L929,  DH82  and  XTC-2  as  described 
below. Cell cultures were maintained as described in section 2.3.2. The Vero cell line 
was derived from the African green monkey (Chlorocebus aethiops) kidney epithelial 
cells. The L929 cell line was derived from the house mouse (Mus musculus) fibroblast  
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cells. The DH82 cell line was derived from the dog (Canis familiaris) macrophage 
cells. The XTC-2 cell line was derived from the South African clawed frog (Xenopus 
laevis) epithelial cells. Unlike the other cell lines mentioned here the latter cell line was 
grown at 28°C degrees, and with different media (see following section). 
 
2.3.2  Maintenance of cell cultures 
Cell cultures were kept at 35°C with 5% CO2 in an incubator (Sanyo, Japan) in 25cm
2 
flasks with 10ml of media. Media used was Roswell Park Memorial Institute (RPMI) 
1640  media  (Gibco,  Australia  or  Thermo  scientific,  Australia)  supplemented  with 
200mM  L-Glutamine  (Gibco,  Australia)  and  3-10%  newborn  calf  serum  (Gibco, 
Australia).  4-(2-HydroxyEthyl)-1-PiperazineEthaneSulfonic  acid  (HEPES)  buffer 
(Gibco, Australia) was also added to a final concentration of 25mM (not required in the 
RPMI 1640 by Thermo Scientific, Australia). The XTC-2 cells were cultured under 
slightly  different  conditions.  These  cells  were  grown  in  25cm
2  flasks  with  10ml 
Leibrovitz  L-15  media  (Gibco,  Australia)  supplemented  with  200mM  L-glutamine 
(Gibco, Australia) 0.4% tryptose phosphate broth (Oxoid, England) and 10% newborn 
calf serum (Gibco, Australia) with 25mM HEPES (Gibco, Australia) and cultured at 
28°C. As C. burnetii does not readily form a CPE, all potentially infected cultures were 
checked at 30 or 60 day intervals for growth of C. burnetii by scraping a small part of 
the monolayer (1cm
2) removing all media and pelleting the cells by centrifugation at 
4,500g for 10 minutes and resuspendion in 0.5-1mL PBS (Oxoid, England). This was 
then tested by IFA (section 2.2.2) and/or PCR (section 2.4.2).  
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2.3.3  Bacterial isolation 
2.3.3.1  From blood samples 
2.3.3.1.1  Red Blood Cell lysis 
Bacterial isolation was performed on enriched white blood cells (or buffy coats) from 
human whole blood  collected in vacuumed tubes containing ethylene-diamine-tetra-
acetic acid (EDTA). Tubes were spun for five minutes at 4,500g in a centrifuge (Sigma, 
USA) to separate the blood into the three fractions. A transfer pipette (Samco, USA) 
was used to remove the buffy coat to a clean 10ml tube (Interpath Services, Australia). 
To this 5ml of red blood cell lysis buffer (Gentra Systems, USA) was added and the 
tube was incubated at 35°C for 10 minutes. The tube was then spun at 4,500g for 10 
minutes.  The  supernatant  was  removed  and  the  pellet  was  resuspended  in  10ml  of 
sterile PBS (Oxoid, England). The tube was then spun again at 4,500g for 10 minutes. 
The supernatant was removed and the pellet was resuspended in 400-500µL of sterile 
PBS (Oxoid, England). 
2.3.3.1.2  Cell culture of the purified buffy coat 
An aliquot (200µL) of the resuspended pellet (from above section 2.3.3.1.1) was used 
for DNA extraction (see section 2.4.1); the remaining 200-300µL was placed into two 
25cm
2 flasks (IWAKI, Crown Scientific, Australia) containing a confluent monolayer 
of Vero or DH82 cells. Diagnostic samples at the ARRL are routinely processed in this 
way except trays are used instead of flasks to minimise incubator space. When trays are 
used samples are placed into three wells of a 24 well tray each containing a confluent 
monolayer of the following cell culture types: Vero, DH82 and L929. Both trays and 
flasks were then centrifuged at 500g for one hour, with a slow rate of increase and 
decrease of revolutions. Serum was also cultured by this method if no EDTA blood was  
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available. However the use of RBC lysis buffer was not required and 200µL was placed 
onto confluent monolayers and spun as described. 
2.3.3.2  From tissue samples 
Samples such as heart valve biopsies were cut into small pieces using a sterile scalpel 
and  were  then  homogenised  (IKA,  Germany)  in  a  small  amount  (500-1000µL)  of 
sterile PBS in a flat-bottomed 5ml tube (Interpath Services, Australia). An aliquot of 
this (~200µL) was used for DNA extraction (section 2.4.1), the remainder was divided 
and placed into four confluent cell culture flasks two of Vero and two of DH82 cells 
and spun as described in section 2.3.3.1.2. To one flask of each cell type media with 
antibacterials,  (5mL  antibiotic-antimycotic  solution  containing  penicillin  G, 
streptomycin sulfate and amphotericin B [Sigma, USA] and 100l gentamicin [Sigma, 
USA]  per  500mL  of  media),  was  added  in  case  of  any  contamination  during  the 
collection  process.  It  was  presumed  that  this  would  not  kill the  C. burnetii  as  they 
would be intracellular. This was changed to media without antibacterials after 2-5 days. 
 
2.4 DNA methods 
Polymerase Chain Reaction (PCR) was used in this study to detect C. burnetii DNA. 
The assay works by amplifying a specific section of DNA (the target  sequence) to 
produce an amplicon. The real time PCRs described here have a fluorescent probe that 
allows  visualisation  of  the  rate  of  amplification  of  the  amplicon.  The  reactions  are 
highly specific and highly sensitive and require the sample’s DNA to be extracted prior 
to testing. Depending on the sample type, different methods of extraction were used but 
for  the  majority  of  sample  types  a  simple  extraction  procedure  was  applied.  These 
samples include serum and cell culture samples. Cell culture samples were collected as  
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described in section 2.2.2. Samples such as blood were prepared for extraction by first 
isolating  the  white  blood  cells  as  described  in  section  2.3.3.  Physical  disruption  of 
samples such as tissue was required prior to DNA extraction as described in section 
2.3.3.2.  For  the  PCR’s  described  a  Platinum  qPCR  SuperMix-UDG  Master  Mix 
(Invitrogen,  USA)  is  used.  This  master  mix  contains  uracil-N-glycosylase  (UDG), 
which with an activation step at the start of the PCR at 50°C for 3 minutes breaks up all 
contaminating amplicons by removing uracil residues from single or double stranded 
DNA. Uracil is put in by the PCR amplification process in place of thiamine residues. 
Hence  DNA  that  has  not  been  amplified  is  left  and  contaminating  amplicons  from 
previous PCR reactions are broken down. The following step of the PCR, a higher 
temporature to separate the double strands of DNA inactivated the UDG. 
 
2.4.1  DNA extraction 
2.4.1.1  Digestion 
DNA was extracted using the Qiagen Extraction Kit (Qiagen, Germany). An aliquot of 
20µL of Proteinase K was added to a 1.5ml tube (Interpath services, Australia). To this 
200µL of buffer AL was added followed by 200µL of sample. This was then incubated 
at  56°C  for  10  minutes  on  a  shaking  heating  block  (Eppendorf,  Germany)  set  to 
900rpm.  Some  sample  types  (including  tissue)  required  longer  digestion  and,  these 
were incubated for 48 hours or until the sample appeared homogeneous. Samples such 
as tissue were then further lysed by the addition of 200µL buffer ATL and incubated 
for  10  minutes  at  70°C.  All  samples  were  then  briefly  centrifuged  (Eppendorf, 
Germany) at 6000g to remove droplets from inside the lid.  
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2.4.1.2  Column extraction 
An aliquot of 200µL of ethanol was added to the digested sample, which was then 
briefly centrifuged (Eppendorf, Germany) at 6000g to remove droplets from inside the 
lid.  The  sample  was  then  placed  onto  a  column,  and  centrifuged  at  6000g  for  one 
minute.  The  filtrate  was  discarded  and  500µL  of  buffer  AW1  was  added  and  the 
column was again centrifuged at 6000g for one minute. The filtrate was discarded and 
500µL of buffer AW2 was added and the column was centrifuged at 20,000g for three 
minutes. The column was then placed in a clean 1.5ml microcentrifuge tube (Interpath 
Services, Australia) and 50µL of elution buffer (AE) was added to the column. This 
was then allowed to incubate at room temperature for one minute. The column was then 
centrifuged at 6,000g for one minute. The column was then discarded and the tube 
containing the purified DNA was stored for short periods (i.e. under 12hours) at 4°C or 
for long periods (over 12hours) at -20°C. 
2.4.2  Com1 PCR 
The following assay targets the Com1 gene, which codes for a highly conserved 27kDa 
outer membrane protein (OMP). PCR reactions targeting the Com1 gene have been 
shown to able to detect a single organism
131. This reaction was designed by Paul Storm 
(personal  communication) for the  Q fever  research  group in Adelaide. The primers 
(Invitrogen,  Australia)  and  probe  (Biosearch  Technologies  Inc.,  USA)  used  in  the 
Com1 assay are described in Table 1. The amplicon produced by this PCR is 76bp long. 
The contents of each PCR reaction are described in Table 2. Pre aliquotted amounts of 
DNA  extracted  from  clone  4  cultures  were  used  as  positive  controls.  These  were 
diluted to yield a Ct result in the range of 28-33; not too strong to increase the chance of 
contamination, and not too low to be disrupted by multiple freeze-thaw cycles. One 
negative control (Milli Q water) was used for every three samples. The PCR reaction  
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was run in a thermocycler (Rotor-Gene 3000, Corbett, Australia) as described in Table 
3.  The  results  were  analysed  using  the  software  of  the  Corbett  Rotor-gene  3000 
(version 6). By selecting analysis of the FAM channel the quantitative graph was then 
slope corrected and a threshold set at approximately halfway on the linear section of the 
positive  control  (generally  around  0.01).  The  setting  of  the  threshold  allowed  each 
positive  result  to  be  measured  by  a  Ct  (cycling  threshold),  which  allowed  an 
approximation of copy numbers in the reaction to be calculated (see section 3.4.1). 
 
Table 1 Com1 primers and probe sequences 
  Sequence 
Com1 Forward  AAA ACC TCC GCG TTG TCT TCA 
Com1 Probe  FAM - AGA ACT GCC CAT TTT TGG CGG CCA - BHQ1 
Com1 Reverse  GCT AAT GAT ACT TTG GCA GCG TAT TG 
 
 
Table 2 Com1 PCR mix 
  Stock  Final Concentration  Amount 
Master mix  2X  1X  12.5µL 
Forward  4µM  400nM  2.5µL 
Reverse  4µM  400nM  2.5µL 
Probe  2µM  200nM  2.5µL 
DNA      5µL 
Total volume      25µL 
 
 
Table 3 Com1 cycling parameters 
  Temperature  Time 
First hold  50°C  3 minutes 
Second hold (denaturation)  95°C  5 minutes 
Cycles:  Denaturation  95°C  20 seconds 
Annealing and Extension  60°C  40 seconds (acquire FAM) 
X 65 cycles     
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2.4.3  IS1111a PCR 
Other assays have targeted the IS1111a bacterial insertion sequence, which has also 
been shown to have a sensitivity of one organism
39. It could be assumed that this target 
would be more sensitive as it is present in multiple copies in the genome although not 
all strains have this insertion sequence
69. The amplicon produced by this PCR is 85bp 
long. This reaction was designed by Michael Banazis (personal communication and 
13). 
The IS1111a primers and probe are as described in Table 4. The contents of each PCR 
reaction are described in Table 5. Positive and negative controls were used as described 
for the Com1 assay (section 2.4.2). This assay was run in a thermocycler (Rotor-Gene 
3000,  Corbett,  Australia)  as  described  in  Table  6  if  run  on  its  own.  The  same 
temperatures were used for the Com1 PCR as for the IS1111a PCR, so they could be 
run together. When run side by side the cycling parameters used were as described for 
the Com1, as it required the slightly longer annealing time. The results were analysed 
using the software of the Corbett Rotor-gene 3000 (version 6). By selecting analysis of 
the FAM channel the slope was corrected on the quantitative graph and a threshold set 
at approximately halfway on the linear section of the positive control (generally around 
0.01). The setting of the threshold allowed each positive result to be measured by a Ct 
(cycling threshold), which allowed an approximation of copy numbers in the reaction to 
be calculated (see section 7.4.1). 
 
 
Table 4 IS1111a primers and probe sequences 
  Sequence 
IS1111a Forward  GTT TCA TCC GCG GTG TTA AT 
IS1111a Probe  FAM - CCC ACC GCT TCG CTC GCT AA - BHQ1 
IS1111a Reverse  TGC AAG AAT ACG GAC TCA CG 
When combined in a duplex the IS1111a probe tag FAM was replaced with Quasar 670 
(Cy5 replacement) and quenched with BHQ3 (Biosearch technologies, USA). 
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Table 5 IS1111a PCR mix 
   Stock  Final Concentration  Amount 
UDG Master mix  2X  1X  12.5µL 
Forward  10µM  1000nM  2.5µL 
Reverse  10µM  800nM  2µL 
Probe  1µM  50nM  1.25L 
MgCl  50mM  1.5mM  0.75µL 
dH2O        1µL 
DNA        5µL 
Total volume      25µL 
 
Table 6 IS1111a cycling parameters 
  Temperature  Time 
First hold  50°C  2 minutes 
Second hold (denaturation)  95°C  5 minutes 
Cycles:  Denaturation  95°C  10 seconds 
Annealing and Extension  60°C  20 seconds (acquire FAM or Cy5) 
X 65 cycles     
 
2.4.4  Duplex of Com1 and IS1111a 
Combining the two assays into a duplex qPCR was investigated in Chapter 7, which 
includes the methodologies used. 
 
2.4.5  DNA precipitation 
DNA extracted by other methods (described in section 2.4.1) required concentrating by 
the following method prior to its use in other applications. Pre-extracted DNA was 
purified by adding 0.04X the volume 5M NaCl and 2X the volume of 100% Ethanol. 
The solution was mixed gently (e.g. by pipetting) and the solution was kept at –20°C 
for a minimum of one hour then spun at max speed (20,000g for 1.5ml tubes) for one 
hour. The supernatant was then removed and the precipitated DNA allowed to air dry. 
The DNA was then resuspended in a suitable amount of EB (Qiagen, Germany – from  
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the  kit  described  in  the  extraction  section  2.4.1)  and  stored  as  stated  previously  in 
section 2.4.1. 
 
2.4.6  Cloning 
In  some  cases  DNA  required  cloning  to  produce  a  high  yield  of  targeted  DNA 
fragments. This method required the target DNA to first be amplified by PCR and 
purified. Cloning was generally carried out to obtain high yields of the target sequence 
for sequencing or for use as positive control. Amplicons were cloned into plasmids 
using the TOPO TA cloning kit (Invitrogen, Australia) with the Top10 Escherichia coli 
cells (Invitrogen, Australia) following the manufacturer’s instructions. 
 
2.4.7  Sequencing 
Amplified  samples  were  sequenced  to  determine  differences  in  gene  sequences. 
Generally, cloning of the fragment was carried out prior to sequencing (see previous 
section). Some PCR products did not need cloning prior to sequencing and a PCR clean 
up  kit  was  used  (Qiagen,  Germany).  The  amount  of  sample  used  depended  on  the 
amount  of  DNA,  which  was  determined  by  the  absorbance  at  260nm  (Nano  Drop, 
Thermo Scientific, Australia). Samples were mixed with the Big Dye terminator as 
described in the equation in Table 7, and run in a thermocycler under the programme 
described  in  Table  8.  Following  this  reaction  the  samples  were  sent  to  Australian 
Genome  Research  Facility,  Melbourne  Australia  and  the  determined  sequences 
analyzed  by  Megalign  (DNA  star)  and  Molecular  Evolutionary  Genetics  Analysis 
(MEGA) 4. 
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Table 7 Big dye terminator mix for Sequencing 
Amount (L) 
DNA  Up to 9 (should contain approximately 250ng of DNA) 
Primer  1 
Big Dye  2 
5x Buffer  3 
H2O  14 - amount added containing 250ng of DNA 
Total volume  20 
 
Table 8 Big dye terminator cycling parameters 
  Temperature  Time 
First hold (denaturation)  95°C  3 minutes 
Cycles:  Denaturation  94°C  40 seconds 
Annealing  55°C  40 seconds 
Extension  72°C  40 seconds 
X 65 cycles     
Final hold (extension)  72°C  15 minutes 
 
 
2.4.8  Animal Infection 
Animal inoculation was carried out in the PC3 laboratory at the Hunter Area Pathology 
Service (HAPS) in Newcastle. All animal work was approved (approval number ACEC 
003) by the Animal Care and Ethics Committee of the Australian Rickettsial Reference 
Laboratory  Foundation Ltd. under the oversight of the Animal Welfare Unit of the 
Department of Industry and Investment, NSW government. Mice were kept at 22°C 
with food Barastoc Rat and Mice Food (Ridley Agri Products, Australia) and water ad 
libitum. The mice and the food and water levels were checked daily. Infected mice 
were kept in “IsoCages” (Techniplast, Australia) with a thick layer of wood shavings 
(Rocky Point Mulching, Australia) for bedding. Mice infected with the same inoculum 
were kept in the same cage (up to a maximum of 4). Each cage had its own HEPA 
filter. The 12-cage unit was contained in a PC3 AQIS approved laboratory. The types 
of mice used included SCID mice and wild type mice. Only mice that were euthanased  
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(and not mice that died otherwise) were tested for C. burnetii infection (by removal of 
the spleen or other organs).  
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3.1 Abstract 
Coxiella burnetii is a zoonotic bacterium and can be shed by infected animals in milk 
and other physiological secretions. This bacterium can survive in the environment (for 
example in soil) but generally infects human hosts by inhalation of infected aerosols. 
This  study  was  conducted  to  determine  the  use  of  a  qPCR  for  the  detection  of 
C. burnetii in various specimens. A qPCR assay targeting the Com1 gene of C. burnetii 
was validated. The sensitivity of this qPCR was between one and 10 organisms per 
reaction. This assay was then used to analyse DNA extracted from a variety of sample 
types for the detection of C. burnetii. The sensitivity of the method described, enabled 
detection  of  approximately  1,100  copies/litre  in  water,  1900  copies/kg  in  soil,  870 
copies/litre in milk, and seven copies/litre of air. PCR inhibition was found in some soil 
samples. This was overcome with a 1:10 dilution. The method of detection in aerosols 
showed potential for use in areas of high risk, such as abattoirs or possibly for use in 
detecting potential bio-warfare actions. The low numbers detected in the air samples 
makes this assay appear highly sensitive. However only 6% of the bacteria aerosolised 
were actually detected and many bacteria were lost during the sampling process. This 
may have been due to the use of an impactor to collect air instead of an impinger. The 
present study used a nebuliser to create aerosols of C. burnetii, which may have been a 
poor simulation of naturally aerosolised bacteria. These findings may have application 
in future studies of C. burnetii detection in contaminated areas. 
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3.2 Introduction 
C.  burnetii  can  produce  small  cell  variants  (SCV),  which  can  survive  heat
86  and 
sonication
73. Due to this hardiness it can survive very well in environmental samples 
such as soil and water
12, 56, 124.  
 
Infected animals shed the bacteria in various physiological secretions including milk
53. 
Antibodies to C. burnetii are produced in humans following consumption of infected 
unpasteurised  milk
16.  Coxiella  burnetii  has  been  found  in  naturally  infected  milk 
samples through PCR detection of C. burnetii DNA
126 and detection of viable bacteria 
through animal inoculation
53. Testing of bulk tank milk has shown a correlation with 
seroprevalence in dairy sheep
41. Hence it could be useful to detect bacteria in milk as a 
way of monitoring shedding and infection within a herd without taking serum samples 
of individual animals. While naturally infected milk samples have been shown to be 
positive by PCR analysis
41,  126 the sensitivity of the method is unknown. Milk may 
contain substances that might inhibit the PCR reaction. In this study the sensitivity of 
detection of C. burnetii in milk by PCR was examined. 
 
While these sample types (water, soil and milk) may contain bacteria they may not be 
the  source  of  infection  for  people  or  other  animals  as  this  generally  occurs  via 
inhalation of infected aerosols
112. Indeed infection can occur from inhalation of a single 
organism
112.  Because  of  this,  there  have  been  several  studies  on  air  sampling  and 
analysis
27, 100, 112. Since C. burnetii is an intracellular bacterium cultivation is difficult 
from  samples  such  as  air  that  may  contain  other  bacteria.  Liquid  impingers  and 
subsequent animal inoculation have been used to detect C. burnetii in aerosols
27, 61. The 
use of PCR has allowed the detection of specific difficult to culture microorganisms in 
highly  contaminated  samples.  PCR  gives  a  faster  result  than  culture  or  animal  
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inoculation. Pascual et al.,(2001)
82 used the MAS-100 (Merck), which is an impactor 
sampling straight onto an agar plate, with liquid media which could then be tested by 
PCR. This method has been used to test for Legionella. A modified version of this 
method was used for detection of C. burnetii in this current study. 
 
The detection of C. burnetii in environmental samples (soil and water), animal samples 
(milk) and transmission samples (i.e. aerosols) were investigated by PCR in this study. 
Detection by methods other than PCR is difficult as these samples are likely to contain 
other bacteria that may interfere with cell culture sterility and animal inoculation. 
 
3.3 Methods 
The sensitivity of a qPCR targeting the Com1 gene (described in section 2.4.2) was 
determined. The amplicon produced by the assay was cloned (as described in section 
2.4.6) and the resulting E. coli were pelleted and purified using the Plasmid Maxi Kit 
(Qiagen, Germany) as per the manufactures specifications. The purified plasmids were 
diluted 1:100 and the DNA (and hence theoretical copy numbers) quantified using a 
Nanodrop ND-1000 spectrophotometer (Thermo Scientific, USA).  A series of 1:10 
serial dilutions of the purified plasmid was analysed by qPCR (in triplicate) to create a 
standard curve from which the sensitivity (in copy numbers) of each reaction could be 
determined. 
 
Each environmental sample required a tailored method to optimise extraction of any 
C. burnetii DNA present and to minimise any potential PCR inhibitors. Samples were 
prepared  as  described  below  before  DNA  extraction  (by  the  methods  described  in 
section 2.4.1) and analysis by PCR of the Com1 gene (method described in section  
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2.4.2).  The  C. burnetii  bacterial  numbers  and  DNA  concentration  (g/l)  could  be 
estimated from the Com1 qPCR Ct result.  
 
3.3.1  Titrations and spiking 
Ten fold serial dilutions of C. burnetii (Nine Mile clone 4) cultures (grown in Vero 
cells  as  described  in  section  2.3.2)  were  made  in  a  soil  (Osmocote  multi  purpose 
potting  mix,  Scotts,  Australia),  potable  water  (laboratory  tap  water,  Geelong, 
Australia), full cream pasteurised milk (homogenised and un-homogenised, Parmalat, 
Australia) and PBS (as a control). The C. burnetii was introduced into the substrates 
and dilutions made that ranged from undiluted (neat) to 10
-8. At least 50ml was made of 
each  dilution.  These  dilutions  were  then  processed  by  their  respective  method 
(described in the respective sections below) with the pellet re-suspended into 600l for 
DNA extraction in triplicate (3 separate extractions of 200l each). Samples that were 
PCR negative were spiked with extracted C. burnetii DNA after DNA extraction to test 
for the presence of inhibitors. 
 
3.3.2  Water 
Water (50ml) was sampled in duplicate and placed in two 50ml tubes. This was then 
centrifuged at 5,000g for 15 minutes. The supernatant was discarded and the pellet 
resuspended in 5mls of PBS in a 10ml tube. This was again centrifuged at 5,000g for 
15  minutes.  The  washing  of  the  pellet  was  repeated  twice.  The  final  pellet  was 
resuspended in 200l of PBS ready for DNA extraction as described in section 2.4.1. If 
the final pellet was particularly large the amount of PBS was adjusted to a maximum of 
2ml. 
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3.3.3  Soil 
Soil (25g or 12.5g) was sampled in duplicate and placed into two 50ml tubes to which 
PBS (approximately 35ml) was added to a final volume of 50ml each. Tubes were 
inverted or vortexed until well suspended. Tubes were centrifuged at 500g for five 
minutes.  The  supernatant  was  then  removed  and  placed  in  a  new  50ml  tube  and 
adjusted  to  50ml  with  PBS.  Tubes  were  then  spun  at  5,000g  for  15  minutes.  The 
supernatant was removed and the pellet was resuspended in 200µl of PBS. This was 
then used in the DNA extraction protocol described in section 2.4.1 with an additional 
incubation with proteinase K for a minimum of 10 minutes to a maximum of three 
hours in order to break open any SCV present and release DNA. 
 
3.3.4  Milk 
Milk (50mls) was placed in a 50ml tube and centrifuged at 5,000g for 15 minutes. The 
floating solids and the top 40ml of supernatant was removed and replaced with 40ml of 
PBS. This was repeated at least three times until all the solids at the top were removed. 
Finally  the  pellet  was  resuspended  in  600µl  of  PBS  and  aliquoted  into  3     1.5ml 
microcentrifuge tubes (Interpath services, Australia) for DNA extraction. This was then 
used in the DNA extraction protocol described in section 2.4.1 and, as with the soil 
samples, the digestion with proteinase K was increased from 10 minutes to three hours. 
 
3.3.5  Air 
Air was sampled using a protocol described by Pascual et al., (2001)
82. This method 
utilised  the  air  sampler  MAS-100  (Merck,  Australia)  shown  in  Figure  7.  The  air 
sampler was used inside a switched off fume cupboard (to reduce sample loss). PBS  
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(20ml) was placed inside a sterile pertri-dish placed in the top of the impactor (where 
an agar plate would normally sit). A 1:20 dilution of the Q Fever vaccine Qvax® (CSL) 
which  contains  a  killed  population  of  C. burnetii,  was  used  to  make  10  fold  serial 
dilutions,  which  were  then  aerosolised  with  a  nebuliser  spray  (Chemist’s  Own, 
Australia, decongestant nasal spray with the contents removed). The spray was held to 
the side of the air sampler and sprayed between five and 10 seconds after the start of air 
sampling. Air was sampled for one minute (100litre of air/minute). Prior to the use of 
C. burnetii  dilutions  the  air  was  collected  without  spraying,  followed  by  an  air 
sampling with dH2O in the nebuliser. The nebuliser was sprayed at different heights to 
determine  the  optimal  height  for  collection  of  the  aerosol.  A  final  air  control  was 
sampled  following  the  C. burnetii  dilutions.  The  PBS  from  each  air  sample  was 
collected into a 50ml tube and centrifuged at 5,000g for 15 minutes. The top 19mls was 
discarded and the remaining 1ml mixed gently by pippetting. This was then placed in a 
1.5ml tube and centrifuged at 10,000g for 15 minutes. The supernatant was removed 
(800µl) and the pellet resuspended in the remaining 200µl, which was used for DNA 
extraction (section 2.4.1) and PCR analysis (section 2.4.2). 
 
To determine if all the bacteria in the spray were collected by the air sampler, the latter 
was swabbed both before and after testing on the air entry (top surface), the air exit (see 
Figure 7) while air was being sampled and on the surface of the buttons (which was 
opposite to the air exit). 
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A     B 
   
Figure 7 MAS-100 impactor air sampler 
The figure shows the Merck MAS-100 impactor used in the air sampling experiments. 
Part A shows the two sections of the air sampler. The top could be removed and an agar 
plate or Petri dish placed therein. Air enters through the top and flows through the 
bottom onto the face of the screen and control buttons. The flow of air through the 
sampler is shown in part B. 
 
 
3.4 Results 
3.4.1  Com1 standard curve 
The  concentration  in  the  DNA  extracted  from  the  purified  plasmids  containing  the 
Com1 gene was determined. This was then converted into theoretical copy numbers as 
described below. A ten-fold serial dilution of the purified plasmid was analysed by 
Com1 qPCR (in triplicate) to create a standard curve (Figure 8) and the sensitivity of 
the reaction determined. The equation produced by the standard curve allowed for the 
estimation of copy numbers from the Ct value as detected by the qPCR. Based on the  
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assumption that one copy of the target gene would have the same Ct value wether it was 
in a plasmid or a genomic copy in the DNA from the bacteria itself, this method of 
converting Ct to copy numbers could be used for both. The formula determined by the 
standard curve was: 
x = e
(y-35.436/1.4131) 
where x is the copy numbers as calculated by Nanodrop ND-1000 spectrophotometer 
(Thermo Scientific, USA) for the fist dilution, and y is the Ct; the copy numbers of the 
C. burnetii  detected  can  be  calculated.  The  copy  numbers  detected  in  all  positive 
reactions  could  then  be  converted  to  DNA  (g/l).  This  was  carried  out  by  first 
calculating the moles (n) of genomes (copy numbers   Avogadro’s constant 6.022   
10
23) then using the formula: g/ml = n/1 10
12 ÷ 1 10
6/1   1/660   1/bp where bp is 
the number of base pairs in the genome (of the five genomes published the average is 
2032674bp). The standard curve shows that this assay has a sensitivity of 1-10 copy 
numbers per reaction. 
y = -1.4131Ln(x) + 35.436
R
2 = 0.998
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Figure 8 Com1 PCR standard curve 
The figure shows the average of the ten-fold dilutions of the purified plasmid clones of 
the  Com1  amplicon.  The  formula  for  the  line  of  best  fit  was  used  to  convert  all 
subsequent Com1 qPCR results to copy numbers or concentration of DNA detected. 
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3.4.2  Detection of C. burnetii in environmental samples 
3.4.2.1  Water samples 
Titrations of C. burnetii were made in potable water to determine the sensitivity of the 
method. This was done in triplicate and the results in Figure 9 show the results of a 
typical ten fold dilution titration. A negative control sample was spiked post extraction 
to determine if any inhibition of the PCR reaction had occurred. No inhibition was 
observed as shown in Table 9. 
 
Twelve field samples were collected (in duplicate) from pond water downstream from 
an  abattoir.  Three  of  the  24  water  samples  were  positive  although  their  respective 
duplicate  samples  were  negative.  Seven  negative  water  samples  were  spiked  with 
extracted C. burnetii DNA and compared to a spiked NTC sample to determine if any 
PCR inhibition had occurred. The average percentage deviation in Ct from the spiked 
NTC was 1.69%, which was within the standard deviation between the spiked samples. 
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Figure 9 DNA (g/l) and C. burnetii bacterial numbers (detected by Com1 PCR) 
in ten fold dilutions of C. burnetii (clone 4) in potable water 
The figure shows the concentration of DNA detected (g/l) and the line of best fit. 
The fifth ten fold dilution was negative. This was consistent with the detection limit of 
the  PCR,  which  was  one  copy  number/reaction.  The  error  bars  show  one  standard 
deviation. 
 
 
Table  9  Com1  Ct  deviation  between  spiked  controls  and  spiked  samples  (post 
extraction)  
Sample spiked 
Average Ct deviation from 
spiked control 
Negative water  -0.7% 
Field water  1.7% 
Negative soil  *-18.12% 
Field soil  -1.8% 
Negative PBS  1.4% 
Negative milk  0.9% 
The percentage inhibition was calculated as the shift in Ct as a percentage of the spiked 
NTC Ct result. * Calculated as ten times the deviation observed in the 1:10 diluted 
samples,  as  those  that  were  not  diluted  were  negative.  This  value  is  close  to  the 
deviation observed in the spiked soil samples diluted 1:10 compared to the spiked water 
in Figure 10 (20%). 
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3.4.2.2  Soil Samples 
Titrations of C. burnetii were made in soil to determine if any inhibition of the PCR 
reaction could have been caused by the soil. This was performed in triplicate and all 
samples were Com1 PCR negative. The samples were diluted 1:10 and re-analysed by 
Com1 PCR and positive results were obtained (Figure 10). For comparative purposes 
the water results from Figure 9 have been superimposed on this figure. A reduction in 
the amount of DNA detected in the soil samples compared to the water can be seen. 
This illustrates the inhibitory effect due to the soil. However all dilutions that were 
positive in the water were also positive in the diluted soil samples. 
 
 
Figure 10 DNA (g/l) and C. burnetii bacterial numbers detected by Com1 PCR 
in ten fold dilutions of C. burnetii (clone 4) in soil (further diluted 1:10 post DNA 
extraction), compared to water 
The figure shows the DNA detected in ten fold dilutions of C. burnetii made in soil 
further diluted 1:10 post DNA extraction. The same dilutions made in water (data from 
Figure 9) are shown to demonstrate the estimation of DNA in the soil samples had they 
not been diluted post DNA extraction. 
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Field soil samples were collected from a building site opposite a livestock sale yard. All 
five soil samples (taken in triplicate) were negative by the Com1 assay in both the neat 
samples and when diluted 1:10. Samples were spiked post DNA extraction to determine 
if any PCR inhibition had occurred (shown in Table 9). The average percent deviation 
in Ct was –1.8%, indicating that these were true negative results (and not due to any 
PCR inhibitors present) and that these soil samples did not contain C. burnetii DNA. 
 
3.4.3  Detection of C. burnetii in milk 
The sensitivity of detection of C. burnetii in milk was determined by analysis of DNA 
extracted from dilutions of C. burnetii in milk. Dilutions in PBS were used as controls. 
Any possible inhibition of the reaction by milk was determined. This was performed in 
triplicate and was repeated with unhomogenised milk to determine if homogenisation 
had any  effect on the amount of DNA detected by PCR. The results are shown in 
Figure 11. More DNA was detected in the milk samples for both the homogenised and 
the un-homogenised samples than in the PBS. This was not true for the 10
-7 dilution in 
the  homogenised  milk  where  the  spiked  milk  was  negative  and  the  PBS  matched 
control was positive. Samples were spiked post DNA extraction to determine if any 
PCR inhibition had occurred (shown in Table 9). The deviation in Ct from the spiked 
control of 0.9% indicated that there was no PCR inhibition. 
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A) 
 
B) 
 
Figure 11 DNA (g/l) and C. burnetii bacterial numbers (detected by Com1 PCR) 
in ten fold dilutions of C. burnetii (clone 4) in PBS and milk homogenised (A) or 
unhomogenised (B) 
The concentration of DNA (g/l) demonstrated was the mean of triplicate samples of 
A) spiked homogenised milk and PBS (as a control) and B) spiked unhomogenised 
milk and PBS. The error bars show one standard deviation. Spiking of milk and PBS 
for graphs A and B were done separately and with different C. burnetii cultures. 
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3.4.4  Detection of C. burnetii in aerosols 
The  nebuliser  containing  a  1 10
-2  dilution  of  the  vaccine  (Qvax®)  was  sprayed  at 
vertical distances of 0cm, 15cm, 30cm and 45 cm above the sampler’s air entry point in 
triplicate. The horizontal distance from the machine was approximately 1cm for all 
sampling. This experiment was performed in triplicate. The results are shown in Table 
10. Maximal DNA was detected when the nebuliser was sprayed next to the air inlet; 
hence this is where all subsequent samples were sprayed. 
 
Table 10 DNA (g/l) detected in air samples with aerosolised Q Fever vaccine 
sprayed from different heights from the air sampler 
Vertical distance 
from sampler’s air 
entry point 
Average DNA (g/l) 
detected 
(positive/total) 
Average copy 
numbers detected 
0cm  2.7 10
-6 (3/3)  1.2 
15cm  1.8 10
-6 (2/3)  0.8 
30cm  1.9 10
-6 (3/3)  0.9 
45cm  3.2 10
-7 (2/3)  0.01 
60cm  Negative (0/3)  Negative 
 
 
The volume of liquid aerosolised by the nebuliser in one spray was determined by 
weighing the nebuliser before and after 10 sprays.  This was performed in triplicate and 
it was determined that on average 92l of liquid was dispersed during one spray from 
the nebuliser. 
 
Dilutions of the vaccine (Qvax®) were aerosolised by the nebuliser and sampled with 
the MAS-100 containing 20ml of PBS and analysed by Com1 PCR (section 2.4.2) for 
the detection of C. burnetii. This was performed in triplicate and the results are shown 
in Figure 12. To determine if there was sample loss during the procedure three sets of 
controls  were  employed.  Firstly  the  nebuliser  was  sprayed  into  a  10ml  tube  (to  
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determine the actual amount of C. burnetii aerosolised by each spray); secondly 92µl of 
the suspension was aliquoted into a 1.5ml tube (to determine if bacteria in the dilution 
were being adequately aerosolised by the nebuliser); thirdly 92µl of the suspension was 
placed into 20ml of PBS and processed as described for the air samples (to determine if 
the centrifugation of the liquid collected all the bacteria in the PBS). 
 
The aliquot of the vaccine placed in 20ml of PBS (control dilution in PBS) had a slight 
reduction  in  DNA  detected  compared  to  the  aliquot  of  the  vaccine  alone  (control 
dilution)  for  the  first  three  dilutions.  The  amount  aerosolised  by  the  nebuliser  and 
collected  into  a  tube  (control  spray)  was  less  than  both  of  the  other  controls.  The 
amount of DNA detected in the aerosolised samples was lower than all of the controls 
at all dilutions and no DNA was detected in dilution 5. The amount of DNA detected in 
these air samples was between 0.1 and 17.5% of that detected in the control spray as 
shown in Table 11. 
 
Several  surfaces  of  the  air  sampler  were  swabbed  before  and  after  sampling  of 
aerosolised C. burnetii (Table 12). Each surface had detectable DNA after use, which 
was stated as a percentage of the amount aerosolised. 
 
Table 13 shows a summary and calculations of the limit of detection for each sample 
type and the amount detected in each sample type as a percentage of the amount in the 
relevant control. 
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Figure 12 DNA (g/l) and C. burnetii bacterial numbers detected by Com1 PCR 
of dilutions of the vaccine Q Vax in aerosol 
The figure shows the average DNA (g/l) detected by PCR in experimental aerosols 
and  three  separate  controls  all  sampled  in  triplicate.  The  controls  include  DNA 
extracted  from  92µl  of  the  diluted  vaccine  (control  dilution),  92µl  of  the  dilutions 
placed  in  20ml  of  PBS  (control  dilution  in  PBS)  and  dilutions  aerosolised  by  the 
nebuliser and  collected  into a tube (control spray). The  experimental aerosols were 
dilutions of the vaccine aerosolised by the nebuliser and collected by the air sampler. 
 
 
 
 
Table 11 Percentage of C. burnetii aerosolised collected by the air sampler 
Dilution of Q-Vax®  Percentage of aerosolised 
C. burnetii collected by the air 
sampler 
10
-1  0.1% 
10
-2  1.4% 
10
-3  5.7% 
10
-4  17.5% 
The table shows the amount of C. burnetii DNA (g/l) detected by the air sampler as a 
percentage of that detected by the control spray, where the aerosolised bacteria were 
collected into a tube. 
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Table 12 C. burnetii detected on the air sampler itself that failed to be captured by 
the liquid medium 
DNA (g/l) per 
reaction 
Copies detected per 
reaction 
Air 
sampler 
area 
swabbed 
Before 
running 
After 
running 
Before 
running 
After 
running 
% of 
aerosolised 
DNA 
Top  5.8 10
-5  5.1 10
-4  26  228.9  3.8% 
Air outline  Negative  *6.7 10
-
6 
Negative  *3.0 
*0.1% 
Buttons  2.4 10
-5  1.6 10
-4  10.8  71.8  1.2% 
* Signifies samples taken during air sampling. 
The percentage of the aerosolised DNA was calculated as the amount (µg/µl) detected 
after sampling (or during sampling in the case of the air outline) as a percentage of the 
amount detected in the control spray i.e. the amount aerosolised by the nebuliser and 
collected in a tube. 
 
 
Table 13 Detection dose and percentage of control DNA detected in each sample 
type 
Sample 
type 
Detection 
dose (DD50) 
Detection 
dose as copies 
per litre or Kg 
DNA (g/l) detected as a 
percentage of DNA detected in 
PBS control 
Standard 
deviation 
Water  3.9   10
-6  1066  69%  +/- 20% 
Soil*  1.7   10
-6  18642  4%  +/- 2% 
Milk~  4.7   10
-6  866  >100%~   
Air  1.6   10
-6  7  6%  +/- 8% 
The Detection dose 50 was calculated using the Spearman Kärber method described in 
Appendix A. This was then converted to the relevant number of copies in one litre (or 
in the case of soil 1kg) required to be positive in 50% of samples. 
* Soil samples had inhibitors and thus were diluted 1:10 to overcome the inhibitory 
effect. This was taken into account during the calculations for the number of copies per 
1kg. 
~More DNA was detected in milk samples than in the PBS control (see discussion). 
 
 
3.5 Discussion 
Detection of C. burnetii in environmental samples can be difficult as these samples are 
likely to contain other contaminating bacteria. One method that is highly sensitive and 
specific is PCR. The sensitivity of a qPCR assay targeting the Com1 region of the  
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C. burnetii genome was determined to be between one and 10 organisms per reaction. 
This assay requires DNA to first be extracted and purified from samples, hence the 
sensitivity of detection by Com1 qPCR from a variety of sample types was analysed. 
 
Coxiella burnetii can produce “spore like” forms or SCV that are capable of surviving 
harsh environments.  These forms can survive in soil and water
12, 56, 124. The sensitivity 
of  detection  of  C. burnetii  by  PCR  was  determined  for  these  sample  types.  The 
sensitivity of the PCR reactions was found to be 1-10 copies per reaction for both 
targets (Com1 and IS1111a). The Com1 PCR was used to calculate the sensitivity of the 
detection of C. burnetii in a variety of environmental samples. 
 
As field water samples were likely to be highly variable a titration was made in potable 
water in an effort to standardize the sample type. In potable water the Detection Dose 
50 (DD50) was 3.9   10
-6 g DNA per reaction, which was very close to the assay’s 
limit of detection of approximately 1   10
-6 g. This equated to approximately 1,100 
genome copies per litre. A negative water control was spiked post DNA extraction and 
this  showed  only  a  slight  change  in  Ct.  However,  as  it  was  within  one  standard 
deviation of the sample Ct mean there was deemed to be no inhibition of the PCR. 
 
With  the  sensitivity  limit  of  the  assay  determined,  the  assays  effectiveness  was 
determined on a small number of water samples that were collected from the field. Of 
the field water samples three gave a positive PCR result but their duplicate samples 
were negative. Hence these samples were considered to have a low positivity. Spiked 
field water samples indicated a lack of inhibition demonstrating the effectiveness of the 
assay. This method may be further improved with the use of magnetic beads to capture  
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the bacteria
64, with the use of large pore filters to eliminate the larger solids in some 
water samples, or by concentration of DNA by precipitation
126. 
 
To determine the sensitivity of C. burnetii detection in soil, titrations were made in 
commercial  potting  mix.  Field  soil  samples  were  found  to  be  quite  variable  hence 
potting mix was used as a standardised soil type. The titration of C. burnetii in soil 
showed complete inhibition of the PCR at all dilutions, including those spiked post 
DNA  extraction.  This  inhibition  was  overcome  when  the  extracted  samples  were 
diluted 1:10.  The Detection Dose 50 (DD50) in the diluted samples was 1.7   10
-6 g 
DNA per reaction. This equated to 1.7   10
-5 g had there been no inhibition. Indeed all 
dilutions made in water that were positive were also positive in the 1:10 diluted soil 
samples.  When  the  1:10  dilution  was  taken  into  account  this  equated  to  detecting 
approximately 19,000 copies/kg in soil. Comparing soil samples to water, less than a 
tenth of the DNA detected in water was detected in soil. In the soil samples diluted 1:10 
no inhibition was found when spiking negative samples post-extraction. This suggested 
that the reduction of detected DNA was due to sample loss during the DNA extraction 
process. This may have occurred during the low speed centrifugation step to pellet the 
larger pieces of soil. Some of the bacteria may have been drawn into the pellet with the 
larger  solids  in  the  soil.  However  this  was  not  investigated  further  as  larger  solids 
would  have  clogged  the  DNA  extraction  column.  This  assay  may  be  improved,  as 
suggested for the water samples, with large pore filters to eliminate the larger solids or 
the use of magnetic beads
64. 
 
With  the  sensitivity  limit  of  the  assay  determined,  the  assay’s  effectiveness  was 
determined on a small number of soil samples collected from the field. All 15 field soil 
samples were negative. Due to the inhibition observed in the titrations of C. burnetii  
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made  in  standard  soil,  samples  were  tested  by  both  spiking  and  diluting  1:10.  No 
inhibition was observed when extracted samples were spiked with positive C. burnetii 
DNA. Indeed none of the field samples was positive even when diluted. Other studies 
showed that 37.5-90% of extracted soil samples had PCR inhibitors when the DNA was 
extracted by a Qiagen stool/blood kit, and Mobio stool kit. This inhibition was reduced 
when both kits were used
38. Hence PCR inhibitors are common in soil samples and this 
could be overcome by the use of a second extraction protocol
38 or a 1:10 dilution of the 
extracted DNA as demonstrated in the present study. Some soil samples did not have 
any detectable inhibitors. Those field soil samples were denser than the soil used in the 
standard  titration  and  thus  approximately  twice  as  much  soil  was  used  in  each 
extraction. 
 
Previous  studies  have  shown  that  milk  samples  from  infected  animals  can  contain 
C. burnetii. Detection of the bacteria in milk has been shown to be a good method of 
determining if a herd is infected and shedding the bacteria
41, 53, 126. In the current study 
a method of DNA extraction was used to determine both the sensitivity and inhibition 
of PCR detection of C. burnetii in milk samples. Commercial pasteurised milk was 
used as it was readily available and it was assumed that the process of pasteurisation 
would have had no affect on the detection of C. burnetii DNA. The initial study was 
performed on homogenised milk and the results showed an enhanced ability to detect 
C. burnetii in samples of PBS spiked with the same numbers of bacteria. Detection of 
C. burnetii in PBS one dilution more than milk (i.e. the 10
-7 dilution in Figure 11 A) 
was unlikely to be due to inhibition of low numbers of C. burnetii as the amount of 
DNA detected in the 10
-6 and 10
-7 dilutions were very close to the limit of detection of 
the qPCR. At the limits of detection some samples will be positive and some will be 
negative. More DNA was detected in milk in the more concentrated dilutions indicating  
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that the milk was not inhibitory. Milk was either improving the PCR efficiency or 
increasing  the  number  of  bacteria  from  which  DNA  was  extracted.  The  latter  was 
possibly the more likely explanation as the milk may have acted as a carrier for the 
bacteria  and  hence  increased  the  number  of  C. burnetii  precipitated  into  the  pellet 
during centrifugation. This result supported the removal of the floating solids during 
the extraction process, as it is unlikely that these solids contained any bacteria. 
 
This experiment was repeated with un-homogenised milk to determine if this had an 
effect on the carrier ability of the milk. Results with the un-homogenised milk were 
similar  to  those  of  the  homogenised  milk.  The  Detection  Dose  50  (DD50)  was 
approximately  4.7     10
-6  g  of  DNA  per  reaction  for  both  homogenised  and  un-
homogenised milk. This equated to approximately 870 copies per litre (0.9 copies/ml). 
This was similar to previous studies demonstrating the sensitivity of detection at one 
organism/ml milk
17. 
 
This method may also be used on milk samples from other animals that are known to 
carry C. burnetii; e.g. goats
18, 93 and ewes
88 or even possibly for lactating mothers as it 
has been shown that expressed human milk can contain C. burnetii
85. It may be useful 
to  test  bulk  milk  as  a  way  of  monitoring  infection  within  a  herd.  Contaminated 
unpasteurised milk may be a source of infection. While ingestion of unpasteurised milk 
from an infected herd has been shown to induce antibody production to C. burnetii,
16 
infection in humans generally occurs from inhalation of infected aerosols
112. 
 
Historically, C. burnetii has been detected in aerosols by the use of liquid impingers 
followed  by  animal  inoculation  of  either  guinea  pigs  or  hamsters
61.  However  the 
sensitivity  of  this  method  is  unknown  and  since  it  requires  animal  inoculation  this  
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method  is  time  consuming,  requires  PC3  animal  containment  facilities  and  can  be 
complicated  by  the  presence  of  other  bacteria.  PCR  has  allowed  for  the  rapid  and 
specific detection of microorganisms in contaminating samples such as aerosols. In a 
previous study by Pascual et al., (2001)
82 an impactor was used with a liquid media 
(such as PBS). This allowed for the detection of bacteria (such as C. burnetii) that are 
difficult to culture and do not grow on agar plates as they are not detected by growth, 
but  by  specific  PCR  detection.  Furthermore  a  liquid  sample  can  be  centrifuged  to 
concentrate the bacteria into a smaller volume. The amount of E. coli detected by air 
sampling onto agar was compared to air sampling through PBS, which was then filtered 
(0.45m)  and  placed  onto  agar
82.  While  both  methods  were  reported  to  be  equally 
sensitive (approximately one CFU/200L air), they did not compare this to the number 
of bacteria aerosolised. Hence it is unknown if any bacteria avoided collection by either 
not entering the air sampler or by bouncing off the surface of the agar or PBS. 
 
In this study aerosolised Q fever vaccine was used to determine the sensitivity of the air 
sampling  technique  used.  The  optimal  height  from  which  to  spray  the  aerosolised 
bacteria was determined by spraying from different heights. At heights at 60cm all 
samples  were  negative,  and  less  bacteria  were  detected  in  those  sprayed  at  45cm 
compared to those sprayed at shorter distances. This may have been due to C. burnetii 
in the spray sticking to the roof of the fume hood (80cm above the air sampler) as 
droplets were observed to form on it. The maximun amount of bacteria were detected 
when the nebuliser was sprayed next to the air inlet of the air sampler (0 cm); hence 
this was where all subsequent spraying and sampling was performed. 
 
In this study the yield of aerosolised bacteria collected in the PBS by the air sampler 
was compared to three controls. The first control tested for the total C. burnetii DNA in  
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the vaccine dilution used. The second control tested for sample loss caused by the 
addition of 20ml of PBS (dilution of the vaccine in 20ml PBS). The third tested the 
efficiency of aerosolisation (vaccine dilution sprayed into a tube). The Detection Dose 
50 (DD50) was approximately 1.6   10
-6 g of DNA per reaction. This equated to seven 
genomic copies per litre of air. However the amount of bacteria detected in the more 
concentrated aerosols did not show the proportional increase in copy numbers expected 
in the ten-fold series dilution. This is seen in the slopes of the trend lines in Figure 12. 
There was considerable sample loss compared to the controls. The vaccine dilution 
placed in PBS showed some reduction of copy numbers detected in comparison to the 
undiluted  vaccine,  at  most  dilutions.  This  reduction  was  minimal  and  not  a  1:20 
dilution and was possibly due to the C. burnetii not being adequately pelleted during 
centrifugation. The control spray collected into the tube had less copy numbers detected 
than the un-aerosolised controls, possibly due to some of the spray escaping from the 
tube. The yields collected by the air sampler were the lowest of all. This indicated that 
only  a  small  proportion  of  the  C. burnetii  aerosolised  by  the  nebuliser  was  being 
collected in the PBS inside the air sampler. Significant sample loss was evident as the 
bacteria detected by the air sampler was on average only 6% of the bacteria detected in 
the spray collected into a tube. 
 
A considerable number of bacteria escaped collection by either not entering the air-
sampling machine or by bouncing off the PBS and being expelled via the exit of the air 
sampler. Swabbing the top of the air sampler showed that not all aerosolised bacteria 
were  even  entering  the  air  sampler.  This  may  have  been  due  to  the  droplet  size 
generated by the nebuliser. The majority of the spray was observed to be a fine mist 
with some larger visible droplets some of which may not have been sucked into the air 
sampler as they were possibly too large to be affected by the vacuum. This may not  
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have been a problem outside these particular experimental conditions, as these droplets 
do not mimic naturally aerosolised bacteria. Not all of those aerosolised bacteria that 
did  enter  the  air  sampler  were  collected  in  the  PBS.  This  was  shown  by  the 
demonstration of bacteria on swabs taken from where air exits the machine and on the 
buttons just opposite, following sampling of aerosolised bacteria. It was unlikely that 
any bacteria on these surfaces would be re-aerosolised and collected by the air sampler 
on subsequent collections as shown by a final negative control taken after all dilutions 
had been sprayed. The low numbers of aerosolised bacteria collected in the PBS may 
have been due to the air sampling method. This was not a true impinger because the air 
was not being drawn through the liquid. Bacterial cells may have “bounced off” the 
surface of the PBS rather than being drawn into the liquid. 
 
While this method has shown promise, further development is required to increase the 
sensitivity and decrease the amount of sample lost before it can be taken to the field 
and used in areas such as abattoirs to determine risk of infection by aerosol. To increase 
sensitivity, the sampling time could be increased or a different method of collection 
could be used such as a true impinger or a vacuum
56 or filters to capture C. burnetii. In 
a previous study air was sampled for 4.5 hours (675 litres) through a glass filter
100. 
 
DNA  extraction  and  PCR  allowed  for  simple,  quick  and  specific  detection  of 
C. burnetii in testing of samples likely to be highly contaminated with other bacteria. 
The limits of sensitivity demonstrated here should be taken into account in possible 
future studies on the prevalence of C. burnetii in these sample types. Due to the ability 
of  the  SCV  of  C. burnetii  to  survive  harsh  conditions
73,  86  it  is  possible  that  this 
bacterium  is  present  in  a  range  of  samples  such  as  soil  and  water  in  a  variety  of 
locations. This was demonstrated in a recent study in the USA where C. burnetii DNA  
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was detected in 23.8% of over 1,600 sponge wipes, vacuum and bulk soil samples from 
six  states
56.  Positive  areas  included  the  expected  rural  locations  such  as  farms  and 
dairies where animals that can carry C. burnetii were common, but also included urban 
areas  such  as  grocery  stores,  post  offices,  banks  and  hospitals.  This  suggested  that 
human exposures and infections were more prevalent than expected and reported. In 
Australia, people at high risk of infection are often vaccinated. This includes abattoir 
workers, veterinarians and dairy  farmers. However if a similar percentage of urban 
areas were positive as those found in the American study, human Q fever infection 
might be more common than currently diagnosed and reported. Indeed, due to the non-
specific  symptoms  of  Q  fever  and  the  misconception  that  close  animal  contact  is 
required, there is a high possibility that many Q fever cases go undiagnosed. 
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Chapter 4.  Extraction of C. burnetii DNA from human 
diagnostic samples and its detection by qPCR 
 
4.1 Abstract 
Polymerase chain reaction (PCR) has been used in the diagnosis of early Q fever. This 
method involves the detection of C. burnetii DNA, which must be first purified from 
samples that may contain substances that inhibit PCR. The method of DNA extraction 
from  clinical  samples  was  examined.  A  silica  column  extraction  and  purification 
method adequately removed potential PCR inhibitors from blood, plasma, serum and 
bone marrow specimens. Furthermore the silica column method was the most effective 
in  purifying  DNA  from  the  small  cell  variant  (SCV)  of  C. burnetii.  This  study 
demonstrated the value of the silica column method of DNA extraction and detection 
by specific qPCR from a variety of diagnostic samples in routine diagnosis of early 
acute Q fever and chronic Q fever. 
 
4.2 Introduction 
Q fever can manifest as acute Q fever, a self-limiting flu-like illness lasting 2-3 weeks, 
chronic Q fever that can last many years and often results in endocarditis, or post Q 
fever  fatigue  syndrome  (QFS)  resulting  in  ongoing  fatigue  lasting  many  years
44,  69. 
Diagnosis of Q fever is generally made serologically by an immunofluorescence assay 
(IFA), which is considered to be the gold standard. For acute Q fever a subsequent 
convalescent sample is required to show at least a four-fold increase in antibodies over 
a 1-2 week period. Other diagnostic methods can be used including enzyme linked  
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immunoassay  (ELISA),  complement  fixation,  polymerase  chain  reaction  (PCR)  and 
isolation of the infectious agent. Isolation is not commonly used in diagnosis but can be 
achieved  by  chicken  embryo,  cell  culture  or  animal  inoculation.  Polymerase  chain 
reaction (PCR) is a quick method that allows for diagnosis in the very early or chronic 
phases of the disease. This method involves the extraction of DNA from samples such 
as serum, blood or biopsies followed by the detection and amplification of unique gene 
target sequences of C. burnetii. 
 
Some sample types contain substances that inhibit or slow down the PCR, either by 
binding  to  DNA  or  by  inhibiting  the  reaction  enzyme  Taq  polymerase.  If  these 
inhibitors were co-purified with the DNA prior to analysis this would contribute to an 
increase in false negative test results and/or reduce the minimum number of copies 
detected in a quantitative PCR assay. The amounts and types of PCR inhibitors vary 
greatly with sample type, so extraction methods need to be optimised accordingly. 
 
Serum  samples  have  been  used  for  the  molecular  detection  of  C. burnetii
39.  Serum 
contains  fewer  inhibitors  than  other  samples  such  as  blood.  However,  it  is  not 
completely free of PCR inhibitors. Immunoglobulin G (IgG) has been identified as a 
major PCR inhibitor in serum and plasma
2. Most IgG should be removed during the 
DNA extraction procedure. Serum samples are only occasionally tested, as serum is a 
less preferable specimen than peripheral blood mononuclear cells as it is assumed that 
most of the C. burnetii would be intracellular within the buffy coat fraction. 
 
Blood samples contain PCR inhibitors such as haemoglobin which is a major PCR 
inhibitor
1. Leukocytes contain lactoferrin which is also a PCR inhibitor
3. Other PCR  
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inhibitors  present  in  diagnostic  blood  specimens  include  anticoagulants  such  as 
EDTA
122 or heparin
129. 
 
Previous studies have shown that, in chronic Q fever, C. burnetii DNA is present in 
bone marrow samples
83 and can persist in the bone marrow from five to 12 years after 
primary  infection
44,  69.  For  this  reason  it  is  thought  that  bone  marrow  may  be  an 
anatomical site involved in persistence of latent infections of Q fever. Coxiella burnetii 
cells in this tissue may not be actively replicating, but remain dormant, shedding low 
numbers of organisms into peripheral blood and organs
69. With significant numbers of 
white blood cell precursors, bone marrow may be expected to have similar or greater 
PCR inhibitors to blood. Containing more cells, this sample type would also have an 
excess of host (eukaryotic) DNA, which in high concentrations is itself inhibitory in a 
PCR.  Inhibition  of  C.  burnetii  detection  by  PCR  in  this  sample  type  has  been 
demonstrated in DNA extracted by phenol-chloroform
44. 
 
In addition to PCR inhibitors, C. burnetii DNA may be inadequately extracted from the 
small  cell  variant  (SCV)  due  to  its  chemical  nature.  It  is  the  resistant  form  of 
C. burnetii  and  it  may  be  the  principal  form  present  during  persistent  infection
69. 
Furthermore, it is thought that the SCV may be more resistant to lysis during the DNA 
extraction process leading to false negative test results
69. Samples containing this cell 
type may require more vigorous lysis to ensure the complete extraction of C. burnetii 
DNA. 
 
In  this  study  three  different  methods  of  DNA  extraction  were  compared  for  the 
detection of C. burnetii by Com1 qPCR in a variety of clinical samples and for the 
detection of C. burnetii DNA from the SCV form.   
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4.3 Methods 
4.3.1  DNA extraction from blood (method 1) 
DNA was extracted from 200µl samples of buffy coat, plasma or serum. Buffy coat 
samples were first purified from whole blood samples, before DNA extraction, with red 
blood cell lysis (RBCL) buffer (Gentra Systems, USA) as described in section 2.3.3.1.1 
and resuspended in 600µl of sterile PBS (Oxoid, England). DNA was extracted using 
the  QIAamp  DNA  Mini  Kit  (Qiagen,  Germany)  according  to  the  manufacture’s 
specifications and as described in section 2.4.1. The amount of elution buffer (AE) 
(Qiagen,  Germany)  added  to  the  column  was  adjusted  to  50µl  in  an  effort  to 
concentrate the DNA. This method was defined as method 1. 
 
4.3.2  DNA extraction from bone marrow 
4.3.2.1  Method 1a 
DNA was extracted from 200µl of bone marrow using the QIAamp DNA Mini Kit 
(Qiagen,  Germany)  according  to  the  manufacturer’s  specifications,  as  described  in 
section  2.4.1.  The  amount  of  elution  buffer  (AE)  (Qiagen,  Germany)  added  to  the 
column  was  adjusted  to  50µl  in  an  effort  to  concentrate  the  DNA.  The  incubation 
period  of  10  minutes  at  56°C  was  increased  to  48  hours  to  conform  to  the  other 
methods (i.e. method 2, see below) and to optimise lysis of the bone marrow. This 
method was defined as method 1a. A variation of this method involved a pre-treatment 
with  RBCL  buffer  (Gentra  Systems,  USA)  as  per  the  manufacturer’s  instructions 
(section  2.3.3.1.1)  and  resuspension  of  the  pellet  in  600µl  of  sterile  PBS  (Oxoid, 
England) (method 1a with RBCL).  
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4.3.2.2  Method 2 
Another  extraction  method  used  to  extract  DNA  from  bone  marrow  included 
chloroform  extraction  followed  by  column  purification
69  (Marmion,  B.  P  personal 
communication). This involved the lysis of cells and separation of the components with 
chloroform followed by purification of the DNA from the aqueous phase using the 
QIAamp DNA Mini Kit (Qiagen, Germany). In 1.5ml tubes 200l of sample was added 
to 200l of TE buffer (10mM Tris-HCl, 1mM EDTA, pH 7.5) and mixed by inversion. 
To this mixture 109.2l of SDS (10% w/v, final working concentration 2%) and 50l of 
Proteinase K (20mg/ml) (Qiagen, Germany) were added. The samples were then further 
incubated at 56°C for 48 hours with continual gentle mixing. The samples were then 
incubated at 100°C for 10 minutes and allowed to cool to room temperature. To this 
mixture 200l of chloroform was added and mixed by shaking for 10 seconds. The 
sample  was  then  centrifuged  at  14,000 g  for  30  seconds.  The  aqueous  layer  was 
removed into a sterile 10ml tube. To this mixture 20l Na acetate (3M pH 5.2) was 
added and mixed followed by 200l of isopropanol (100%). This was then held at 
-20°C for 60 minutes, after which it was centrifuged at 14,000 g for 30 minutes. The 
supernatant was discarded and the pellet washed with 70% v/v Ethanol. The resulting 
pellet was dissolved in 200l of H2O. To this was added 200l of lysis buffer (AL) 
(Qiagen, Germany), followed by 200l of 100% ethanol. This mixture was then applied 
to  a  spin  column  from  the  QIAamp  DNA  Mini  Kit  (Qiagen,  Germany),  spun  and 
washed  as  per  the  manufacturer’s  specifications  (as  described  in  section  2.4.1)  and 
eluted in 50l of elution buffer (AE) (Qiagen, Germany). This method was defined as 
method 2. For some samples an additional heating step was included following the 
addition of the TE buffer. These samples were incubated at 95°C for 15 minutes and 
defined as method 2a. 
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4.3.2.3  Method 3 
A phenol/chloroform extraction method was also compared. In a 1.5ml tube 200l of 
sample  was  added  to  200l  of  phenol:  chloroform  (1:1  v/v)  and  vortexed  for  five 
seconds. The sample was then spun at 14,000 g for two minutes. The aqueous layer 
was removed into a sterile 1.5ml tube. To this mixture 200l of phenol:chlorofom was 
added and the mixing, centrifuging and separation of the aqueous phase repeated. To 
the second separated aqueous phase 200l of chloroform was added and the mixing, 
centrifuging and separation of the aqueous phase repeated as before. The final aqueous 
phase was ethanol precipitated and the resulting pellet resuspended in 50l of elution 
buffer (AE buffer from the QIAamp DNA Mini Kit, Qiagen, Germany). This method 
was defined as method 3. 
 
The methods of DNA extraction and purification are coded and summarised in Table 
14. These methods were compared for their ability to purify DNA and reduce PCR 
inhibition  from  samples  spiked  with  C. burnetii  and  analysed  by  Com1  qPCR  (as 
described in section 2.4.2). 
 
Table 14 Methods used in this chapter and their codes 
Method  Method code 
Column Method (with a digestion time of 10 minutes)  1 
Column Method (with a digestion time of 48 hours)  1a 
Column  Method  (with  a  digestion  time  of  48  hours 
and pre-treated with RBC lysis buffer) 
1a with RBCL 
Chloroform method (without initial heating step)  2 
Chloroform method (with initial heating step)  2a 
Phenol chloroform method  3 
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4.3.3  Controls 
DNA extracted from C. burnetii (Nine Mile clone 4) was used as a positive control for 
all PCRs. This extracted DNA was also used to spike samples post DNA extraction to 
determine if any PCR inhibitors were present in the final eluate. 
 
Coxiella burnetii (Nine Mile clone 4) grown in Vero cells was used to spike samples 
prior to DNA extraction to determine the efficiency of extraction. Maintenance and 
growth of C. burnetii (Nine Mile clone 4) in African green monkey kidney (Vero) cells 
was undertaken as described in section 2.3.2. In some cases cultures that had been 
induced to produce an increased proportion of SCV following the method described by 
Coleman et al., were used to determine the efficiency of the method of DNA extraction 
on these cell types
25. Some cell cultures were also filtered through a 0.22m filter to 
reduce the number of LCV and enrich for SCV. Normal bone marrow samples were 
pooled  to  a  volume  of  5ml  before  spiking  with  aliquots  of  the  filtered  (SCV)  and 
unfiltered  (LCV  and  SCV)  C. burnetii  culture.  For  comparative  purposes  Q  fever 
Vaccine Q-Vax® (CSL, Australia), which contains formalin fixed whole C. burnetii 
(Henzerling  isolate)  was  also  used  to  spike  bone  marrow  samples  prior  to  DNA 
extraction. 
 
4.3.4  Statistical analysis 
Each DNA extraction was performed in triplicate and the significance between results 
was determined by the Student’s t test using the concentration of C. burnetii DNA (in 
g/l)  as  detected  and  calculated  from  the  Ct  results  of  the  Com1  qPCR  assay  as 
obtained from the standard curve (Figure 8 and section 3.4.1). p values were calculated 
and only those less than 0.05 were considered statistically significant.  
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4.4 Results 
4.4.1  Buffy Coat, Plasma and Serum samples 
The concentration of DNA detected by qPCR of spiked buffy coat, plasma and serum 
samples extracted by the silica column method (method 1) are shown in Figure 13.  
 
 
Figure 13 C. burnetii DNA detected in spiked normal clinical samples or PBS 
The  differences  observed  in  the  above  four  sample  types  were  not  statistically 
significant. The error bars represent one standard deviation of the mean. 
 
Inhibition of the qPCR by an excess of host (eukaryotic) DNA in buffy coat samples 
was investigated. Previously extracted DNA from C. burnetii negative specimens and 
matched  PBS  controls  were  spiked  with  C. burnetii  DNA.  Inhibition  of  the  qPCR 
would  have  been  detected  by  an  increase  in  Ct  between  the  PBS  controls  and  the 
clinical samples. qPCR negative buffy coats DNA samples (n=88) were tested. Only a 
slight  difference  in  Ct  was  observed.  This  delay  in  Ct  was  0.1%,  equivalent  to  a 
reduction  in  detected  organisms  of  only  3%.  This  reduction  was  not  considered  
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significant as it was within two standard deviations of the population mean and it was 
evident that inhibition did not occur in this assay (Table 15). 
 
Table 15 Difference from control (shift) in DNA (g/l) detected in 88 negative 
samples spiked with C. burnetii DNA 
  Shift in g/l  Percentage variance 
Difference from control  3.2   10
-3  3.2% 
Standard deviation within spiked samples  6.7   10
-2  16.6% 
Shift in g/l was calculated by comparing the spiked pre-extracted negative sample to 
a spiked negative control (NTC). The percentage inhibition was calculated as the shift 
in  g/l  as  a  percentage  of  the  DNA  detected  in  the  spiked  NTC.  The  standard 
deviation shows the variation within the spiked sample population and this deviation as 
a percentage of the average value. 
 
4.4.2  Bone Marrow samples 
DNA  extraction  methods  1a  and  2  were  compared  with  10-fold  serial  dilutions  of 
C. burnetii (Nine Mile clone 4) cultures in both normal bone marrow and PBS and the 
amount of DNA detected by qPCR was compared (Figure 14 and Table 16). Of the 
dilutions  made  in  PBS  more  DNA  was  detected  in  those  extracted  by  the  column 
methods (method 1a) for the first five (most concentrated) dilutions. This was not true 
for the final two dilutions (six and seven). In dilution seven no DNA was detected in 
the spiked PBS extracted by the column method (method 1a). In this dilution (seven) 
the amount of DNA detected in the spiked PBS extracted by the chloroform method 
(method 2)  was very  close to the detection limit of the PCR (1 10
-6g/l). Of the 
dilutions made in bone marrow the least amount of DNA was detected in samples pre-
treated with RBCL. For all dilutions those extracted by the column method (method 1a) 
had more detectable DNA than those extracted by the chloroform method (method 2). 
 
 
  
64 
A) 
 
B) 
 
Figure 14 C. burnetii (Nine Mile Clone 4) DNA (g/l) detected in 10 fold dilutions 
in either PBS or bone marrow 
This figure shows the average amount of DNA (g/l) detected in PBS (A) or bone 
marrow (B) spiked with an aliquot of C. burnetii Clone 4 in Vero cells and extracted by 
2 or 3 different methods in triplicate. The C. burnetii was diluted ten fold in both bone 
marrow  and  PBS  before  DNA  extraction  by  column  method  (method  1a),  column 
method  (method  1a)  with  a  red  blood  cell  lysis  treatment  (RBCL)  or  chloroform 
method (method 2). The raw data used in these graphs is shown in Table 16. 
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Std dev g/l 
+/-5.6 10
-1 
+/-1.1 10
-1 
+/-2.8 10
-2 
+/-4.7 10
-4 
ND 
ND 
ND 
Chloroform (method 2) 
Average 
g/l 
2.4 10
0 
8.9 10
-2 
1.8 10
-2 
3.4 10
-4 
8.7 10
-5 
2.2 10
-5 
3.4 10
-6 
1.5 10
5 
Std dev 
+/-1.3 10
0 
+/-1.4 10
-1 
+/-2.9 10
-3 
+/-1.3 10
-4 
+/-7.6 10
-6 
ND 
ND 
Column method (1a with 
RBCL) 
Average 
g/l 
9.3 10
-1 
1.0 10
-1 
3.0 10
-3 
1.6 10
-4 
9.1 10
-6 
NEG 
NEG 
3.2 10
5 
Std dev 
+/-8.2 10
0 
+/-1.5 10
0 
+/-8.1 10
-2 
+/-5.6 10
-3 
+/-5.1 10
-4 
ND 
ND 
Bone Marrow 
Column method (1a) 
Average 
g/l 
1.1 10
1 
1.0 10
0 
6.5 10
-2 
4.0 10
-3 
4.7 10
-4 
2.4 10
-5 
5.6 10
-6 
6.8 10
5 
Std dev g/l 
+/-1.1 10
1 
+/-3.4 10
-1 
+/-2.0 10
-2 
+/-1.2 10
-3 
+/-6.1 10
-5 
+/-1.0 10
-5 
ND 
Chloroform method (2) 
Average 
g/l 
7.3 10
0 
2.3 10
-1 
2.0 10
-2 
9.9 10
-4 
6.3 10
-5 
1.1 10
-5 
6.9 10
-7 
1.5 10
6 
Std dev 
+/-2.6 10
-1 
+/-1.6 10
0 
+/-1.3 10
-1 
+/-1.0 10
-2 
+/-3.9 10
-4 
+/-5.0 10
-6 
ND 
PBS 
Column method (1a) 
Average 
g/l 
3.0 10
1 
2.4 10
0 
9.3 10
-2 
7.4 10
-3 
3.1 10
-4 
7.5 10
-6 
NEG 
6.8 10
6 
Table 16 C. burnetii DNA (g/l) detected in either PBS or bone marrow extracted by 2 or 3 different methods 
Substrate Dilutions made in 
DNA extraction Method 
Number of 10 fold dilutions of C. 
burnetii 
1 
2 
3 
4 
5 
6 
7 
Detection Dose 50 (DD50) where 
50%  samples positive 
The Detection Dose 50 (DD50) was calculated from dilutions four to 7 (only) using the Spearman-Kärber method (see Appendix A). A 
higher number indicates a more sensitive extraction and detection method because this number represents the approximate number of 
organisms  in  the  neat  (undiluted)  sample  as  calculated  by  the  amount  detected  by  that  method.  NEG  (negative)  denotes  when  all 
triplicates were negative, ND (not done) denotes only one of the triplicates was positive, hence standard deviation could not be calculated.  
The average concentration of DNA (g/l) detected by each titration is graphed in Figure 14.  
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4.4.3  DNA extraction from the SCV of C. burnetii 
DNA extraction methods were compared using SCV enriched cultures. These included 
the column method with a 10-minute digestion (method 1), the column method with an 
increased digestion time of 48 hours (method 1a) and the chloroform method (with the 
95°C incubation) (method 2a). The results are shown in Figure 15. The amount of DNA 
extracted by the chloroform method was significantly less than that extracted by the 
column method with either a standard (10-minute) or long (48-hour) digestion. The 
increase in the amount of DNA detected from the 48-hour digestion compared to the 
normal 10-minute digestion almost reached statistical significance (p=0.07). 
 
 
 
Figure 15 DNA extracted from SCV enriched cultures of C. burnetii 
The  error  bars  represent  one  standard  deviation  of  the  mean  of  triplicate  samples. 
Methods used were column with a short digestion (method 1), column with a long 
digestion (method 1a) and chloroform (method 2a). 
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4.4.4  DNA extraction from bone marrow spiked with SCV enriched 
cultures of C. burnetii 
Bone marrow samples spiked with A) unfiltered (containing a mixture of LCV and 
SCV) and B) 0.22m filtered (containing the SCV only) C. burnetii cultures grown in 
Vero cells under conditions to enrich for the SCV, were used to compare the extraction 
of C. burnetii DNA by four different methods. These methods were Column (method 
1a), chloroform (with and without heating) (method 2 and 2a respectively) and phenol-
chloroform  (method  3).  The  results  are  shown  in  Figure  16.  The  column  method 
(method 1a) recovered high amounts of DNA in both mixed LCV/SCV and SCV-only 
spiked  samples.  The  phenol-chloroform  method  yielded  the  lowest  amounts  of 
detectable  DNA  in  both  spiked  sample  sets.  The  additional  heating  step  in  the 
chloroform method (method 2a) significantly reduced the amount of detectable DNA 
for those samples spiked with a mixture of LCV and SCV. This difference was not seen 
in samples spiked with 0.22m filtered C. burnetii. 
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A) Samples spiked with unfiltered cultures of C. burnetii (LCV and SCV) 
 
 
B) Samples spiked with 0.22m filtered cultures of C. burnetii (SCV) 
 
Figure 16 DNA extracted from bone marrow spiked with SCV enriched C. burnetii 
culture 
Methods  of  DNA  extraction  used  were  column  method  (method  1a),  chloroform 
method  (method  2),  chloroform  method  with  heating  (method  2a)  and  the  phenol 
chloroform  method  (method  3).  Only  p  values  <0.05  are  shown.  The  error  bars 
represent one standard deviation of the mean of triplicate samples.  
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This comparison was repeated with bone marrow spiked with A) unfiltered and B) 
0.22m  filtered  Q-Vax®.  The  methods  compared  were  the  column  method  with 
(method  1a  RBCL)  and  without  (method  1a)  the  prior  use  of  RBC  lysis  solution 
(RBCL)  and  the  chloroform  method  with  heating  (method  2a)  and  without  heating 
(method 2). The results are shown in Figure 17. There was no significant difference in 
the  amount  of  DNA  detected  between  the  four  extraction  methods  in  the  samples 
spiked with unfiltered Q-Vax®. However for those spiked with filtered Q-Vax® there 
was significantly more DNA detected in samples extracted by the column method (with 
or without the RBC lysis buffer) when compared to the chloroform (with or without 
heating) method of DNA extraction. 
 
To determine if a reduction in the amount of DNA detected was due to carry over of 
PCR inhibitors, samples were spiked after DNA extraction and compared to a matched 
PBS control. Results are shown in Figure 18. With the use of the red blood cell lysis 
buffer less DNA was detected in those extracted by the column method (method 1a), 
likewise with the addition of the heating step in the chloroform method (method 2a). 
However no differences between spiked samples and spiked control were significant. 
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A) Samples spiked with unfiltered Q-Vax® 
 
 
B) Samples spiked with 0.22m filtered Q-Vax® 
 
Figure 17 DNA extracted from bone marrow spiked with Q-Vax® 
Methods  of  DNA  extraction  used  were  the  column  method  (method  1a),  column 
method  with  pre-treatment  with  RBC  lysis  buffer  (method  1a  RBCL),  chloroform 
method (method 2) and chloroform method with heating (method 2a). Only p values 
<0.05  are  shown.  The  error  bars  represent  one  standard  deviation  of  the  mean  of 
triplicate samples. 
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Figure 18 C. burnetii DNA (µ µ µ µg/µ µ µ µl) detected in bone marrow samples spiked post 
DNA extraction 
Extraction  methods  used  were  column  (method  1a),  column  (method  1a)  with  pre 
treatment  with  red  blood  cell  lysis  buffer  (RBCL),  chloroform  (method  2)  and 
chloroform  with  heating  (method  2a).  Differences  were  not  statistically  significant 
(p>0.05).  The  error  bars  represent  one  standard  deviation  of  the  mean  of  triplicate 
samples. 
 
 
 
 
Table 17 is a summary of the amount of DNA (g/l) detected in samples extracted by 
the column method (method 1a) and chloroform method (method 2 or 2a whichever 
was higher). In every assay the former was superior to the latter. 
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+/- 0.74 
+/- 0.002 
+/- 0.91 
+/- 0.003 
+/- 0.03 
1.5 10
5 
Chloroform method 
(the higher of 2 or 2a) 
6.84 
0.006 
2.75 
0.006 
0.20 
 
+/- 0.34 
+/- 0.005 
+/- 0.83 
+/- 0.005 
+/- 4.38 
6.8 10
5 
Column method 
(1a) 
5.36 
0.011 
3.08 
0.074 
16.56 
 
Table 17 Summary of DNA (µ µ µ µg/µ µ µ µl) detected when extracted by the column (method 1a) and 
chloroform method (method 2 or 2a) 
Sample of C. burnetii in bone marrow 
Unfiltered SCV enriched C. burnetii culture (LCV and SCV) 
Filtered (0.22m) SCV enriched C. burnetii culture 
Unfiltered Q-Vax® (LCV and SCV) 
Filtered (0.22m) Q-Vax® (SCV) 
Filtered (0.22µm) SCV enriched C. burnetii culture 
(not in bone marrow) 
Detection Dose 50 (DD50) 
Data in this table is summarised from Table 16, Figure 15, Figure 16 and Figure 17. DD50 calculated using 
the Spearman Kärber method described in Appendix A. 
 
  
73 
4.5 Discussion 
Diagnosis of acute Q fever is generally made by serology. This method relies on the 
availability of a convalescent serum sample and hence diagnosis can be delayed for 
several weeks post infection. PCR allows for early diagnosis and is both specific and 
sensitive. However diagnosis by this method requires the DNA to be extracted and 
purified  from  a  clinical  sample.  This  study  was  conducted  to  establish  the  optimal 
method of DNA extraction and to test the use of PCR for detection of C. burnetii in 
common clinical samples.  
 
Extracted blood samples that were negative for C. burnetii were spiked with C. burnetii 
DNA and analysed by qPCR alongside matched spiked PBS controls. The slight change 
in Ct observed was not considered to be inhibition of the assay as it was within two 
standard deviations of the mean of the spiked controls. The spiking of PBS, buffy coat, 
plasma and serum samples prior to DNA extraction showed no significant difference in 
the  yield of bacterial DNA detected. These results indicate the effectiveness of the 
column extraction method on buffy coat, plasma and serum and that the use of PCR as 
a method for early diagnosis of Q fever is quick, sensitive and specific. 
 
The  use  of  PCR  in  the  early  diagnosis  of  Q  fever  has  been  previously  reported
39. 
However, in chronic Q fever, C. burnetii may not be circulating in the blood but may 
be  present  in  other  tissues.  For  example  C.  burnetii  has  been  isolated  from  bone 
marrow
83. In a study by Harris et al., C. burnetii DNA was found in 13 out of 20 bone 
marrow aspirates from patients with post Q fever fatigue syndrome (QFS) five years 
after the primary infection
44. A similar study by Marmion et al., found 28 positives in 
32 samples of bone marrow from patients 12 years following infection; five of these 
had QFS, 15 had fatigue with a co-morbidity and 12 had Q fever without sequelae
69. It  
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has been shown that bone marrow eukaryotic DNA can inhibit the PCR detection of 
C. burnetii  DNA
44.  In  the  present  study  different  methods  of  DNA  extraction  were 
compared using ten fold dilutions of C. burnetii in bone marrow or PBS (Figure 18). 
By comparing the dilutions made in PBS a trend became visible where more DNA was 
detected in those samples extracted by the column method. This was most obvious for 
the more concentrated preparations. 
 
Bone marrow samples extracted by the column method with prior treatment with RBC 
lysis buffer had the least detected DNA at all dilutions. The possibility of the RBC lysis 
buffer introducing an inhibitor was unlikely as similar amounts of DNA were detected 
in negative samples spiked with C. burnetii after DNA extraction. The column method 
with prior treatment using RBC lysis solution reduced the amount of C. burnetii DNA 
extracted and detected and should not be used. As this reduction was seen across each 
dilution it could be due to a diluting of the C. burnetii DNA by the RBC lysis step. As 
the white blood cells were pelleted in this method it was possible that some of the 
C. burnetii used to spike the bone marrow was not collected in the pellet and was lost 
when  the  supernatant  was  removed.  Spiking  with  C. burnetii  cultures  was  not  an 
accurate representation of naturally infected bone marrow as the ratio of intracellular 
and extracellular bacteria would have been different to that in clinical samples. 
 
By comparing the spiked PBS samples with the spiked bone marrow samples another 
trend became visible. More DNA was detected in the spiked PBS samples for the first 
four dilutions, after which more DNA was detected in the spiked bone marrow samples 
extracted by the same method. For example in dilution six (for both the chloroform and 
the column method) more DNA was detected in the spiked bone marrow compared to 
the spiked PBS. This was similar to the results seen with the buffy coat, plasma and  
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serum samples and suggests that in some unspecified way the bone marrow enhanced 
the  DNA  detection  of  low  numbers  of  C. burnetii.  The  improvement  of  the  PCR 
reaction with increased non-target DNA was seen in a previous study by Al-Soud et 
al.,
3 and may be due to the presence of a PCR inhibitor that binds to any DNA. Such an 
inhibitor would be less likely to bind to target DNA if more host DNA were present. 
 
In a previous study by Harris et al., dilutions of the vaccine Q-Vax® (approximately 
1x10
9 cells per 25uL) were made in buffer both with and without eukaryotic DNA 
extracted  by  phenol-chloroform  method  from  normal  bone  marrow  samples.  The 
presence of bone marrow DNA delayed the Ct by approximately 12 cycles suggesting 
that  eukaryotic  DNA  from  bone  marrow  led  to  a  significant  reduction  in  PCR 
amplification  efficiency
44.  The  opposite  was  found  in  the  present  study  where  a 
comparable amount of DNA was detected in bone marrow samples compared to PBS 
controls  spiked  post  DNA  extraction.  This  was  true  for  extraction  by  either  the 
chloroform or the column methods. This suggests that the reduction of PCR efficiency 
observed by Harris et al.,
44 may have been due to the method of DNA extraction and 
not due to the sample type.  Indeed, in the current study, more DNA was detected in 
every dilution of the spiked bone marrow samples extracted by the column method 
when compared with those extracted by the chloroform method. 
 
Since  it  has  been  postulated  that  the  C.  burnetii  in  the  bone  marrow  may  be 
predominantly in the SCV form
69, C. burnetii Nine Mile clone 4 cultures were induced 
to produce an increased proportion of cells in the SCV form using a method described 
by Coleman et al., (2004)
25. The SCV-enriched cultures were then used to determine 
the optimal DNA extraction methods for the SCV cell type. There was a significant 
(p<0.05) increase in the amount of DNA extracted by the column method compared  
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with  the  chloroform  method.  This  clearly  demonstrated  that  the  column  DNA 
extraction  method  was  more  efficient  at  extracting  DNA  from  the  SCV.  Extra 
extractions using numerous washes with chloroform were not necessary  to lyse the 
SCV. A longer digestion with proteinase K did appear to improve the PCR detection of 
C. burnetii DNA slightly (although it was not statistically significant). This difference 
may be important for samples with a lower concentration of C. burnetii, as this slight 
increase may be the difference between a positive and a negative result on a clinical 
sample. The use of a longer digestion period and the slight increase in amount of DNA 
detected would have to be weighed against the clinical need for a quick result. 
 
To determine if the optimal DNA extraction method for the SCV was also the optimal 
method  for  bone  marrow  samples  containing  C.  burnetii  in  the  SCV  form,  DNA 
extraction  methods  were  compared  using  bone  marrow  samples  spiked  with  either 
filtered  (0.22µm)  or  unfiltered  SCV-enriched  cultures.  The  filtered  sample  was 
expected to contain only SCV although this was not explicitly confirmed. The phenol-
chloroform  method  (method  3)  was  the  least  successful  among  the  methods  tested 
demonstrating  the  least  amount  of  DNA  in  both  the  filtered  and  unfiltered  spiked 
samples. The laborious phenol-chloroform method appears to be unnecessary as was 
also  demonstrated  by  Stien  et  al.,
106.  By  comparing  different  methods  of  DNA 
extraction  on  density  gradient  purified  C. burnetii  cell  cultures,  they  found  that  the 
phenol-chloroform method was not necessary and that bacterial DNA could be detected 
by a simple boiling method using Chelex
R 1000 (Biorad, USA). This method was even 
simpler than the column method, although they did not compare the yield of the DNA 
obtained by each method. Furthermore this boiling method may not be suitable for 
clinical  samples  due  to  the  presence  of  PCR  inhibitors  in  patient  samples  such  as 
haemoglobin
3 and EDTA
122.  
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The  results  of  the  current  study  have  shown  that  less  DNA  was  detected  in  bone 
marrow specimens spiked with C. burnetii SCV cells when extracted by the chloroform 
method with 95°C incubation (method 2a). The unfiltered SCV-enriched spiked bone 
marrow samples showed similar results to the SCV-enriched cultures alone (not used to 
spike bone marrow, Figure 15). The addition of the 95°C incubation step significantly 
decreased the amount of bacterial DNA detected. This may have been due to inhibitors 
binding to the single stranded DNA. A similar result was seen in a previous study that 
showed that the inhibitory effect of IgG was increased if the sample was heated to 95°C 
or if there was less non-template DNA present
2. The SCV appeared to be protected 
from  these  effects,  as  no  significant  difference  was  demonstrated  in  the  filtered 
samples.  The  SCV  of  C.  burnetii  has  condensed  chromatin
74,  which  may  prevent 
inhibitors binding and or increase the temperature required to separate the strands of 
DNA hence protecting the DNA from inhibitors binding to the separated strands. For 
the samples spiked with either the unfiltered or filtered cultures, the column method 
(method 1a) extracted the highest yield of detectable DNA. 
 
The  comparison  of  different  extraction  methods  was  repeated  using  bone  marrow 
samples  spiked  with  Q-Vax®  the  human  Q  fever  vaccine.  This  was  based  on  the 
assumption that the formalin killed cells in the vaccine would have less cell debris and 
less cell free DNA than cell cultures, hence any differences in the amount of DNA 
detected would represent the ability of the method to release DNA from the cells and 
reduce the amount of PCR inhibitors. The phenol-chloroform method (method 3) was 
not used on the subsequent Q-Vax® spiked samples as it had shown the least amount of 
DNA detected from the SCV enriched cell culture spiked bone marrow. RBC lysis 
buffer was tested in the Q-Vax® spiked samples to determine if it had any effect on the  
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detection  of  C. burnetii  SCV.  No  significant  difference  was  observed  between 
extraction  methods  when  it  was  used  on  samples  spiked  with  Q-Vax®.  This  was 
different to the samples spiked with C. burnetii cell cultures, where the addition of a 
heating step significantly decreased the amount of DNA detected. This suggests that the 
formalin killed C. burnetii were resistant to the inhibitory effect caused by the 95°C 
incubation  step.  The  samples  spiked  with  filtered  Q-Vax®  demonstrated  that 
significantly more DNA was detected in samples extracted by the column method than 
those extracted by the chloroform method. The use of the RBC lysis buffer reduced the 
amount of DNA detected (similarly to the serial dilutions of C. burnetii in bone marrow 
shown in Table 16) although the difference was not statistically significant. 
 
Summaries of the results comparing the column and chloroform method are given in 
Table 17. The results of this study support previous studies that have compared DNA 
extraction  methods  on  different  sample  types  in  order  to  optimise  detection  of 
infectious  agents  by  PCR.  In  a  study  by  Roussel  et  al.,
92  three  different  extraction 
methods  and  two  sample  preparation  methods  were  compared  for  the  detection  of 
Helicobacter pylori in mouse spleens. They showed that column extraction samples 
contained less inhibitors than those extracted by phenol-chloroform. The results of a 
study by Kok et al.,
58 suggested that a phenol chloroform method yielded the highest 
amount of DNA on respiratory, genital, faecal and peripheral blood mononuclear cell 
samples  compared  to  a  column  extraction  method  when  tested  by  an  enzyme 
immunoassay. However, when tested by PCR, the phenol-chloroform and the column 
extraction methods could detect viral DNA to the same limiting dilution. This indicated 
that while DNA samples extracted by the phenol chloroform method may contain more 
DNA it may also contain more PCR inhibitors, although the authors did not directly test 
this theory. A previous study demonstrated that while the phenol chloroform method  
79 
had  a  recovery  of  genomic  DNA  relative  to  that  of  a  column  method  with  EDTA 
preserved  blood,  it  was  less  efficient  at  extracting  DNA  from  clotted  blood 
23. 
Furthermore, when internal amplification controls were used, the phenol-chloroform 
extracted samples had a significantly increased inhibition of PCR compared to those 
extracted by a column method
23. It was hypothesised that while the amount of DNA 
extracted by each method was similar, the phenol-chloroform method left behind PCR 
inhibitors and hence a lower quantity of DNA was detected and measured. 
 
The present study has demonstrated that the phenol chloroform method of C. burnetii 
DNA extraction was not the best method for bone marrow samples. Furthermore, the 
chloroform method (with or without the 95°C incubation step) was not the best method 
for extracting DNA from SCV-enriched cultures or from bone marrow spiked with 
SCV  C.  burnetii  (from  either  filtered  SCV-enriched  cultures  or  filtered  Q-Vax® 
vaccine). Both the phenol-chloroform and the chloroform methods of DNA extraction 
were time-consuming, labour intensive, complicated, expensive, unsuitable for treating 
large  numbers  of  samples,  used  hazardous  chemicals  and  had  many  steps  which 
increased the possibility of human error, loss of sample and contamination. The results 
of  this  study  indicated  that  these  methods  were  not  necessary  for  suitable  DNA 
extraction from the SCV. Indeed, in the current study, the optimal method for detection 
of  C.  burnetii  was  the  silica  column  method,  which  was  relatively  simple, 
straightforward and is currently used widely in both research  and diagnostic fields. 
Furthermore the use of the Com1 qPCR was a quick, sensitive and specific way of 
detecting C. burnetii DNA in human diagnostic samples.  
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5.1 Abstract 
Coxiella burnetii is an obligate intracellular bacterium that causes the disease Q fever. 
This is usually diagnosed by serology (IFA) and/or PCR detection of C. burnetii DNA. 
However,  neither  of  these  methods  can  determine  the  viability  of  the  bacterium. 
Isolation of the bacterium can be achieved using embryonated eggs, animal inoculation 
or cell culture. In this study four different cell culture types were compared for their 
ability to amplify very low numbers of viable C. burnetii (their sensitivity) and their 
ability to grow the bacterium to a high yield. For the C. burnetii Arandale isolate the 
Vero cell line was the most sensitive and for the C. burnetii Henzerling isolate the 
DH82  cell  line  was  the  most  sensitive.  With  regard  to  yield,  the  DH82  cell  line 
appeared to yield high amounts of bacteria with three out of four C. burnetii isolates 
used.  The  Vero  cell  line  was  most  useful  for  the  observation  of  microscopically 
infected vacuoles in unstained infected cells. The findings of this study favour the use 
of Vero and DH82 tissue culture cell lines for isolation and growth of C. burnetii in 
vitro. The other cell lines, XTC-2 and L929 were less suitable. 
 
5.2 Introduction 
Diagnosis  of  Q-fever  is  generally  made  by  serological  testing  such  as 
immunofluorescence assay (IFA) of two samples to show a seroconversion, which may 
take one to two weeks. Studies have shown that PCR analysis may be more sensitive  
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and can be used early in the onset of the disease
39. Isolation of the infective agent may 
be even more sensitive than diagnosis by PCR. This may be due in part to the volume 
of the sample used in each assay. In addition isolation allows for the detection and 
isolation of viable C. burnetii whereas PCR cannot differentiate between viable and 
non-viable  bacteria  and  does  not  yield  an  isolate.  Isolation  of  the  infective  agent 
enables further studies to be undertaken on the strain. 
 
Traditionally,  C. burnetii  has  been  considered  an  obligate  intracellular  bacterium. 
However,  C. burnetii  was  recently  grown  without  host  cells
79.  Most  commonly, 
embryonated  chicken  eggs  have  been  used  for  the  isolation  and  growth  of  large 
numbers of C. burnetii and other rickettsiae. Advances in cell culture have allowed the 
growth of intracellular bacteria in flasks or multi-welled trays containing a monolayer 
of eukaryotic host cells. Cell culture may be more cost effective and time efficient than 
the use of embryonated eggs or animal inoculation. 
 
Four  cell  lines  were  compared  for  their  sensitivity  to  C. burnetii  growth  and  their 
ability to  grow the bacteria to high  yield. The  cell lines chosen included two used 
previously for C. burnetii amplification, namely Vero (African green monkey kidney 
cells)
22 and mouse L cells including L929 (mouse, fibroblast cells)
11, 22, and two other 
cell lines including a macrophage cell line DH82 (dog, macrophage cells) as this is the 
cell type that C. burnetii infects in Q fever and the XTC-2 cell line (South African 
clawed frog epithelial cells) which is grown at a different temperature with different 
media which may affect the isolation and amplification of C. burnetii. Four different 
isolates  of  C. burnetii  were  used;  the  Henzerling  strain  (the  strain  used  for  the 
Australian vaccine Qvax®, originally isolated in Italy) was used as a reference along 
with three recent Australian isolates. These were Arandale, Cumberland and Timony  
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(all from acute human cases of Q fever). The case histories of the Australian isolates 
are given in more detail in Chapter 8, where characterisation and grouping of these 
isolates is reported. Different cell culture types were compared for their ability to grow 
high yields of C. burnetii and also for their sensitivity of detection by isolation and 
amplification of low numbers of the bacteria. 
 
5.3 Methods 
In this study ten fold dilutions were made of suspensions of the various isolates of 
C. burnetii to test the sensitivity of four different tissue culture cell lines for amplifying 
small numbers of C. burnetii. The starting material for the Henzerling isolate was a 
homogenate of infected egg yolk sack (CSL, Australia) and for the Australian isolates, 
Arandale Cumberland and Timony, the starting material used was a homogenate of 
infected  SCID  mice  spleens.  SCID  mice  were  inoculated  intraperitoneally  with  the 
respective C. burnetii isolates (grown in tissue culture and kept as described in section 
2.3.2) until they became unwell, at which time they were euthanased and their spleens 
(which were typically enlarged) removed aseptically and homogenised in 5ml of sterile 
Hanks’  balanced  salt  solution  (HBSS,  Gibco,  Australia).  Ten  fold  dilutions  of  this 
starting material were made in HBSS (Gibco, Australia). The growth and maintenance 
of the four cell culture types Vero, L929, DH82 and XTC-2 are described in section 
2.3.2. 
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5.3.1  Sensitivity  of  four  different  cell  cultures  for  growing  two 
isolates of C. burnetii 
Six, 24 well trays of each of the four cell culture type were grown to confluency. Ten 
fold  dilutions  were  made  of  high  titre  Henzerling  and  Arandale  strain  suspensions. 
Dilutions 10
-6 to 10
-11 (Arandale strain) and 10
-5 to 10
-10 (Henzerling strain) were used 
to infect cell cultures. The use of these dilutions was determined by preliminary assays 
to gauge approximate concentrations of C. burnetii.  Six wells of each cell culture type 
were infected with 200µL of each dilution. Cultures were incubated for six weeks (42 
days) at which time the monolayer from each well was completely harvested, pelleted 
and resuspended to 300l for DNA extraction (method described in section 2.4.1) and 
analysis by PCR (method described in section 2.4.2) for the presence of C. burnetii 
DNA. 
 
5.3.2  Maximum yield of four isolates of C. burnetii in four different 
cell culture types 
Eight flasks (25cm
2) of each cell culture type were grown to confluency. Dilutions of 
Henzerling, Arandale, Cumberland and Timony isolates of C. burnetii were made as 
stated  above.  Spleen  homogenate  (Cumberland)  or  spleen  and  liver  homogenate 
(Arandale, Henzerling and Timony) (0.5ml) were diluted in 9.5mL of HBSS. This was 
then filtered through a 0.45m filter and 0.8ml of the filtrate was added to each flask. 
Two flasks of each cell line were inoculated with each isolate. Cultures had fortnightly 
changes of media for six weeks (42 days) at which time the monolayer was harvested, 
pelleted and resuspended in 1ml PBS, 200l of which was tested by DNA extraction 
and  Com1  qPCR  (method  section  2.4.2).  The  Ct  result  was  used  to  calculate  the  
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approximate  C. burnetii  DNA  concentration  (g/l)  in  each  reaction  following  the 
equation given in section 3.4.1. 
 
5.3.3  Analysis 
The significance between bacterial yield comparisons was determined by the Student’s 
t test on the C. burnetii DNA concentration g/l and the p value calculated. In the 
sensitivity experiments, the TCID50 (Log10 of the C. burnetii dilution that would infect 
50% of tissue cultures) was calculated using the Spearman-Kärber method described in 
Appendix A. A higher number indicates a more sensitive cell line. 
 
5.4 Results 
5.4.1  The sensitivity of four different cell culture lines to amplify low 
numbers of viable C. burnetii 
Ten-fold  serial  dilutions  of  a  C. burnetii  suspension  were  inoculated  into  confluent 
monolayers  of  the  four  different  cell  lines  in  order  to  determine  the  cell  line  most 
susceptible (sensitive) to infection. The DNA concentration of each positive PCR result 
was calculated and shown in Table 18 (Arandale) and Table 19 (Henzerling) with the 
TCID50 for both isolates shown in Table 20. For the Arandale isolate the Vero cell line 
was the most sensitive with a TCID50 of 1.5   10
10, followed by the L929 cell line with 
a TCID50 of 4.6   10
8. For the Henzerling strain the DH82 cell line was the most 
sensitive with a TCID50 of 3.2   10
6 followed by the L929 cell line with a TCID50 of 
2.2   10
6. 
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Table 18 Detection of C. burnetii (Arandale isolate) DNA (g/l) in serial ten fold 
dilutions inoculated into four different cell lines after six weeks incubation 
Replicate wells  Dilution of 
C. burnetii 
suspension  1  2  3  4  5  6 
Positive
/ 
Total 
DH82 cell line 
10
-7  7.8  10
-4  1.9  10
-4  5.5  10
-3  ND  ND  ND  3/3 
10
-8  6.0  10
-4  1.0  10
-5  0.0  ND  ND  ND  2/3 
10
-9  0.0  0.0  0.0  ND  ND  ND  0/3 
10
-10  0.0  0.0  0.0  ND  ND  ND  0/3 
10
-11  0.0  0.0  0.0  ND  ND  ND  0/3 
L929 cell line 
10
-6  2.8  10
-2  4.3  10
-2  5.2  10
-2  5.5  10
-2  4.4  10
-2  8.6  10
-2  6/6 
10
-7  1.8  10
-2  8.2  10
-3  4.1  10
-3  1.0  10
-2  9.0  10
-3  5.5  10
-3  6/6 
10
-8  2.3  10
-4  8.2  10
-5  2.7  10
-4  1.1  10
-3  2.2  10
-4  1.1  10
-4  6/6 
10
-9  0.0  2.0  10
-5  0.0  0.0  0.0  0.0  1/6 
10
-10  0.0  0.0  0.0  0.0  0.0  0.0  0/6 
10
-11  0.0  0.0  0.0  0.0  0.0  0.0  0/6 
Vero cell line 
10
-6  4.1  10
-1  4.0  10
-1  2.7  10
-1  3.7  10
-1  3.8  10
-1  4.8  10
-1  6/6 
10
-7  4.8  10
-2  1.4  10
-1  2.9  10
-1  3.8  10
-1  2.4  10
-1  1.1  10
-1  6/6 
10
-8  1.2  10
-3  4.9  10
-3  2.8  10
-3  3.4  10
-2  3.3  10
-3  3.8  10
-3  6/6 
10
-9  2.8  10
-4  1.3  10
-3  2.4  10
-3  2.3  10
-4  5.0  10
-4  4.0  10
-5  6/6 
10
-10  0.0  0.0  8.5  10
-6  6.3  10
-6  1.4  10
-4  3.8  10
-4  4/6 
10
-11  0.0  0.0  0.0  0.0  0.0  0.0  0/6 
XTC-2 cell line 
10
-6  1.6  10
-4  1.9  10
-4  1.7  10
-4  1.6  10
-4  5.8  10
-5  1.1  10
-4  6/6 
10
-7  7.2  10
-6  0.0  1.1  10
-5  2.1  10
-5  0.0  2.9  10
-6  4/6 
10
-8  0.0  0.0  0.0  0.0  0.0  0.0  0/6 
10
-9  0.0  0.0  0.0  0.0  0.0  0.0  0/6 
10
-10  0.0  0.0  0.0  0.0  0.0  0.0  0/6 
10
-11  0.0  0.0  0.0  0.0  0.0  0.0  0/6 
ND – Not Done. A contamination issue was experienced within the initial DH82 cell 
line experiment, which was then repeated in triplicate only and not at 10
-6. 
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Table 19 Detection of C. burnetii (Henzerling isolate) DNA (g/l) in serial ten fold 
dilutions inoculated into four different cell lines after six weeks incubation 
Replicate wells  Dilution of 
C. burnetii 
suspension  1  2  3  4  5  6 
Positive 
/ 
Total 
DH82 cell line 
10
-5  2.5  10
-5  3.7  10
-5  2.1  10
-5  ND  ND  ND  3/3 
10
-6  1.3  10
-5  0.0  5.8  10
-6  ND  ND  ND  2/3 
10
-7  1.2  10
-6  0.0  0.0  ND  ND  ND  1/3 
10
-8  0.0  0.0  0.0  ND  ND  ND  0/3 
10
-9  0.0  0.0  0.0  ND  ND  ND  0/3 
L929  cell line 
10
-5  1.2  10
-4  2.6  10
-5  1.1  10
-5  8.0  10
-5  6.9  10
-5  7.0  10
-5  6/6 
10
-6  6.2  10
-6  0.0  0.0  0.0  1.9  10
-6  0.0  2/6 
10
-7  0.0  3.6  10
-6  0.0  4.4  10
-6  0.0  0.0  2/6 
10
-8  0.0  2.5  10
-5  0.0  0.0  0.0  0.0  1/6 
10
-9  0.0  0.0  0.0  0.0  0.0  0.0  0/6 
Vero cell line 
10
-5  5.5  10
-6  6.1  10
-6  1.0  10
-5  ND  ND  ND  3/3 
10
-6  0.0  0.0  0.0  ND  ND  ND  0/3 
10
-7  0.0  0.0  0.0  ND  ND  ND  0/3 
10
-8  0.0  0.0  0.0  ND  ND  ND  0/3 
10
-9  0.0  0.0  0.0  ND  ND  ND  0/3 
XTC-2 cell line 
10
-5  2.1  10
-6  1.2  10
-5  5.4  10
-5  1.2  10
-5  6.5  10
-6  1.3  10
-6  6/6 
10
-6  0.0  0.0  8.5  10
-6  1.5  10
-5  0.0  0.0  2/6 
10
-7  0.0  0.0  2.7  10
-6  0.0  0.0  0.0  1/6 
10
-8  0.0  0.0  0.0  0.0  0.0  0.0  0/6 
10
-9  0.0  0.0  0.0  0.0  0.0  0.0  0/6 
ND – Not Done. A contamination issue was experienced within the initial DH82 and 
Vero cell lines experiments, which were then repeated in triplicate only. 
 
Table 20 TCID50 of C. burnetii (Arandale and Henzerling isolates) in different cell 
lines 
Cell line 
C. burnetii strain  DH82  L929  Vero  XTC-2 
Arandale  1.5  10
8  4.6  10
8  1.5  10
10  1.5  10
7 
Copy numbers required for 
50% positive cell culture  11.7  3.2  0.1  157.7 
Henzerling  3.2   10
6  2.2   10
6  3.2   10
5  1.0   10
6 
Copy numbers required for 
50% positive cell culture  14.6  22.0  170.2  49.8 
TCID50  was  calculated  using  the  Spearman-Kärber  method  and  converted  to  copy 
numbers  of  C.  burnetii  cells  per  100µl  required  for  50%  infection  as  described  in 
Appendix  A.  A  higher  TCID50  number  indicates  a  cell  line  was  more  sensitive  to 
C. burnetii infection. 
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5.4.2  Maximum yield of C. burnetii in four different tissue culture 
cell lines 
To compare the maximum yield of C. burnetii in each of four different cell lines the 
tissue  cultures  were  inoculated  in  duplicate  with  100l  of  the  same  dilution  of 
C. burnetii from a mouse spleen homogenate. The concentrations of C. burnetii DNA 
detected by the Com1 qPCR in each of the cell lines for each isolate are presented in 
Figures 20, 21, 22 and 23. There was little difference the yield of bacteria between cell 
culture  types  for  the  isolates  Cumberland,  Timony  and  Henzerling.  The  Arandale 
isolate  demonstrated  significantly  higher  yield  of  C. burnetii  in  the  DH82  cell  line 
compared to the XTC-2 cell line (p=0.03) (Figure 19). With the Henzerling strain the 
yield from the DH82 cell line almost reached statistical significance compared to the 
L929  and  XTC-2  cell  lines  (p  values  0.07  and  0.09  respectively)  (Figure  20).  The 
significance of the difference between L929 and XTC-2 was p=0.08. Overall DH82 cell 
cultures  appeared  to  yield  the  most  C. burnetii  DNA  with  all  isolates,  with  the 
exception of the Timony strain, which appeared to grow best in XTC-2 but was not 
statistically significant (Figure 22). 
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Figure 19 C. burnetii (Arandale isolate) yield from different cell culture lines after 
six weeks in culture 
In the figure the error bars represent one standard deviation of the mean. 
 
 
 
 Figure 20 C. burnetii (Henzerling isolate) yield from different cell culture lines 
after six weeks in culture 
In the figure the error bars represent one standard deviation of the mean. The difference 
between DH82 and L929 approached statistical significance (p=0.07) 
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Figure 21 C. burnetii (Cumberland isolate) yield from different cell culture lines 
after six weeks in culture 
In  the  figure  the  error  bars  represent  one  standard  deviation  of  the  mean.  The 
differences observed were not statistically significant. 
  
 
 
Figure 22 C. burnetii (Timony isolate) yield from different cell culture lines after 
six weeks in culture 
In  the  figure  the  error  bars  represent  one  standard  deviation  of  the  mean.  The 
differences observed were not statistically significant. 
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During  the  growth  of  C. burnetii  in  the  yield  experiments,  the  monolayers  were 
observed  under  light  microscopy  when  the  media  was  changed.  Differences  were 
observed between the infected cell lines. Infection with C. burnetii could be clearly 
seen as large vacuoles in the Vero cells. The uninfected cell line and the large vacuoles 
seen are shown in Figure 23. 
 
A)   B)  
Figure 23 Vero cell line uninfected (A) and infected (B) with C. burnetii (clone 4) 
( 100 magnification) 
The  figure  shows  the  vacuoles  of  unstained  Vero  cells  under  an  inverted  light 
microscope.  The  arrow  shows  one  of  the  visible  vacuoles  in  the  infected  Vero 
monolayer. 
 
5.5 Discussion 
The isolation of C. burnetii definitively demonstrates a current infection with viable 
bacteria.  In  this  study  the  use  of  cell  cultures  for  the  isolation  of  C. burnetii  was 
investigated. Four different cell culture types were compared for their sensitivity and 
yield of C. burnetii.  Four different isolates (3  new local Austlaian isolates plus the 
Henzerling isolate) were used as it has been shown that different strains have different 
pathogenicity
108 and may interact differently with the various cell lines. These cell lines 
were inoculated with spleen homogenate from SCID mice infected with the respective  
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C. burnetii isolate so that the inocula were not biased (pre-adapted) towards any of the 
cell lines. 
 
A starting dilution of the C. burnetii suspension was selected based on preliminary 
testing i.e. 10
-6 (Arandale) and 10
-5 (Henzerling). From this ten fold serial dilution of 
C. burnetii were used to infect confluent monolayers of the four different cell lines. 
Only two C. burnetii isolates were used (Arandale and Henzerling). The TCID50 of the 
cell lines (Table 20) demonstrate that the Vero cell line was the most sensitive for 
isolating C. burnetii Arandale isolate while the DH82 cell line was the most sensitive 
for isolating the C. burnetii Henzerling isolate. 
 
Previous  studies  have  shown  a  difference  between  cell  lines  in  their  sensitivity  to 
C. burnetii infection
94. Indeed, continuous cell lines such as Vero and L929 cells are 
useful for studies on C. burnetii as they are not killed by the bacteria and are capable of 
persistent infection with C. burnetii
22. It has been shown that both Phase I and Phase II 
cells can persistently infect cell cultures
11 and through cell culture passages C. burnetii 
may revert to Phase II. The difference demonstrated between the two isolates was in 
agreement with previous studies that have shown a difference in pathogenicity amongst 
isolates of C. burnetii
108. The isolates used in the current study were both from acute 
cases, one from genomic group III (Arandale, see Chapter 8) and the other from group 
II  (Henzerling)
50.  It  may  be  possible  that  cell  lines  have  different  sensitivities  to 
C. burnetii  isolates  from  different  genomic  groups.  It  has  been  found  that  “acute” 
isolates (with plasmid QpH1) and “chronic” isolates (with no plasmid) infected cells 
more readily and caused an increased amount of C. burnetii antigen to be displayed on 
the host cell membrane compared to other isolates also implicated in chronic Q fever 
(such as Priscilla Q177 and F Q228 both with the plasmid QpRS)
91.  
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In  this  study  the  yield  of  C. burnetii  grown  in  each  tissue  culture  cell  line  was 
investigated.  For the Henzerling and Arandale isolates greater  yields of DNA were 
detected  in  the  DH82  cell  line,  whereas  for  the  Cumberland  and  Timony  isolates 
greater yields of DNA were detected in the XTC-2 cell line. For the Arandale isolate 
more DNA was detected in the DH82 cell line than the XTC-2 cell line (p=0.03). The 
remaining differences observed between cell lines were not statistically significant. To 
determine if the lack of statistical significance between each cell line was due to high 
variability of host cell numbers the optical density (OD) of the cells was determined 
(data  not  shown).  While  variation  was  found  in  OD  between  flasks  this  did  not 
correlate  with  the  variability  in  the  amount  of  C. burnetii  DNA  detected  when 
compared across either isolate or cell line groupings. 
 
Nonetheless this study showed a general trend of increased yields in the DH82 cell line 
for  the  Arandale,  Henzerling  and  Cumberland  isolates.  The  Timony  isolate  had 
increased yields in the XTC-2 cell line albeit with high flask-to-flask variability. The 
Henzerling isolate has been shown to have a higher infectivity for Vero cells compared 
to the Zamosc isolate of C. burnetii
94. The preference of one cell line over another may 
be  due  to  the  cell  line  itself  and  the  ease  with  which  the  C. burnetii  enters  and 
multiplies within that host cell. In the case of Timony, which had a higher yield in 
XTC-2 cells, it may not be the cell line itself but a component of the different media or 
the lower temperature that the cell line was grown in. 
 
Considering the amount of DNA detected in the sensitivity assay (Table 18 and Table 
19) it would appear that a greater difference in yield between tissue culture cell lines 
occurred with a lower concentration of inoculum. However, this may have been due to  
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the sensitivity of the cell line only, as the more sensitive to C. burnetii a cell line was 
the more C. burnetii would have become intracellular and multiplied. This was why a 
more  concentrated  inoculum  was  used  to  compare  the  maximum  yield  of  bacteria 
grown in the four different cell lines. 
 
The cell lines themselves had certain differences as observed by routine use. Vero cells 
are widely used and are easy to grow and (when infected with C. burnetii) vacuoles 
could be seen under  a  100  light microscope (Figure 23).  Infected vacuoles in the 
DH82, L929 and XTC-2 cells were much harder to see. 
 
Although not commonly used for diagnosis, obtaining C. burnetii isolates is very useful 
in order to learn more about the pathogenicity and genetics of different isolates and for 
epidemiological comparisons. Cell culture was probably more cost effective and time 
efficient than other methods used, including embryonated eggs or animal inoculation. 
The findings of this study suggest the use of the cell lines Vero and DH82 for isolation 
and  growth  of  C. burnetii,  as  they  were  the  most  sensitive  (for  the  Arandale  and 
Henzerling isolates respectively) and the DH82 cells were able to grow C. burnetii to a 
higher yield. Recently, C. burnetii has been grown without the use of host cells
79. The 
results  of  the  current  study  could  be  used  in  comparison  with  cell-free  media  to 
determine if the latter is more sensitive and can yield more bacteria than the cell lines 
used here. The use of cell culture for the detection of C. burnetii when compared to 
PCR and animal inoculation is examined and discussed in the following chapter.  
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6.1 Abstract 
C. burnetii is an obligate intracellular bacterium that causes the disease Q fever. This 
disease is usually diagnosed by serology (IFA) and/or PCR detection of C. burnetii 
DNA. In this study the sensitivity of detection of C. burnetii by PCR was compared to 
cell culture and SCID mice inoculation. Mouse inoculation was the most sensitive of 
the  three  methods  of  detection  for  the  two  different  isolates  of  C. burnetii  studied 
(Henzerling and Arandale). The findings of this study favour the use of SCID mice 
inoculation for isolation of C. burnetii from clinical specimens, although this may not 
be practicable for routine diagnosis. 
 
6.2 Introduction 
Studies have shown that PCR may be more sensitive for diagnosis early in the onset of 
acute Q fever. Isolation of the infective agent may be even more sensitive than PCR 
provided viable bacteria (and not just DNA) are present in the clinical specimen.  
 
As  mentioned  in  the  previous  chapter,  advances  in  cell  culture  have  permitted  the 
isolation of C. burnetii in flasks. This may be more cost effective and time efficient 
than other methods such as the use of embryonated eggs or animal inoculation. Cell 
culture  of  C. burnetii  has  been  achieved  in  a  variety  of  cell  types  including  Vero 
(African  green  monkey  kidney  cells)
22,  and  mouse  L  cells  including  L929  (mouse 
fibroblast cells)
11,  22. Amoebae (Acanthamoeba castellanii) have also been shown to 
maintain C. burnetii intracellularly
60. In Chapter 5 four different cell culture types were  
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compared and it was found that the DH82 and Vero cell lines were the most sensitive to 
infection with two different isolates of C. burnetii. 
 
Animal inoculation is the only way to maintain C. burnetii as virulent Phase I. Small 
animal models that have been used to amplify C. burnetii include mice, hamsters and 
guinea pigs
4,  95,  96,  98. One organism can initiate infection in guinea pigs
96 and large 
numbers of bacterial cells can be recovered from their spleens following infection
120. It 
is hypothesised that animal inoculation may be more sensitive than cell culture for 
detection of very low numbers of viable C. burnetii. 
 
Severely combined immunodeficiency (SCID) mice are homozygous for a mutation 
that results in few if any lymphocytes and are deficient in immune functions mediated 
by  T  and  B  lymphocytes  necessary  for  C.  burnetii  clearance
6.  These  mice  have 
increased  susceptibility  to  C.  burnetii
6,  with  a  lethal  dose  10
8  times  less  than  for 
immuno-competent mice
4. In this study we investigated the sensitivity of the SCID 
mouse  animal  model  in  comparison  to  cell  culture  and  PCR  for  detecting  small 
numbers of C. burnetii. 
 
Previous  studies  have  shown  differences  in  the  infectivity  of  different  C. burnetii 
isolates  in  animal  models  (hamsters,  guinea  pigs  and  mice) 
108;  hence  two  distinct 
isolates were used in this study. The Henzerling isolate was isolated in Italy (1945) and 
is  used  in  the  Australian  human  Q  fever  vaccine  Q-Vax®.  It  was  used  as  the 
“reference”  strain.  The  other  isolate  was  a  new  Australian  isolate  of  C. burnetii 
(Arandale). The history for the Arandale isolate is described in Chapter 8 where the 
characterisation and grouping of this isolate is reported. Both isolates were used in the 
previous  study  to  determine  the  optimal  cell  culture  type  for  growing  C. burnetii  
96 
(Chapter  5).  In  the  current  chapter  these  two  isolates  were  used  to  determine  the 
sensitivity of three different methods for detection of C. burnetii; namely PCR, cell 
culture and SCID mouse inoculation.  
 
6.3 Methods 
Starting material for both C. burnetii isolates was obtained by the methods described in 
Chapter  5.  The  starting  material  for  the  Henzerling  isolate  was  a  homogenate  of 
infected  egg  yolk  sack  (kindly  provided  by  CSL,  Australia)  and  for  the  Australian 
isolate Arandale the starting material used was a homogenate of infected SCID mice 
spleens.  A  SCID  mouse  was  inoculated  intraperitoneally  with  C. burnetii  Arandale 
(grown in tissue culture and kept as described in section 2.3.2) until it became unwell, 
at  which  time  it  was  euthanased  and  the  spleen,  liver,  brain,  lungs  and  heart  were 
removed aseptically and placed into a pre-weighed sterile container and weighed again. 
Each  organ  was  then  homogenised  in  5ml  of  sterile  Hanks’  balanced  salt  solution 
(HBSS, Gibco, Australia). Following qPCR (section 2.4.2) the Ct result was used to 
calculate the approximate copy numbers of C. burnetii per gram of tissue (wet weight). 
From  this  the  best  SCID  mouse  organ  for  detecting  C. burnetii  infection  was 
established.  
 
Dilutions of the same starting material (described in 5.3) were used to compare the 
sensitivity of the three different assays; qPCR, cell culture and SCID mice inoculation. 
These dilutions were made as described in the previous chapter (Chapter 5). Ten fold 
dilutions  of  this  starting  material  were  made  in  HBSS  (Gibco,  Australia).  Previous 
studies (Chapter 5) demonstrated an approximate number of C. burnetii copies present 
in each of the dilutions (10
-5 to 10
-10) of the Henzerling isolate and (10
-8 to 10
-12) of the  
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Arandale  isolate.  These  dilutions  were  then  used  for  cell  culture  and  SCID  mice 
inoculation. 
 
6.3.1  Sensitivity of real time PCR (qPCR) 
DNA was extracted from 100µl suspensions of each dilution by the method described 
in  section  2.4.1  and  eluted  into  50µl  before  analysis  by  Com1  qPCR  (described  in 
section 2.4.2). As 5µl was used in each PCR analysis this was effectively 1/10
th (or a 
one in 10 dilution) of the bacterial DNA in the original starting suspension. The Ct 
results of positive qPCR tests were used to calculate the approximate copy numbers in 
each dilution from which a standard curve was made. This method was also used with 
cell cultures and SCID mice spleens to determine infection by the methods described 
below. 
 
6.3.2  Sensitivity of cell culture 
The various dilutions of C. burnetii were inoculated onto confluent 24 well plates of 
four different cell cultures (see Chapter 5) and allowed to grow for six weeks. Each 
monolayer was then collected, pelleted and resuspended in 300l of PBS and tested by 
Com1 qPCR for the presence of C. burnetii. The Vero and DH82 cell lines were shown 
to  be  the  most  sensitive  to  C. burnetii  infection  with  the  isolates  Arandale  and 
Henzerling  respectively  (Chapter  5)  and  therefore  these  were  used  in  the  current 
comparison experiments. 
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6.3.3  Sensitivity of SCID mice inoculation 
A volume (100l) of each dilution was inoculated intraperitoneally into three or four 
SCID  mice.  Dilutions  10
-8  to  10
-12  (Arandale  strain)  and  10
-5  to  10
-10  (Henzerling 
strain) were used to infect mice. Mice were kept at 22°C with food and water ad libitum 
(as described in section 2.4.8). They were observed daily  and the day  of death (or 
euthanasia) post infection (D.P.I.) was recorded. If observed to be terminally ill (e.g. 
hunchbacked, lethargic or losing fur) mice were euthanased. Euthanased mice were 
tested for the presence of C. burnetii by the removal of their spleen from which a 
homogenate was made in HBSS (Gibco, Australia). Other organs (liver, lung and brain) 
were removed and weighed from one mouse inoculated with a high concentration of the 
Arandale  isolate.  DNA  was  extracted  from  organ  homogenates  with  an  extended 
digestion time of 48 hours or until it appeared homogeneous, before testing by Com1 
qPCR as described previously. 
 
6.3.4  Analysis 
The  Spearman-Kärber  method  was  used  to  calculate  the  log10  of  the  C. burnetii 
suspension dilution that was 50% positive in the assay (Appendix A). These include i) 
50% positive by PCR i.e. Detection Dose 50 (DD50), ii) Tissue Culture Infectious Dose 
50  confirmed  by  Com1  qPCR  (TCID50),  iii)  SCID  mice  Infectious  Dose  50 
demonstrated by Com1 qPCR on SCID spleen homogenates (ID50) and iv) Lethal Dose 
50 for SCID mice (LD50). The analysis by qPCR was also used to generate standard 
curves  and  the  Ct  values  used  to  calculate  copy  numbers  and  concentration  of 
C. burnetii  DNA  (g/l).  These  standard  curves  were  then  used  to  calculate  the 
minimum copy numbers detected by each assay. 
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6.4 Results 
6.4.1  Mouse organ bacterial load 
The  bacterial  load  of  the  various  organs  from  a  single  mouse  inoculated  with  the 
Arandale  strain  are  shown  in  Figure  24.  The  spleen  had  the  most  concentrated 
C. burnetii followed by the lungs and the liver. The heart and the brain had the lowest 
concentration  of  C. burnetii.  The  spleen  was  used  in  all  subsequent  assays.  This 
experiment was not repeated as animal ethics approval could not be obtained for repeat 
investigations. 
 
 
Figure 24 Bacterial Load of C. burnetii DNA in SCID mouse organs 
The figure shows the concentration of C. burnetii cells (DNA) detected by Com1 PCR 
in five organs taken from one infected SCID mouse. The Ct result of the PCR was used 
to calculate the copy numbers per gram of tissue (wet weight). 
 
6.4.2  PCR 
PCR was compared with cell culture and SCID mouse inoculation for the detection of 
C. burnetii and also used as a means of semi-quantifying the numbers of bacteria used  
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in  the  titrations.  Each  dilution  was  tested  in  triplicate  by  the  Com1  assay  and  the 
approximate  copy  numbers  were  calculated  from  the  average  Ct  result.  Results  are 
shown in Figure 25 and Figure 26. 
 
 
 
Figure 25 Calculated copy numbers in the Henzerling dilutions 
The figure shows the average copy numbers calculated from the Com1 Ct result of the 
Henzerling dilutions from 10
-2 to 10
-7 tested in triplicate. The trend line was generated 
from dilutions 10
-2 to 10
-6 only as dilution 10
-7 was positive in only 2/3 tests.  
 
 
  
101 
 
Figure 26 Calculated copy numbers in the Arandale dilutions 
The figure shows the average copy numbers calculated from the Com1 Ct result of the 
Arandale dilutions from 10
-4 to 10
-9 tested in triplicate. The trend line was generated 
from dilutions 10
-4 to 10
-7 only as dilution 10
-8 and 10
-9 were both positive in only 1/3 
tests. 
 
6.4.2.1  Cell culture 
In the previous chapter four different tissue culture cell lines were analysed for their 
sensitivity in detecting C. burnetii. The most sensitive cell lines were DH82 for the 
Henzerling isolate (Table 21) and Vero cells for the Arandale isolate (Table 22). 
 
Table  21  Amplification  (detected  by  Com1  PCR)  of  C. burnetii  in  DH82  cell 
cultures  (in  triplicate)  six  weeks  after  inoculation  with  10-fold  dilutions  of 
C. burnetii suspension (Henzerling isolate) 
Dilution of  
C. burnetii inoculated 
Positive PCR flasks 
of DH82 cell culture 
10
-5  3/3 
10
-6  2/3 
10
-7  1/3 
10
-8  0/3 
10
-9  0/3 
Data in this table is summarised from Chapter 5 (Table 18). 
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Table  22  Amplification  (detected  by  Com1  PCR)  of  C. burnetii  in  Vero  cell 
cultures  (in  triplicate)  six  weeks  after  inoculation  with  10-fold  dilutions  of 
C. burnetii suspension (Arandale isolate) 
Dilution of 
 C. burnetii inoculated 
Positive PCR flasks 
of Vero cell culture 
10
-8  6/6 
10
-9  6/6 
10
-10  4/6 
10
-11  0/6 
Data in this table is summarised from Chapter 5 (Table 19). 
 
6.4.2.2  SCID mice inoculation 
The PCR results from testing of the homogenised mice spleens on the post infection 
day of death (before day 50) is shown in the following tables (Table 23 and Table 24). 
22 mice died due to C. burnetii infection, four mice died early (before day 30 and were 
not  considered  to  be  due  to  C. burnetii  infection),  six  euthanased  mice  were  PCR 
positive for C. burnetii and 12 euthanased mice were PCR negative. 
 
 
Table 23 Day of death or euthanasia (post-infection) of SCID mice inoculated with 
10-fold dilutions of a suspension of C. burnetii (Henzerling isolate) 
Day of death/euthanasia of four SCID mice  Dilution of C. 
burnetii inoculated  1  2  3  4 
Average 
(day) 
10
-5  35  35  45  48  41 
10
-6  39  39  40  40  40 
10
-7  42  43  43  44  43 
10
-8  39  49  +  -  ND 
10
-9  46  +  +  -  ND 
10
-10  -  -  -  -  ND 
The nine surviving mice were euthanased and the spleens removed, tested by Com1 
PCR and designated + for positive and – negative for C. burnetii DNA. ND: Not Done 
as less than three of the four mice died. 
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Table 24 Day of death or euthanasia (post-infection) of SCID mice inoculated with 
10-fold dilutions of a suspension of C. burnetii (Arandale isolate). 
Day of death/euthanasia of four SCID mice  Dilution of C. 
burnetii inoculated  1  2  3  4 
Average 
(day) 
10
-8  34  34  35  38  35 
10
-9  3*  22*  34  +  ND 
10
-10  34  37  +  +  ND 
10
-11  5*  16*  -  -  ND 
10
-12  -  -  -  -  ND 
The nine surviving mice were euthanased and the spleens removed, tested by Com1 
PCR and designated + for positive and – negative for C. burnetii DNA. Those with an * 
died well before day 30 and were considered to be deaths not due to C. burnetii (data 
not used in calculations). 
ND: Not Done as less than three of the four mice died due to C. burnetii infection. 
 
6.4.2.3  Summary of the three detection methods 
The  results  of  all  three  methods  of  detection  are  summarised  in  Table  25  (for  the 
Henzerling isolate) and Table 26 (for the Arandale isolate). For both isolates the SCID 
mouse inoculation and examination of the spleen by Com1 qPCR after day 42 was the 
most sensitive method for detecting viable C. burnetii in the original sample. 
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Table 25 Summary of sensitivity of detection of C. burnetii (Henzerling isolate) by 
direct qPCR, cell culture (at day 42) and SCID mouse inoculation after 49 days 
(death or spleen qPCR positivity). 
Number positive / total number tested 
C. burnetii Dilution 
Direct 
qPCR 
Cell 
culture 
SCID mouse 
death 
SCID mouse 
(spleen) infection 
10
-5  3/3  3/3  4/4  ND 
10
-6  3/3  2/3  4/4  ND 
10
-7  2/3  1/3  4/4  ND 
10
-8  0/3  0/3  2/4  1/2 
10
-9  0/3  0/3  1/4  2/3 
10
-10  0/3  ND  0/4  0/4 
Log of 50% detection dose  DD50 
1.5 10
7 
TCID50 
3.2 10
6 
LD50 
1.8 10
8 
ID50 
1.0 10
9 
Numbers of C. burnetii cells 
(copy numbers/100l) required 
for 50% positive assay response 
2.8  14.6  0.2  0.03 
ND not done as none of the four inoculated mice were alive at day 42. ID50 calculations 
include both qPCR positive spleens and SCID mice death due to C. burnetii infection. 
 
 
Table 26 summary of sensitivity of detection of C. burnetii (Arandale isolate) by 
direct qPCR, cell culture (at day 42) and SCID mouse inoculation after 42 days 
(death or spleen qPCR positivity). 
Number positive / total number tested 
C. burnetii Dilution 
Direct 
qPCR 
Cell 
culture 
SCID mouse 
death 
SCID mouse 
(spleen) infection 
10
-8  1/3  6/6  4/4  ND 
10
-9  1/3  6/6  1/2  1/1 
10
-10  0/3  4/6  2/4  2/2 
10
-11  0/3  0/6  0/2  0/2 
10
-12  0/3  0/6  0/4  1/4 
10
-13  0/3  ND  0/1  0/1 
Log of 50% positive dose  DD50 
1.5 10
8 
TCID50 
1.5 10
10 
LD50 
3.2 10
9 
ID50 
6.8 10
10 
Numbers of C. burnetii cells 
(copy numbers/100l) required 
for 50% positive assay 
response 
11.7  0.1  0.4  0.01 
ND not done as none of the four inoculated mice were alive at day 42. ID50 calculations 
included both qPCR positive spleens and SCID mice death due to C. burnetii infection. 
Those that died before  day 30  were not considered to be deaths due to C. burnetii 
infection and were not included for the LD50 or ID50 calculations. 
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6.5 Discussion 
The  gold standard and  most widely used technique for the diagnosis of Q  fever is 
serology by IFA. This is due to not only the ease of serum sample collection but also 
due  to  the  difficulty  involved  in  cultivating  these  obligate  intracellular  bacteria. 
However this method ideally requires the patient to be tested at the onset of Q fever and 
2-3  weeks  later  to  show  a  seroconversion.  Hence  the  technique  is  more  of  a 
retrospective diagnosis, and with acute cases usually only allows for diagnosis when 
the patient is recovering. 
 
It has been shown that PCR is a valuable tool for use early in the diagnosis as bacterial 
DNA can be detected in the patient’s blood within the first two weeks of illness
39. 
Isolation  of  C.  burnetii  is  only  rarely  used  for  diagnosis,  although  it  definitively 
demonstrates a current infection. It is also very useful to obtain isolates of C. burnetii in 
order  to  investigate  the  pathogenicity  and  genetics  of  different  isolates  and  for 
geographical comparisons.  In this study  three  different methods for detection of C. 
burnetii were compared. Two different isolates of C. burnetii were used as it has been 
shown that different strains can have different pathogenicity
108. 
 
In this study the Com1 qPCR assay was shown to have a sensitivity of three and 12 
copies  per  100µl  of  sample  (DD50)  respectively  for  the  Henzerling  and  Arandale 
isolates  of  C. burnetii.  This  limit  of  detection  by  PCR  was  in  agreement  with  the 
sensitivity found using cloned plasmids of the PCR product (section 3.4.1). The Com1 
assay could detect 1-10 copy numbers per reaction (in a ten fold series dilution). Since 
each reaction used 5µl and DNA was eluted in 50l, the limit of the PCR equates to 20-
200 copies per 100µl. Indeed a limit of three and 12 copies per 100µl (i.e. 30 and 120  
106 
copies per ml) was considerably better than previously published studies demonstrating 
a detection limit of 2,881 copies per ml (cloned plasmids)
81. There may even have been 
an underestimation of copy numbers detected by the PCR as not all DNA may have 
been  collected  in  the  elution  buffer.  It  might  be  feasible  to  further  increase  the 
sensitivity of the assay by increasing the elution volume and concentrating the DNA by 
precipitation, evaporation and re-suspension in a smaller volume. This would further 
increase the sensitivity of the PCR test. 
 
A greater concentration of C. burnetii cells was detected in the spleen of one infected 
SCID mouse than in any of the other five organs tested. This was in accordance with a 
previous study
6, which showed that among organs collected from mice infected with 
Phase I C. burnetii, spleens had the highest inflammation and antigen scores. Other 
organs with high bacterial loads were the liver and the lung. Hence it was the spleen 
that was used in subsequent testing of animal infections, with the liver as a possible 
alternative. 
 
Three different methods were compared for their sensitivity to detect C. burnetii in ten 
fold dilutions of a C. burnetii suspension. For both isolates the most sensitive method 
was  the  SCID  mouse  inoculation.  SCID  mice  are  known  to  be  highly  sensitive  to 
C. burnetii as shown by a loss of weight, splenomegaly and high numbers of bacteria in 
the spleens (compared to other mouse strains) when inoculated with low doses of Nine 
Mile Phase I C. burnetii
6. Indeed the lethal dose (LD50) of C. burnetii in SCID mice is 
10
8 times less than that for immuno-competent mice
4. 
 
A previous study showed that PCR detecting as few as 10 infecting units, was more 
sensitive than a centrifugation shell-vial isolation technique
105. However, cultures were  
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grown  for  six  days  only  and  vials  were  inoculated  with  dilutions  of  cell  culture 
suspensions  that  had  been  frozen,  which  may  have  reduced  the  viability  of  the 
C. burnetii cells. Previously it has been shown that buffalo green monkey (BGM) cover 
slip  cell  cultures  were  more  sensitive  to  C. burnetii  than  plaque  assays  and 
embryonated  chicken  eggs
99.  Indeed  cell  culture  is  faster,  less  laborious  and  more 
economical than these other methods. 
 
Previous  studies  have  demonstrated  differences  in  the  virulence  of  strains  of 
C. burnetii
55, 108. In this current study, fewer C. burnetii cells (Arandale isolate) were 
required  to  infect  SCID  mice  compared  to  the  Henzerling  isolate.  However,  more 
Arandale cells were required for a 50% lethal dose compared to the Henzerling isolate 
(Table 25 and Table 26), indicating that the Arandale isolate was less virulent for SCID 
mice. This may be due to bacterial genetic differences and this is examined in Chapter 
8. The two isolates also differ in the TCID50. However in this case the Henzerling 
isolate required >100  more C. burnetii cells to infect 50% of cell cultures than the 
Arandale isolate. Cell culture isolation of C. burnetii favours growth of isolates that are 
less virulent or that are recovered from acute cases of Q fever
5. This is possibly a 
reflection  of  the  Phase  change  as  Phase  I  cells  are  highly  virulent  with  a  low  cell 
infectivity, while Phase II cells are more easily phagocytosed yet very susceptible to 
host  defences
76.  This  was  demonstrated  previously  by  guinea  pig  inoculation  as 
infection with 10
8 Phase II organisms produced no seroconversion while as few as two 
to four Phase I organisms produced a seroconversion
76. If cell culture was more likely 
to grow Phase II C. burnetii this would lead to an overestimation of these less virulent 
strains  compared  to  more  virulent  isolates.  In  the  current  study  both  isolates  were 
considered to be in Phase I as they were derived from homogenates of SCID mice 
spleens.  Cell  culture  was  more  sensitive  than  SCID  mouse  death  for  the  Arandale  
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isolate suggesting it has a relatively low virulence. Indeed studies in another laboratory 
on the Arandale isolate have shown that it does not produce a fever (40°C) in guinea 
pigs nor does it produce an ELISA-detectable serological response in guinea pigs or 
mice  in  a  dose  response  manner  (Dr.  Brenda  Govan,  personal  communication). 
However, the Arandale isolate may be considered more virulent than the Henzerling 
isolate as it caused earlier deaths of the SCID mice with an equivalent inoculum as 
shown in the current study. 
 
In this study SCID mouse infection (as monitored by the detection of C. burnetii DNA 
by qPCR on spleen samples) was the most sensitive of the three methods tested for both 
isolates  (Arandale  and  Henzerling).  Despite  the  increased  sensitivity  of  the  SCID 
mouse assay, the practicality, ethics and cost effectiveness of animal inoculation is an 
important drawback to using this method. Coxiella burnetii isolation can take longer 
than serology even with a 2-3 week wait for the second serum sample to demonstrate a 
seroconversion. Isolation of C. burnetii is hazardous and costly in comparison to PCR 
analysis. Due to the bacteria’s classification as a category B bioterrorism agent in the 
USA, isolation must be carried out in a PC3 level bio-containment facility and hence it 
is not routinely performed. PCR is a technique increasingly used in diagnostic testing 
as it allows for a diagnosis to be made within a day whereas seroconversion can take 
several weeks. Indeed despite the lower sensitivity of PCR (compared to cell culture or 
SCID mice inoculation) it is the most useful method for a diagnostic laboratory due to 
its low cost, ease of analysis, speedy result and usefulness on samples that don’t have 
viable organisms (such as frozen samples) or contaminated samples. PCR also does not 
require PC3 level containment as bacteria are inactivated during the DNA extraction 
procedure and large numbers of organisms are not produced (unlike cell culture and  
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animal inoculation). PCR and isolation can also be used in chronic cases to determine 
the effectiveness of treatment
62. 
 
Our  study  shows  that  SCID  mice  inoculation  is  the  most  sensitive  assay  for  the 
detection of viable C. burnetii. However it is impractical to use SCID mice for routine 
diagnostic procedures due to the high probability of many negative samples and the 
length  of  time  taken  to  establish  an  infection  in  the  mice.  However,  SCID  mouse 
inoculation could be best used with known PCR positive samples to attempt isolation of 
C. burnetii for further studies. This would reduce the number of animals required and 
allow for the possibility of a centrally located PC3 animal house to provide mice for 
inoculation of positive samples from various diagnostic laboratories. SCID mice are 
more expensive to buy and maintain in comparison to cell culture. However, given that 
this study shows that they are five to 150 times more sensitive, the high value of this 
method for C. burnetii isolation makes the technique a valuable diagnostic and research 
tool. 
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C Ch ha ap pt te er r   7 7. .    A As sy ym mp pt to om ma at ti ic c   c ch hr ro on ni ic c   C Co ox xi ie el ll la a   b bu ur rn ne et ti ii i   
b ba ac ct te er ra ae em mi ia a   w wi it th ho ou ut t   s se er ro oc co on nv ve er rs si io on n   
   
7.1 Abstract 
Asymptomatic  or  subclinical  cases  of  Q  fever  represent  approximately  60%  of 
infections. Such infections have been previously diagnosed by serology or occasionally 
by  PCR  but  are  usually  not  detected  as  the  “patient”  is  well  and  not  investigated. 
Asymptomatic cases are thought to follow a similar progression to acute cases with the 
bacteria clearing in 2-3weeks. However previous studies have suggested the possibility 
of chronic, subclinical Q fever. Presented here is the description of a case of chronic 
bacteraemia  with  C. burnetii  in  a  person  who  was  not  only  asymptomatic  but  also 
seronegative. Their blood samples were positive by at least one PCR target (Com1 or 
IS1111) if not both the Com1 qPCR and a qPCR targeting the insertion sequence, on an 
ongoing basis (16 samples) over six months. Coxiella burnetii was cultured from one of 
the blood specimens by SCID mouse inoculation and passage of spleen homogenates 
into cell culture. The isolate (Poowong) has since been maintained in cell culture. The 
results  of  this  study  support  the  use  of  PCR  as  a  diagnostic  assay  at  any  stage  of 
infection or in instances of suspected Q fever exposure, and hence a duplex of the two 
qPCR assays was developed in which each target in the duplex qPCR had a sensitivity 
of one copy number per reaction while other medically important bacteria were not 
amplified. 
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7.2 Introduction 
Q fever is a zoonotic disease caused by the intracellular bacterium Coxiella burnetii. 
Around 54% of infected people do not display symptoms
34. The majority of patients 
with  symptoms  will  experience  acute  Q  fever,  a  self-limiting  “flu-like”  condition 
lasting 2-3 weeks. Q fever can also become chronic, persisting for six months to many 
years. Another recently recognised manifestation is the post Q fever fatigue syndrome 
(QFS) that presents similarly to Chronic Fatigue Syndrome (CFS) more than 12 months 
after acute Q fever
44. 
 
The gold standard and most widely used technique for diagnosis of acute Q fever is 
demonstration of a seroconversion by immunofluorescence assay (IFA). Occasionally a 
blood sample will be PCR positive and IFA negative. These are generally seen early in 
the onset of Q fever and later seropositive samples are PCR negative. A reduction in 
PCR positivity has been shown to occur as antibody titres increase
39 (Figure 27) and is 
due to bacteria being cleared from circulation. This has led to the suggested diagnostic 
strategy (Figure 28) of PCR and serology for the first two weeks, serology and PCR 
(for confirmatory purposes) in the following two weeks and serology only from week 
five onwards
39. 
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Figure 27 Cumulative sensitivity of PCR and serology
39 
The figure is from Fournier, P. E., and Raoult, D. (2003) and shows the comparative 
cumulative percentage of two different diagnostic methods, namely serology and PCR. 
The white circles represent the cumulative serology percentage with the trend marked 
by the dotted line. The black squares represent the cumulative PCR percentage with the 
trend marked by the solid line. 
 
 
 
 
 
 
Figure 28 Diagnostic strategy for the early diagnosis of acute Q fever
39 
The figure is from Fournier, P. E., and Raoult, D. (2003) and shows the suggested 
method of diagnosis made from the results of Figure 27. They used a light cycler nested 
PCR (LCN-PCR). It is suggested to use both methods in weeks one and 2, to use PCR 
only as a back up if the serology is below 1:25 in weeks three and four, and from week 
five to use serology only. 
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A second qPCR targeting a bacterial Insertion Sequence was analysed for sensitivity 
and specificity. Since the Insertion Sequence (IS1111a) occurs in 20 copies in Nine 
Mile Phase I strain
103, and in other isolates has been shown to vary from seven to 110 
copies
57 it was assumed to be a more sensitive target.  
 
Asymptomatic or subclinical Q fever infections have been previously  diagnosed by 
serology
63 and have been shown to remain seropositive for at least 12 months after the 
initial  test
28.  Many  asymptomatic  cases  go  undiagnosed  as  there  is  no  need  to 
investigate  a  disease  in  a  “patient”  who  is  well.  Generally  asymptomatic  cases  are 
considered to be part of the spectrum of acute infection and the bacteria are assumed to 
be cleared. However studies have shown PCR evidence of ongoing Coxiella burnetii 
infection (or antigenaemia) in cases five years
44 and (in asymptomatic cases) 12 years
69 
after infection. Q fever endocarditis has developed 5-10 years
80 and possibly even 20 
years
127 after acute disease. This indicates that C. burnetii can persist within the host 
without causing clinical symptoms, possibly due to the presence of a dormant form of 
the bacterium that is neither replicating nor being adequately cleared by the host. It may 
be  presumed  that  in  cases  of  relapsing  disease,  leading  to  chronic  Q  fever  or 
endocarditis, the C. burnetii are viable, while in cases that have only been proven by 
PCR the bacterium may not be viable and the PCR may be detecting dead bacteria. 
Indeed the persistence of antigen (or non-viable bacteria) has been postulated
70.  
 
A single case of asymptomatic C. burnetii bacteraemia is presented here, which was 
seronegative and diagnosed by PCR and isolation. Should more cases like this appear 
in the future it will lead to a reappraisal of C. burnetii pathogenesis and the relative role 
of serology and PCR in diagnosis.   
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7.2.1  Case history 
A  26-year-old  male’s  blood  sample  was  taken  as  part  of  his  normal  clinical 
investigations. Seven years prior to the sample being taken he had been employed in an 
Australian abattoir. He had received vaccination against Q fever after working there for 
approximately three months. He had no recollection of any symptoms consistent with Q 
fever.  
 
7.3 Methods 
The sensitivity of a qPCR targeting the insertion sequence IS1111 gene (described in 
section 2.4.3) was determined. The amplicon produced by the assay was cloned (as 
described  in  section  2.4.6)  and  the  resulting  transformed  E.  coli  were  pelleted  and 
purified  using  the  Plasmid  Maxi  Kit  (Qiagen,  Germany)  as  per  the  manufacturer’s 
specifications.  The  purified  plasmids  were  diluted  1:100  and  the  theoretical  copy 
numbers quantified using a Nanodrop ND-1000 spectrophotometer (Thermo Scientific, 
USA).  A series of 1:10 serial dilutions of the purified plasmid was analysed by qPCR 
(in triplicate) to create a standard curve from which the sensitivity of each reaction 
could be determined. Clinical samples from the case were tested by serology, qPCR of 
both targets (Com1 and IS1111) and some by inoculation onto confluent cell lines or 
into SCID mice as described below. 
 
7.3.1  Serology 
Analysis of antibody levels was performed by IFA with both Phase I and Phase II 
antigens. Serum was diluted both 1:25 and 1:400 (to detect any prozone effect) and  
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fluorescent FITC labelled anti-human conjugate was used for detection of antibodies 
(IgA, IgG, IgM and total) as described in section 2.2.1. 
 
7.3.2  PCR 
Buffy  coats  were  purified  from  blood  samples  before  cell  culture,  SCID  mouse 
inoculation and PCR as described in section 2.3.3.1.1. DNA was extracted from the 
purified buffy coats as described in section 2.4.1. qPCR analysis was performed using 
the methods described in sections 2.4.2 and 2.4.3. 
 
7.3.3  Cell culture 
Two hundred microliters of the purified buffy coat was placed into two 25cm
2 flasks 
with confluent monolayers of Vero and DH82 cell lines. Cultures were analysed by 
IFA  or  PCR  every  two  weeks  until  60  days  post  inoculation.  Media  was  changed 
fortnightly. 
 
7.3.4  SCID mice 
Four SCID mice were inoculated with 100l of blood intraperitoneally and observed 
for 60 days as described in section 2.4.8. 
 
7.3.5  qPCR duplex 
To reduce the amount of sample utilised by qPCR analysis and to increase the value of 
both qPCR assays, the two reactions were combined into a duplex. The two reactions 
and the primer and probe sequences are given in section 2.4.2 for Com1 and 2.4.3 for 
IS1111a. Each duplex reaction contained 400nM of Com1 primers, 200nM of Com1  
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probe  and  insertion  sequence  primers  and  100nM  of  insertion  sequence  probe,  1  
Platinum  qPCR  SuperMix-UDG  Master  Mix  (Invitrogen,  USA)  supplemented  with 
0.75l of 1.5mM MgCl and 5l of extracted DNA to a final reaction volume of 25µl. 
For  each  reaction,  one  positive  C.  burnetii  control  was  used  and  one  negative  “no 
template control” was used for every three samples. The qPCR was performed in a 
Rotor-Gene 3000 thermocycler (Corbett, Australia) with an initial holding temperature 
of 50°C for three minutes, followed by 95°C for five minutes then 60 cycles of 95°C 
for 20 seconds and 60°C for 40 seconds. Emission was monitored at the end of every 
60°C annealing and elongation step. Sensitivity of both reactions was determined using 
cloned amplicons as described in section 3.3 (for the Com1) and above (section 7.3) 
(for the IS1111). 
 
7.3.6  qPCR specificity 
To determine the specificity of the duplex reactions DNA was extracted by the column 
method (method 1) from other bacteria (Anaplasma phagocytophilium, Bacillus cereus, 
Capnocytophaga  canimorsus,  Enterococcus  faecalis,  Escherichia  coli,  Klebsiella 
pneumoniae, Legionella pneumophila, Listeria monocytogenes, Moraxella catarrhalis, 
Proteus  mirabilis,  Pseudomonas  aeruginosa,  Rickettsia  australis,  Staphylococcus 
aureus, Staphylococcus epidermidis and Streptococcus pneumoniae). Eluted DNA was 
quantified using a Nanodrop ND-1000 spectrophotometer (Thermo Scientific, USA) 
and diluted to a concentration containing approximately 1,000 copies per 5l (i.e. 1,000 
copies per reaction) before analysis by qPCR. These organisms were chosen to cover a 
variety of medically important bacteria and included gram negative and gram positive 
bacteria and both cocci and bacilli. 
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7.4 Results 
7.4.1  IS1111a standard curve 
The OD reading at 260nm was used to calculate the amount of DNA from which the 
numbers  of  plasmids  and  the  number  of  copies  of  the  IS1111a  amplicon  were 
determined. Ten fold dilutions of the extracted plasmids were then used to create a 
standard curve (Figure  29) from which an  equation was generated to  allow for the 
estimation of copy numbers from Ct values in subsequent PCR assays. The IS1111a 
gene has been found in 20 copies in the Nine Mile Phase I strain
103, in other isolates the 
number of IS1111 elements has been shown to vary from seven to 110
57. Due to this 
variability  numeration  of  IS1111a  copies  within  a  sample  was  not  generally 
determined, as it does not reflect the number of bacterial cells. The formula used to 
calculate copy numbers generated from the IS1111a standard curve was: 
x = e
(y-39.317/1.4527) 
where x is the copy number and y is the Ct. The standard showed a sensitivity of 1-10 
copy numbers per reaction. 
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Figure 29 IS1111a PCR standard curve 
The trend line in the figure was calculated with the copy number range 1x10
2 to 1x10
9. 
Those  containing  approximately  10  and  one  were  not  included  as  not  all  three 
triplicates were positive (and had a Ct result) and did not follow the expected trend. 
 
7.4.2  Initial Samples 
Blood in EDTA and clotted blood (serum) were taken each time the volunteer had 
blood collected for other clinical purposes. Four initial blood samples were collected 
and  tested  for  Q  fever  by  PCR,  serology  (IFA)  and  SCID  mouse  inoculation  (one 
sample only). Following the analysis of these samples a month long surveillance was 
undertaken  during  which  blood  samples  were  taken  three  times  per  week  for  four 
weeks. 
 
All four samples were negative by IFA yet three of the four samples taken were PCR 
positive by Com1. Each sample was tested “blind” as it was labelled and tested along 
side routine diagnostic specimens, the majority of which were negative. To confirm the 
PCR results coded samples were sent to an independent external laboratory along with 
other samples, including both positive and negative controls. Their results confirmed 
our findings. Blood samples were also inoculated onto confluent Vero and DH82 cell  
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cultures all of which were negative after 60 days growth. A PCR positive blood sample 
was used for inoculation into four SCID mice. Three of which subsequently died on the 
40
th day post inoculation. The fourth mouse was then euthanased and the spleen, liver 
and lung were homogenised, and were positive by PCR. All three homogenates were 
subsequently inoculated into Vero and DH82 cell culture. It was by this process that an 
isolate was obtained. 
 
7.4.3  Month long surveillance 
As a result of this unexpected finding a regular assessment was initiated whereby blood 
samples were taken every Monday, Wednesday and Friday for four weeks. As before, 
each  sample  was  tested  “blind”  as  it  was  labelled  and  tested  alongside  routine 
diagnostic specimens, the majority of which were negative.  
7.4.3.1  Serology 
All samples were tested for the presence of C. burnetii antibodies by IF at dilutions of 
1:25 and 1:400. All were screened as routine diagnostic specimens. All serology results 
were negative. 
7.4.3.2  Culture 
All samples obtained by the monthly assessment were also put into Vero and DH82 cell 
cultures as part of the normal diagnostic procedure. All cell cultures were negative 
when tested by IFA and PCR on 30 days and 60 days post inoculation. 
7.4.3.3  PCR 
DNA from all samples was extracted and tested for the presence of C. burnetii by two 
qPCR assays targeting the Com1 and insertion sequence IS1111a. Due to the small  
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elution volumes (to concentrate DNA) the PCRs could only be repeated three and two 
times respectively for each assay. The results are shown in Figure 30. Ten of the 12 
samples were positive by the Com1 PCR at least once. All 12 were positive by IS1111a 
PCR at least once. 
 
 
 
Figure  30  PCR  results  over  one  month  in  surveillance  of  an  asymptomatic 
“patient” 
The figure shows the number of times a blood sample was PCR positive by the Com1 
and IS1111a assays. Each sample was tested three and two times respectively. Only 
two samples were consistently Com1 negative (3 and 4). All samples were positive 
both times with the IS1111a assay, with the exception of the sample 3, which was 
positive only once. The diamonds represent the average concentration of DNA (g/l) 
derived from the Com1 assay. 
 
7.4.4  Sensitivity of the duplex qPCR 
By  analysis  of  plasmid  containing  target  amplicons  in  concentrations  ranging  from 
1 10
9 to 1 10
-3 copies per reaction the sensitivity of both reactions in the duplex qPCR 
was  determined  to  be  approximately  1-10  copies  per  reaction.  This  is  the  same  
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sensitivity  as  observed  in  each  reaction  alone  (Figure  8  and  Figure  29).  The  other 
intracellular bacteria and medically important bacteria tested were all negative for both 
targets. 
 
7.5 Discussion 
Diagnosis of Q fever generally relies on serology. The gold standard and most widely 
used  technique  is  IFA.  A  case  of  seronegative  chronic  asymptomatic  C. burnetii 
bacteraemia is described here that would have been unrecognised had it not been for 
the positive PCR assay for C. burnetii DNA in the blood. As two qPCR targets were 
used here this study has also shown a difference in the sensitivity of the two assays and 
that with the use of only one reaction very low numbers of bacteria may be missed. The 
second target, the bacterial insertion sequence IS1111, was shown to be as sensitive as 
1-10 copy numbers per reaction. The Com1 qPCR is also as sensitive as 1-10 copies per 
reaction,  however  as  the  insertion  sequence  is  present  in  multiple  copies  in  the 
C. burnetii genome, up to 110 copies 
57 this assay is likely to be more sensitive. 
 
It has been suggested that confirmation of PCR positive asymptomatic cases is rare and 
should be treated with caution
89. However, it would be unreasonable to dismiss these 
results as faulty serological tests or contaminated PCRs as it is extremely unlikely that 
all  16  samples  became  contaminated  when  they  were  tested  “blind”,  run  alongside 
other  diagnostic  specimens  (most  of  which  were  negative),  there  being  one  “no-
template control” for every three samples tested and at least one negative diagnostic 
specimen in each PCR run. Furthermore an independent external laboratory confirmed 
the results of the initial four samples. Moreover the isolation of C. burnetii confirms the 
PCR results. The isolate was named “Poowong” after the region the isolate was most  
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likely to have originated from. The variation in the PCR results and the amount of 
DNA  detected  suggests  that  the  bacteria  were  circulating  intermittently  and  when 
bacteraemic the concentration of bacteria present in the blood was extremely low. 
 
This case is particularly interesting, as while the PCR positivity did not disappear with 
time, serology remained negative in all four of the initial samples and, six months later, 
in 12 samples taken over a one month period. The lack of serological response has been 
reported previously in nude mice (deficient in T cells) following infection with Nine 
Mile Phase I C. burnetii
6. These mice have an impairment in antibody production due 
to a lack of helper T-cells and a defect in B-cell maturation. Nude mice did however 
have an antibody response to infection with Phase II C. burnetii although the titres were 
decreased compared to other immunodeficient and wild type mice. It was speculated 
that this could be because Nine Mile Phase I cells (unlike Phase II cells) do not activate 
dendritic cells, hence B-cells do not become activated and with a lack of T helper cells 
in the nude mice this resulted in a lack of antibody production
6. In addition to nude 
mice  studies  have  shown  that  several  animals  may  also  be  infected  with  and  shed 
C. burnetii without detectable antibodies, including goats
93 and sheep
19. 
 
Whilst serology is recommended as an integral part of the diagnostic strategy (Figure 
28) at all stages and is considered the diagnostic gold standard there have been reports 
of negative serology in some patients. In studies following Q fever vaccination only 56 
to 64% of subjects seroconverted
68. In a further study only 65% of vaccinated subjects 
seroconverted
128. A seronegative result has been reported in an infected case although 
only one serum sample was acquired
115. Another study showed that after only one year 
following acute Q fever, 1.2% of patients had no detectable antibodies
33. Indeed it has 
been  recommended  that  one  negative  complement  fixation  test  for  culture  negative  
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endocarditis is not sufficient to rule out Q fever as a diagnosis
45. This leads to the 
possibility that not all Q fever infections will produce a detectable antibody response. 
 
This study supports the use of PCR as a diagnostic assay to supplement serology at any 
stage of Q fever infection. Both PCR assays are required, as shown by this study, as 
occasionally the Com1 assay alone would have missed the low numbers of circulating 
bacteria. The Com1 PCR is less sensitive than the IS1111a PCR as demonstrated here 
as the number of IS1111a elements has been shown to vary from between seven to 
110
57. For example, in the Nine Mile Phase I strain there are 20 copies of this Insertion 
Sequence
103. However, Com1 is very useful as it is present as one copy only in all C. 
burnetii genomes and can therefore be used to quantify the numbers of bacteria present. 
It  is  also  useful  for  confirmatory  purposes  and  for  strains  that  may  not  have  the 
insertion sequence. However, a study by Marmion et al.,
69 suggested that it may not be 
present in all strains of the bacteria. DNA from all 22 acute Q fever and eight QFS 
patients, from one outbreak of the disease in Birmingham, UK in 1989 (and hence 
presumably all the one strain) were Com1 positive but IS1111a negative. More recently 
C. burnetii  strains  detected  in  placental  tissues  of  marine  mammals  by  C. burnetii 
specific PCR (Com1, CBU_0678 and CBU_0686) and confirmed by high homology 
with  known  C. burnetii  16S  rRNA  sequences,  were  also  negative  in  a  PCR  assay 
targeting the Insertion Sequence IS1111a
102. For this reason both qPCR assays (Com1 
and  IS1111a)  were  combined  into  a  duplex.  This  duplex  qPCR  assay  was  highly 
specific  producing  negative  results  for  all  other  bacteria  tested.  The  Com1  and  the 
IS1111a  PCR  assays  were  highly  sensitive,  detecting  1-10  copies  per  reaction  as  a 
duplex assay. The use of the two targets allows for identification of potential amplicon 
contamination. 
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The results of this study raise a few questions: how many people have sub-clinical 
infections but are not tested because they have no symptoms? Q Fever is a disease that 
is possibly widely under diagnosed because of its non-specific flu-like symptoms and 
also due to the misconception that animal contact is required. Indeed 24% of samples 
taken  from  areas  including  grocery  stores,  post  offices,  banks  and  hospitals  in  the 
United States of America were positive suggesting that human exposure to C. burnetii 
is more common than reported
56. How many infections or exposures are missed by only 
testing for a serological response? If tested only by serology, cases similar to the one 
presented  here  would  be  missed.  What  are  the  long  term  effects  of  circulating 
C. burnetii? Could these latent infections become reactivated later and cause serious 
problems such as endocarditis? Studies have shown that reactivation can occur 5-10 
years after original infection
80. What are the implications of a carrier of C. burnetii for 
blood donations and organ transplants? Until this study was conducted the volunteer 
was a blood donor. The Australian (Red Cross) blood bank does not test for Q-fever 
and asymptomatic carriers are unlikely to be tested for Q fever. 
 
The possibility that this asymptomatic, seronegative case of Q fever is due to a genetic 
difference in the isolate, which may thus be a less virulent strain, is investigated in 
Chapter  8.  The  inadequate  clearance  of  the  C. burnetii,  the  lack  of  symptoms  and 
antibody production may also be due to differences in the host response to infection, 
which should be further investigated. 
 
Since this study was completed a second asymptomatic person who was seronegative 
had been found to be qPCR positive and from whom an isolate of C. burnetii was 
obtained  (C2V2)  through  cell  culture  (Dr  Hazizul  Hussain-Yusef,  personal  
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communication).  This  isolate  has  been  grouped  in  geno-group  III  (Mr  Mohammad 
Yazid Abdad, personal communication).  
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8.1 Abstract 
Seven new Australian isolates of Coxiella burnetii from humans (six cases of Q fever 
and  one  asymptomatic  person)  were  genetically  analysed  and  classified  into  geno-
groups. Six of the isolates were placed in geno-group III and one (Poowong) from the 
asymptomatic person, was classified in geno-group II. This geno-group classification 
claims to separate isolates into acute and persistent (group I), acute only (group II) and 
animal infections (group III). The new Australian isolates were further analysed by low 
cost  and  density  (LCD)-array  targeting  the  insertion  sequence  gene  and  the  acute 
disease  antigen  gene  (adaA).  The  six  Australian  isolates  from  geno-group  III  were 
negative for the adaA gene suggesting that these six isolates were from chronic cases of 
Q fever. However five were from clinically acute cases and only one was isolated from 
a  chronic  case.  One  isolate  (Poowong),  from  an  asymptomatic  case  of  chronic 
bacteraemia,  was  classified  in  Group  II  and  was  positive  for  the  adaA  gene.  The 
Poowong isolate was found to have a 2bp difference in a 468bp sequenced portion of 
the ankyrin gene (ankH) to both reference strains Nine Mile (clone 4) and Henzerling. 
 
8.2 Introduction 
Coxiella  burnetii  is  the  cause  of  Q  fever,  a  disease  that  manifests  with  clinical 
presentations ranging from asymptomatic to acute to chronic disease.  Several studies 
have  been  undertaken  in  an  effort  to  determine  if  the  disease  outcome  was  due  to  
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genetic  differences  between  the  bacteria.  Historically  the  only  variation  in  Coxiella 
burnetii isolates that has resulted in a difference of virulence was the Phase change. 
More recently genetic studies have revealed differences in isolates of C. burnetii (e.g. 
plasmid type)  as possible causes of different disease manifestations
97. Isolates have 
been grouped into three plasmid types and two different disease types. It was suggested 
that chronic Q fever was caused by isolates containing the plasmid QpRS and those 
with plasmid sequences integrated into the chromosome but not those containing the 
plasmid QpH1
97. This led to the development of probes to differentiate plasmid types
65. 
However this hypothesis was confounded when it was demonstrated that an isolate 
from a case of endocarditis was positive for a PCR assay targeting sequences on the 
plasmid QpH1 and had the same restriction pattern as the Nine Mile strain
110. Indeed 
another plasmid was found, QpDV, which was associated with both acute and chronic 
isolates
116. 
 
Several  studies  have  been  conducted  on  the  genetic  diversity/homology  between 
C. burnetii strains. Genetic analyses have been  performed by a number of methods 
including: restriction endonuclease fragment length polymorphism (RFLP)
118 separated 
by  sodium-dodecyl  sulfate-polyacrylamide  gel  electrophoresis  (SDS-PAGE)
50  or 
pulsed  field  gel  electrophoresis  (PFGE)
46,  54,  111,  PCR-RFLP
77  and  sequencing  of 
particular genes
101, 132, variable number tandem repeats (VNTR), multiple-locus VNTR 
analysis  (MLVA)
8,  109,  infrequent  restriction  site-PCR  (IRS-PCR)
8,  multi-spacer 
sequence typing (MST)
42, micro-array
14 and IS1111 conventional PCR
30. A summary 
of the methods used previously to genotype isolates of C. burnetii is shown in Table 27. 
These genetic analyses have revealed differences in isolates from cases of acute and 
chronic  disease.  For  example,  comparisons  of  isolate  genomes  that  have  been 
completely sequenced have suggested that the isolate Dugway is more primitive than  
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the other isolates. Dugway has undergone the least amount of genome reduction and 
has features that the other more virulent strains have lost, presumably during adaptation 
to their hosts
15. Some studies have shown a difference in isolates with different passage 
histories
118 suggesting that Phase variation by passages in cell culture may be due to 
deletions.  However,  others  have  shown  that  isolates  remain  genetically  the  same 
despite their passage history
109. The ability of acute isolates to cause fever in the guinea 
pig is currently the only detectable pathogenic difference between acute and chronic 
isolates of C. burnetii
49, 76. 
 
Table 27 Published methods of genotyping C. burnetii 
Method  No. of groups/isolates  Notes  Reference 
and year 
RFLP  4 different patterns 
6 isolates 
Digested by HaeIII 
118 1986 
RFLP  SDS-
PAGE 
6 groups 32 isolates  Digested by EcoRI, BamHI 
and HindIII 
50 1991 
Com1 gene  4 groups 
21 isolates 
19 nucleotide differences, 10 
amino acid changes of 1,060bp 
sequenced 
132 1997 
RFLP-PFGE  20 patterns, 80 isolates  Digested by NotI 
54 1998 
Com1  and 
mucZ gene 
5 groups by Com1 
4 groups by mucZ 
37 isolates 
715bp Com1, 774bp mucZ. In 
agreement with each other but 
not with disease 
101 1999 
icd  gene 
sequence  or 
PCR-RFLP 
3 groups icd gene 
2 groups PCR-RFLP 
19 isolates 
RFLP digested by AccII, 
1 or 2 bands – separating acute 
from chronic  
77 1999 
MST  30 groups, 173 isolates  3 major clusters 
42 2005 
Micro-array  7 groups, 24 isolates  2,103 ORFs of Nine Mile with 
139 polymorphic ORF’s 
14 2006 
MLVA  9 types in 5 clusters 
16 isolates 
7 marker loci 
 
109 2006 
MLVA  36 groups 42 isolates  17 marker loci 
8 2006 
IRS-PCR  6 patterns 14 isolates  4 different IRS-PCR assays 
8 2006 
IS1111 PCR  5 groups 21 isolates  Same as RFLP SDS-PAGE 
30 2007 
 
As well as whole genome analyses, another study grouped isolates by differences in the 
insertion sequence IS1111 genes
30. This was possible as each of the 20 IS1111 genes in 
the Nine Mile sequence is surrounded by different flanking sequences
30. The insertion  
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sequences used to differentiate groups were IS9, IS20, IS5 and IS14. PCR assays were 
developed with one common primer within the IS1111 gene and four primers outside 
the gene, each PCR was performed separately and isolates were grouped according to 
which IS PCR produced a positive ~500bp product following the algorithm shown in 
Figure 31 (in methods section 8.3.1). Grouping by this method correlated well with the 
grouping performed by RFLP SDS-PAGE analysis
50. Unfortunately no isolates from 
group VI were used in the development of this method so it is unknown which IS PCRs 
would be positive and which group they would belong to following the algorithm. 
 
 
In  addition  to  the  genetic  studies,  several  studies  have  been  initiated  to  determine 
antigenic differences between acute and chronic isolates. One such study identified a 
28kDa polypeptide in human cases of acute Q fever, ticks and milk but not in human 
cases of chronic Q fever
114. This marker was named the “acute disease antigen A” 
(adaA) and it’s genetic sequence has been determined (GenBank ID AA090475.1)
130. 
Primers were developed to detect this gene and it was not found in isolates from cases 
of chronic Q fever
130. It was thought that isolates that cause chronic Q fever in humans 
were also the cause of abortion in goats. The adaA gene however was not found in 
isolates from naturally infected goats that had aborted
37. Due to it’s presence in acute 
disease isolates and not in chronic isolates it may be useful in differential diagnosis as a 
PCR  target  or  adaA  antigen-based  serodiagnostic  test
130.  A  ‘low  cost  and  density’ 
(LCD) DNA micro array chip (Coxiella 2.5) was developed which targeted the adaA 
gene  and  the  insertion  sequence  as  a  control
40.  A  summary  of  some  isolates  of 
C. burnetii and their grouping, plasmid type and presence of the adaA gene is given in 
Table 28. 
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Table 28 Published group, plasmid and adaA gene in several isolates of C. burnetii 
Isolate  Isolated from  Disease type  Group(50)  Plasmid(50)  adaA(114) 
Nine Mile  Tick  Unknown  I  QpH1  + 
California 
76 
Cow  Persistent  I  QpH1  + 
El Tayeb  Tick  Unknown  I  QpH1  + 
Ohio 314  Cow  Persistent  I  QpH1  + 
Australia 
QD 
Human blood  Acute  I  QpH1  Unknown 
Henzerling  Human blood  Acute  II  QpH1  + 
Priscilla  Goat  Unknown  IV  QpRS  - 
Ko Q229  Heart Valve  Chronic  V  NP  - 
SQ 217  Liver  Chronic  V  NP  - 
GQ212  Heart Valve  Chronic  V  NP  - 
Dugway  Rodents  Unknown  VI  QpDG  + (40) 
References used are indicated in brackets. NP (no plasmid) sequences integrated into 
genome. 
 
 
In the current study the method of grouping by IS1111 PCR
30 and the LCD-array chip
40 
were  used  to  classify  seven  new  Australian  isolates.  This  method  involves  the 
amplification of certain C. burnetii specific genes and the hybridisation of the amplified 
genes onto a chip. Positive hybridisation is then viewed with a label that produces a 
colour change. The most divergent Australian isolate (Poowong) was further studied by 
sequence analysis of the ankyrin gene, which has been shown to have considerable 
heterogeneity among isolates
15. 
 
8.2.1  Case histories: 
The background information and diagnostic test results of the patients from whom the 
seven C. burnetii isolates were obtained are presented below. 
8.2.1.1  Arandale 
This isolate was obtained from a 56 year old male who lived in northern NSW. He had 
symptoms  of  Q  fever  following  attendance  at  a  goat  parturition.  The  isolate  was  
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obtained  through  cell  culture  of  the  buffy  coat  from  an  EDTA  blood  sample.  The 
original serum sample was seronegative by IFA. A serum sample taken three days later 
was seropositive with total antibody titres of 400 for Phase II and 3200 for Phase I. 
This serological result was highly unusual as typically antibodies to Phase II arise first 
and probably represents a laboratory error. Seven days later a third serum sample was 
collected which was also seropositive with titres of 3200 for Phase II and 400 for Phase 
I. This was an acute case of Q fever. 
8.2.1.2  Cumberland 
A 64 year old male farmer from northern NSW who worked with cattle presented with 
fever and headache. A serum sample was negative by IFA. An EDTA sample taken two 
days later was PCR positive for C. burnetii DNA and an isolate was obtained through 
cell culture. Seventeen days later a subsequent serum sample was seropositive with 
titres of 1600 to Phase II and 400 to Phase I. This was an acute case of Q fever. 
8.2.1.3  Harvey 
A 27 year old male abattoir worker from northern Victoria presented with aortic valve 
endocarditis. A serum sample was seropositive for Q fever with titres of 3200 for both 
Phase II and Phase I. His aortic valve was removed and was positive by PCR. An 
isolate  was  obtained  from  this  specimen  by  cell  culture  from  a  homogenate  of  the 
tissue. This was a case of chronic Q fever. 
8.2.1.4  Marshall 
An  82  year  old  male  from  northern  NSW  presented  to  hospital  with  Q  fever 
pneumonia. He was seropositive with titres of 3200 to Phase II and 1600 to Phase I. A 
blood sample was taken 47 days later and although PCR negative, yielded an isolate of 
C. burnetii through SCID mouse inoculation and subsequent isolation from the spleen.  
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As this isolate was obtained 47 days after onset it may have been a case of persistent 
bacteraemia following acute illness. This was a case of acute Q fever due to the higher 
Phase II titres. 
8.2.1.5   Poowong 
The case history and isolation of the Poowong isolate was described in Chapter 7. This 
was an asymptomatic case of chronic bacteraemia that was seronegative. 
8.2.1.6  Timony 
A  56  year  old  male  from  central  NSW  presenting  with  fever  and  headache 
demonstrating  leucopaenia,  neutropaenia  and  thrombocytopaenia  was  negative  by 
serology but positive for C. burnetii by PCR on an EDTA sample, which subsequently 
yielded an isolate by SCID mouse inoculation followed by cell culture of the spleen 
homogenate. The following day a serum sample was taken that was seronegative. An 
EDTA sample collected two days later was again positive by PCR for C. burnetii DNA. 
A serum sample taken 131 days following the initial sample was positive with titres of 
800 to Phase II and 200 to Phase I. This was an acute case of Q fever. 
8.2.1.7  Wicks 
A 32 year old male abattoir worker from northern NSW presented with a flu like illness 
and was tentatively diagnosed with a possible chronic localised infection. An initial 
serum sample was seronegative although it yielded an isolate of C. burnetii by cell 
culture. A serum sample taken 14 days later was positive with titres of 3200 to both 
Phase II and Phase I. In a serum sample taken 38 days later the Phase II titres had 
remained  but  the  Phase  I  titres  had  dropped  to  1600.  On  the  105
th  day  titres  had 
dropped further to 800 (Phase II) and 400 (Phase I). The high titre to Phase I in the 14 
day sample was unusual as Phase I antibodies generally take a few weeks to develop.  
133 
However, this pattern was consistent with a previous infection with C. burnetii. Indeed 
this patient claimed to have been infected with Q fever at the age of 10 and was said to 
be seropositive in 1999, although this was not documented. His immunity may have 
waned. This was an acute case of Q fever due to the lack of remaining high Phase I 
titres. 
  
8.3 Methods 
The seven isolates were genotyped along with two reference strains (Nine Mile clone 4 
and Henzerling). Australian isolates were obtained from uncoagulated blood or buffy 
coats, serum or tissue samples as described in the case histories following the methods 
described  in  section  2.3.3.  Cell  cultures  of  C. burnetii  isolates  were  maintained  as 
described in section 2.3.2. 
8.3.1  Differentiation by conventional PCR 
Coxiella  burnetii  isolates  were  grouped  by  IS1111  conventional  PCR as  previously 
described
30.  Samples  were  grown  in  cell  culture  as  previously  described  in  section 
2.2.1, and DNA was extracted as described in section 2.4. The IS1111 primers are 
described in Table 29. Each PCR reaction contained 20l of 1.25  master mix, 200nM 
of IS111-1 primer, 200nM of the other primer and 2l of DNA template in a total 
reaction volume of 25l. Each reaction has the same thermocycle parameters of three 
minutes at 95°C, 40 cycles of 30 seconds at 95°C and 30 seconds at 68°C, followed by 
a final extension of seven minutes at 72 °C. Amplicons were analysed on 1.2% agarose 
gel (Sybre-Safe; Invirtrogen, USA) and photographed. The isolate was then grouped 
based on which PCRs were positive following the algorithm (Figure 31). An isolate is 
first tested for the IS9 gene, if this is missing the isolate can be placed in the IV group. 
If IS9 is present the isolate is then tested for the IS20 gene, if it is missing the isolate  
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can be placed into group II. If present the isolate is then tested for the IS5 gene, if it is 
missing the isolate is placed into group V. If present the isolate is then tested for the 
IS14 gene, the isolate can be placed into group III if the IS14 gene is missing, and if 
present in group I.
30 
 
Table 29 IS1111 primer sequences for genotyping 
Primer  Sequence 
IS1111-1  ACT GCG TTG GGA TAC CCA TC 
IS9  GCC TCA GCC GAT TTC GAG 
IS20  ACG TCA ATT ACA TCG AGC ATT CA 
IS5  GTC GGT CAA CGT CGT CAC AT 
IS14  TGC TAC CAA CAG ACT TAC GGC A 
 
 
Figure 31 Method for grouping by IS1111 differences
30 
The  figure  (from  Denison,  A.  M.  et  al.,  2007)  shows  a  simplified  way  to  group 
C. burnetii isolates by differences in IS1111 genes.  
 
8.3.2  LCD-array gene chip 
This assay was kindly supplied by Dr Dimitrios Frangoulidis (Bundeswehr Institute of 
Microbiology, Munich). Detection of the adaA gene was achieved by LCD-array DNA- 
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DNA  hybridisation  as  per  the  manufacturer’s  instructions  (Chipron,  Germany).  All 
reagents were supplied with the LCD-array kit. Each isolate was amplified individually 
and  eight  isolates  were  analysed  on  a  single  slide.  DNA  from  each  isolate  was 
amplified  for  the  adaA,  IS1111a  (internal  C. burnetii  positive  control)  and  Lambda 
control genes. The primers and reaction mixtures are described in Table 30 and Table 
31 respectively. The cycling parameters were three minutes at 96°C, followed by 35 
cycles of 45 seconds at 94°C, 45 seconds at 54°C and 45 seconds at 72°C, followed by 
a final extension of three minutes at 72°C. 
 
Table 30 LCD-array primer sequences 
Primer  Sequence 
IS1111 Forward  GGT AAA GTG ATC TAC ACG AGA CGG 
IS1111 Reverse  BIO-TCT TTA ACA GCG CTT GAA CGT C 
adaA Forward  AAT AGA TTC GCT CTC TCA AGC CG 
adaA Reverse  BIO-GGT TTC TTC CCA AAG TCA CCG 
Lambda Forward  ATG CCA CGT AAG CGA AAC A 
Lambda Reverse  BIO-GCA TAA ACG AAG CAG TCG AGT 
The reverse primers were biotinylated as indicated by BIO- 
 
Table 31 LCD-array PCR mix 
Reagent  Amount for 1 sample  Amount for 9 samples 
PCR Buffer 10   2.5l  22.5µl 
MgCl 50mM  1l  9l 
taq polymerase 5U/l  0.15l  1.35l 
dNTP’s 200M  0.5l  4.5l 
IS1111 primer mix  1l  9l 
adaA primer mix  1µl  9µl 
Lambda primer mix  1µl  9µl 
PCR water  15.85l  142.65µl 
Total  24l   
Template  1l   
 
 
The PCR products were prepared before they were applied to the slide. To each well 
22l of hybridisation buffer and 2l of modulator (included in the kit) was added. To  
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an individual well 10l of PCR product from one isolate was added and mixed by 
gently pipetting up and down. This was placed inside the humidity chamber supplied 
and incubated  at 35°C for 30 minutes. The slide was then  washed three times and 
allowed to air dry. The label mix was made up as per the manufacturer’s instructions 
and  added  to  each  well  and  the  slide  was  incubated  at  room  temperature  for  five 
minutes, the slide was then re-washed and dried. Stain solution was added to each well 
used  and  the  slide  was  incubated  at  room  temperature  until  spots  became  clearly 
visible. The staining was stopped by rinsing for 15 seconds, after which the slide was 
dried and photographed. There are eight wells in each chip as shown in Figure 32. 
 
 
Figure 32 LCD-array chip and well layout 
The figure shows the layout of the Coxiella LCD-array and the layout of one well. The 
capture probes are as follows; 1 and 2 are IS1111 (IS1111-S-01 and IS111-S-02), 3 and 
4 are adaA Gen (ada A-S-01 and ada A-S-02), 5 and 6 are Lambda (Lambda-S01 and 
Lambda-S02) and C (the hybridisation control) is “Alien” sequence. 
 
8.3.3  Ankyrin gene sequencing 
Primers were designed to amplify a fragment of the ankyrin gene (ankH) using Primer 
select software (DNA Star, USA). The primers were Ankyrin F (AAA AGC AGC CGA 
AAA TAA ACA TCA) and Ankyrin R (TGG CCC AAC AAC TCA TTC ACT ACT) 
and  they  amplified  a  468bp  region  of  the  gene.  Each  PCR  reaction  contained  the  
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reagents described in Table 32, with cycling parameters of an initial three minutes at 
95°C followed by 40 cycles of 30 seconds at 95°C, 30 seconds at 55°C and 30 seconds 
at 72°C, followed by seven minutes at 72°C. The PCR products were removed from the 
thermocyler as soon as it had cooled enough to touch. Samples were analysed on a 
1.2% agarose gel containing Sybre-Safe (Invitrogen, USA). 
 
Table 32 Ankyrin PCR mix 
Reagent  Amount per sample 
PCR Buffer 10   2.5l 
MgCl 50mM  1.5l 
taq polymerase 5U/l  0.4l 
dNTP’s 200M  0.5l 
Ankyrin F 200nM  2.5l 
Ankyrin R 200nM  2.5µl 
PCR water  13.1l 
Total  23l 
Template  2l 
 
Samples with positive amplicons (as observed by a band on the gel at 400-500bp) were 
cloned
107.  Purified  plasmids  were  diluted  1:100  and  the  theoretical  copy  numbers 
quantified using a Nanodrop ND-1000 spectrophotometer (Thermo Scientific, USA).  
Plasmids were sequenced as described in section 2.4.7. Sequences were then compared 
using MegAlign (DNA star, USA) alignment software. 
 
8.4 Results 
The seven Australian isolates were grouped by IS1111 PCR and by LCD-array gene 
chip  analysis.  The  most  divergent  isolate  (Poowong)  was  further  analysed  by 
comparing the sequence of the ankyrin gene with two reference strains (Nine Mile and 
Henzerling).  
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8.4.1  IS1111 genotyping 
The results of the IS1111 PCR grouping of isolates are summarised in Table 33. 
 
Table 33 Insertion sequence conventional PCR results 
Isolate  IS9  IS20  IS5  IS14  Group  Origin 
Nine Mile (Clone 4)  +  +  +  +  I  USA 
Henzerling  +  -  +  -  II  Italy 
Arandale  +  +  +  -  III  Australia 
Cumberland  +  +  +  -  III  Australia 
Harvey  +  +  +  -  III  Australia 
Marshall  +  +  +  -  III  Australia 
Poowong  +  -  +  -  II  Australia 
Timony  +  +  +  -  III  Australia 
Wicks  +  +  +  -  III  Australia 
+  indicates  that  a  band  approximately  500bp  was  amplified  and  was  considered 
positive, - indicates a negative as no band was observed. The groupings were made by 
the algorithm shown in Figure 31. 
 
8.4.2  LCD-array gene chip 
The results of the LCD-array gene chip analysis of the isolates are summarised in Table 
34. 
 
Table 34 Summary of LCD-array results 
Sample  Com1 Ct  IS1111  adaA 
Negative control (no template)  -  -  - 
IS1111 plasmid (positive control)  ND  +  - 
adaA plasmid (positive control)  ND  -  + 
Nine Mile (Clone 4)  24  +  + 
Henzerling  16  +  + 
Arandale  15  +  - 
Cumberland  16  +  - 
Harvey  10  +  - 
Marshall  17  +  - 
Poowong  17  +  + 
Timony  15  +  - 
Wicks  8  +  - 
ND: Com1 PCR was not performed on these samples as they were plasmid controls 
provided in the kit that would not contain the Com1 gene, + positive – negative. 
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8.4.3  Sequencing 
The ankyrin gene ankH (468bp) of the Poowong isolate was sequenced and compared 
to  the  sequences  of  the  two  reference  strains  used  in  this  study.  The  gene  was 
sequenced in both directions for a total of three times for each isolate. The sequences of 
the Poowong strain compared to two reference strains demonstrated 2bp differences 
(Table  35)  out  of  a  total  468bp  this  equates  to  0.4%.  At  the  protein  level  the 
substitutions  translated  to  two  amino  acid  substitutions  reducing  the  homology  by 
1.3%. A Hydrophobicity  Plot was  generated (Figure 33) by  the Kyte and Doolittle 
method
59 (using website: http://www.vivo.colostate.edu/molkit/hydropathy/index.html 
accessed  03/03/2010),  which  demonstrates  the  differences  made  by  the  amino  acid 
changes. The differences in amino acid have resulted in a change in hydrophobicity of 
two  sections  of  the  protein.  A  Cysteine  was  replaced  with  a  Serine  changing  the 
hydrophobicity index of the amino acid from 2.5 to –0.8, and a Glutamine was replaced 
with an Arginine changing the hydropathy index from –3.5 to –4.5 and also resulting in 
a positive charge in place of a neutral charge and this may affect its configuration. 
 
Table 35 Nucleotide sequence differences in a 468bp section of the Ankyrin gene 
Position in 468bp of the amplified Ankyrin gene   125  333 
Position in 2,576bp gene  1168  1376 
Nine Mile  T  A 
Henzerling  T  A 
Poowong  A  G 
Translated protein     
Position in 858 amino acid sequence of protein  309  459 
Nine Mile  Cysteine  Glutamine 
Henzerling  Cysteine  Glutamine 
Poowong  Serine  Arginine 
The 468bp sequence of the Ankyrin gene was sequenced in both directions for a total of 
three times. The differences in the Poowong isolate compared to the two reference 
isolates  are  shown  along  with  their  respective  differences  in  the  translated  protein. 
Ankyrin gene Gene ID: 5457302 from Coxiella burnetii Dugway 5J108-111, position 
1003099-1005675.  T  =  Thymine,  A  =  Adenine  and  G  =  Guanine.  Protein  NCBI 
Reference Sequence: YP_001424395.2 ankyrin repeat protein from Coxiella burnetii 
Dugway 5J108-111  
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Figure  33  Hydrophobicity  plot  of  Dugway  and  Poowong  translated  ankyrin 
sequences 
The figure shows the Hydrophobicity plot of the translated section of the Poowong 
ankyrin gene that was sequenced (in purple) compared to the sequence of the Gene ID: 
5457302  from  Coxiella  burnetii  Dugway  5J108-111,  position  1003099-1005675  (in 
blue). The differences (shown by arrows) show that the two changes in amino acid have 
changed the hydrophobicity of the protein. 
 
8.5 Discussion 
In  this  study  seven  new  Australian  human  isolates  of  C. burnetii  were  genetically 
analysed  by  a  variety  of  methods.  The  isolates  were  first  geno-grouped  and  it  was 
found that six of the isolates were in geno-group III. Other isolates in this group include 
isolates  from  goats  and  ticks
50.  One  of the  new  Australian  isolates  (Poowong)  was 
placed in geno-group II. This group contains isolates from acute cases of Q fever and 
includes the Henzerling isolate
50 from Italy which is used in the Australian Q fever 
vaccine. The only Australian isolate previously grouped was placed in geno-group I by 
both  RFLP  SDS-PAGE
50  and  IS1111  PCR
30.  The  groups  I,  II  and  III  all  have  the 
plasmid QpH1. These groups contain isolates from acute and persistent (group I), acute 
only (group II) and animal infections (group III). The Poowong isolate in group II was  
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from an asymptomatic case of chronic C. burnetii bacteraemia, suggesting that not all 
“acute” isolates in this group will be cleared by the host. 
 
Of  the  six  isolates  placed  in  geno-group  III,  five  were  from  acute  cases  and  one 
(Harvey) from a chronic case of Q fever. This result was further confounded by the 
discovery that the Arandale and Cumberland isolates contain the QpRS plasmid (Dr 
Dimitrios  Frangoulidis,  personal  communication).  Although  this  observation  is  not 
consistent with their classification into geno-group III (which typically have QpH1 and 
are positive for the adaA gene) it does agree with the negative result with the adaA 
gene  as  other  isolates  with  QpRS  do  not  have  this  gene.  While  these  two  isolates 
belong  to  the  same  group  by  MLVA  (Dr  Dimitrios  Frangoulidis,  personal 
communication)  they  did  have  a  difference  in  virulence  as  the  Cumberland  isolate 
caused fever in guinea pigs while the Arandale isolate did not (Dr. Brenda Govan, 
personal communication). 
 
The Australian isolates were further analysed by LCD-array
40. This detected the adaA 
gene,  which  was  supposedly  unique  to  acute  strains
114.  A  blast  search  (available 
through NCBI website at http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) of the primers 
used in this study had 100% homology with complete genomes of C. burnetii strains: 
RSA331 (Henzerling), Dugway and RSA 439 (Nine Mile). The primer sequences could 
not be found in other C. burnetii genomes completely sequenced in Genbank; CbuK-
Q154 (CP001020) and CbuG-Q212 (CP001019). In the current study, all six Australian 
isolates that were grouped in geno-group III were also negative for the adaA gene. The 
Australian isolate (Poowong) that was grouped in geno-group II was positive for the 
adaA gene, as were the reference strains. This would suggest that the Poowong isolate 
is  an  acute  strain,  which  does  not  agree  with  the  clinical  circumstances  as  it  was  
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obtained from an asymptomatic case of chronic bacteraemia. While the other isolates 
were theoretically grouped as “chronic”, in fact only one of the six (Harvey) was from 
a  case  of  chronic  Q  fever.  It  was  not  known  if  other  isolates  in  geno-group  III, 
previously  isolated  from  goats  and  a  tick
50,  had  the  adaA  gene  as  they  were  not 
included in previous studies
114. 
 
As  it  has  been  shown  that  16  ankyrin  repeat  genes  present  in  C. burnetii  are 
considerable heterogenous among isolates
15 a 468bp fragment of ankH was sequenced 
from the Poowong isolate. This was performed in an effort to differentiate this isolate 
from the Henzerling isolate and to rule out intra-laboratory contamination. Two base 
pair differences were observed between the Poowong isolate and the Henzerling and 
Nine Mile reference strains (Table 35).  The differences observed  equates to 99.6% 
homology. Similar differences have been seen with other between-isolate comparisons 
of the Com1 and mucZ genes with homologies of 99.4% and 99.5% respectively. These 
base pair changes both resulted in a change in two amino acids in the translated protein. 
These amino acid substitutions have resulted in changes in hydropathy and charge, 
which may affect the secondary and tertiary structure of the protein. These differences 
between Poowong and the only other group II isolate in the laboratory (Henzerling) 
indicate that the Poowong isolate is genuinely different. This result rules out laboratory 
contamination  as  an  explanation  for  the  extremely  unusual  finding  of  chronic 
C. burnetii  bacteraemia  in  an  asymptomatic  seronegative  host  (Chapter  7).  Further 
analysis of this isolate is required, such as MST and MLVA (as performed for the 
Arandale  and  Cumberland  isolates  by  Dr.  Dimitrios  Frangoulidis).  The  complete 
genome of Poowong has been sequenced and will be compared to other isolates in 
future work. 
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In this study seven new Australian isolates of C. burnetii were genotyped. Isolates from 
Australia have now been grouped in geno-groups I (previous study)
50, II (Poowong) or 
III (most isolates, present study). Other geno-groups may also be present in Australia. 
Detection of other geno-groups may be restricted as it has been shown that cell culture 
may be selective for acute isolates as these strains have a higher infectivity for cell 
lines
5. Hence fewer chronic isolates may be obtained. 
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9.1 Abstract 
During an outbreak of Q fever in Newport, Wales (2002) 95 people were infected
117. 
Six  years  post  outbreak,  plasma,  serum  and  PBMC  samples  were  taken  from  12 
patients and were analysed by IFA, qPCR, cell culture and SCID mouse inoculation. 
Eleven of these patients had a detectable serological response. All plasma and PBMC 
samples were negative by qPCR suggesting that C. burnetii was either not present or 
below the limit of detection of the assay. Cell culture demonstrated very low positives 
(high Ct values by qPCR) in only two patients suggesting that viable C. burnetii were 
not present in these samples, however the SCID mice produced some unusual results. 
Of 36 mice inoculated with PBMC, 22 survived to day 42; six of these had spleens that 
were positive by qPCR detection of C. burnetii DNA and six were positive by IFA 
detection of C. burnetii antigen. Only two were positive by both methods. The survival 
of most SCID mice to day 42 suggested that viable C. burnetii were not present in the 
original patient samples inoculated into the mice. However, C. burnetii antigen/DNA 
may have been present. A similar phenomenon has been reported after the Birmingham 
(1989)  outbreak
70.  Alternatively,  this  could  also  be  due  to  a  low  concentration  of 
bacteria from a strain with a low virulence that takes longer to kill SCID mice, as 
discussed in Chapter 6 with the Henzerling isolate. 
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9.2 Introduction 
Q fever is generally diagnosed serologically by IFA. PCR detection of the causative 
agent Coxiella burnetii in blood and tissue samples is quickly becoming a useful tool in 
diagnosis of early cases before a serological response has occurred. A cohort of 95 
cases of Q fever from Newport, Wales (UK) was reported six years ago
117. This current 
study  was  conducted  to  determine  the  persistence  of  the  serological  response  to 
C. burnetii and to detect any viable bacteria or antigen/DNA. Peripheral blood samples 
were taken from 12 patients (of 53 patients followed up after six years) and these were 
investigated by serology (by IFA), PCR, cell culture and SCID mouse inoculation. 
 
9.3 Methods 
The peripheral blood samples were separated into serum, plasma and peripheral blood 
mononuclear  cells  (PBMC)  in  the  UK  and  shipped  to  Australia  on  dry  ice.  Serum 
samples were tested by IFA as described in section 2.2.1. Plasma and PBMC samples 
were tested for the presence of C. burnetii DNA by Com1 qPCR as described in section 
2.4.1 and 2.4.2. Peripheral blood mononuclear cell samples were put onto confluent cell 
cultures  of  Vero  cells  as  described  in  section  2.3.3.1.2  and  kept  for  six  weeks  as 
described in section 2.3.2 after which the monolayers were scraped, the DNA extracted 
and  tested  by  Com1  qPCR  (as  described  in  sections  2.4.1  and  2.4.2).  Each  PBMC 
sample was inoculated into three SCID mice via the intra-peritoneal route and the mice 
were observed for six weeks (described in section 2.4.8). At the end of the six weeks 
(42 days) surviving mice were euthanased and their spleens were removed aseptically. 
One part of the spleen was tested for C. burnetii DNA by Com1 qPCR and another part 
was analysed for antigen by IFA and was fixed in formalin, wax embedded, sectioned, 
fixed  to  a  slide  and  stained  with  anti-Phase  I  C. burnetii  LPS  (or  anti-whole  cell  
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C. burnetii) followed by anti-mouse antiserum as described previously
70. Haemotoxylin 
and eosin (H&E) staining was also performed (Dr O. Sukocheva, Australian Rickettsial 
Reference Laboratory, Adelaide). 
 
9.4 Results 
9.4.1  Serology 
Antibodies to both phases of C. burnetii were determined by IFA (Table 36). Only one 
sample (#8) was negative. Eleven had antibodies to Phase II. Only four of these had 
antibodies to Phase I. One (#12) had a higher titre to Phase I than Phase II.  
 
Table 36 Serology Results 
Phase II  Phase I  Patient 
No  IgM  IgG  IgA  Total  IgM  IgG  IgA  Total 
1  -  800  200  800  -  25  -  25 
2  -  200  -  200  -  -  -  - 
3  25  200  -  200  -  -  -  - 
4  25  200  -  200  -  -  -  - 
5  50  800  200  800  -  400  100  400 
6  25  800  -  800  -  -  -  - 
7  -  800  100  800  -  400  -  400 
8  -  -  -  -  -  -  -  - 
9  -  400  -  400  -  -  -  - 
10  25  25  -  25  -  -  -  - 
11  25  800  25  800  -  -  -  - 
12  50  50  -  50  -  200  -  200 
In the table the last dilution to give a positive IFA result is recorded (titre). 
- (negative) no antibodies were detected when screened at dilutions 1:25 and 1:400. 
 
9.4.2  Com1 qPCR 
Plasma samples were initially tested by Com1 qPCR for C. burnetii DNA. This assay 
was later conducted on the PBMC samples as it was thought that they might contain 
more C. burnetii. However all twelve patients were negative using both sample types.  
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9.4.3  Cell Culture 
An aliquot of the PBMC samples was inoculated onto confluent monolayers of Vero 
cells and allowed to grow for six weeks. Only two samples were positive (#3 and #5). 
They had Com1 qPCR Ct values of 36.7 and 35.4 respectively. These were above the Ct 
cut  off  value  used  in  our  laboratory  for  diagnostic  purposes  as  the  upper  limit  of 
genuine positivity (Ct 35). 
 
9.4.4  SCID mouse inoculation 
SCID mouse inoculation and subsequent testing of spleens at day 42 has been shown to 
be a more sensitive method of detecting C. burnetii (Chapter 6). Hence PBMC samples 
were used as inocula for SCID mice. Mouse survival was monitored for 42 days, after 
which all surviving mice were euthanased. The spleens were removed aseptically and 
tested  for  C. burnetii  DNA  by  qPCR.  SCID  mouse  spleens  were  also  tested  for 
C. burnetii antigenic material by IFA. Results are shown in Table 37. 
 
Table 37 SCID mouse spleen results; of testing for C. burnetii DNA (qPCR) and 
C. burnetii antigen (IFA) 
qPCR  IFA* 
Patient No  positive/total spleens  Ct  positive/total spleens 
1  0/1    1/1 
2  1/2  29.8  0/2 
3  1/3  32.1  0/3 
4  0/1    1/1 
5  1/3  25.6  2/3 
6  0/1    0/1 
7  1/2  28.4  0/2 
8  0/1    1/1 
9  0/2    0/2 
10  0/2    1/2 
11  1/2  35.8  0/2 
12  1/2  31.1  1/2 
*  Performed  by  Dr  O.  Sukocheva  (Australian  Rickettsial  Reference  Laboratory, 
Adelaide)  
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9.5 Discussion 
In this study samples from twelve patients involved in a previous outbreak of Q fever
117 
were assessed by serology, qPCR, cell culture and SCID mouse inoculation. Of these 
twelve, eleven had a serological response; seven had antibodies only to Phase II, and 
four also had antibodies to Phase I. One patient had higher titres to Phase I than Phase 
II  (#12).  Only  two  patients  (#5  and  #7)  had  a  robust  serological  immune  response 
remaining six years after initial infection. 
 
Only one patient did not have antibodies remaining after six years (#8). This patient 
was also the  youngest in this group of twelve.  Perhaps in this case the serological 
response  had  diminished  in  the  six  years  since  the  outbreak  to  below  the  limit  of 
detection of the assay. This is most unusual considering that the spleen from the mouse 
inoculated  with  this  sample  was  PCR  negative  but  IFA  positive  suggesting  the 
persistence of antigen but not DNA. 
 
As all plasma and PBMC samples were negative by qPCR it is presumed that these 
samples contained none or very low numbers of C. burnetii, i.e. below the limit of 
assay detection. Cell culture was also performed on the PBMC samples and while two 
of these were positive by qPCR after six weeks in culture, their Ct values were not 
indicative of growth of C. burnetii in cell culture. They may have been due to non-
viable  C. burnetii  or  just  DNA  present  in  these  samples,  as  the  Ct  values  did  not 
increase as expected during the growth of C. burnetii. 
 
Previous studies have shown that SCID mouse inoculation and testing of the mouse 
spleen 42 days later was more sensitive than qPCR and cell culture for detecting low 
numbers  of  viable  C. burnetii  (Chapter  6).  Consequently  these  samples  were  also  
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inoculated into SCID mice. Twenty-two mice (out of 36 mice originally inoculated) 
survived, although none had splenomegaly. Six of the mice spleens were positive by 
qPCR (5 had Ct values that would be considered genuine positives). However not all 
mice inoculated with samples from the same patient were positive suggesting that the 
inocula contained either none or very low numbers of C. burnetii and consequently 
C. burnetii  was  not  inoculated  into  all  mice.  Six  spleens  were  positive  by  IFA  for 
C. burnetii antigen but only two of these were also positive by qPCR (#5 and #12). 
This was not surprising for patient #5 as this sample had a most convincing Ct of 25.6. 
It was unlikely that such a low Ct value was due to contamination as this equates to 
approximately 1,000 copies per reaction. 
 
Those  samples  positive  for  DNA  by  qPCR  and  negative  for  antigen  by  IFA  could 
possibly be due to a difference in sensitivity of the two assays. This may also explain 
why some SCID mice were positive while all cell cultures were negative as SCID mice 
inoculation has been shown to be up to 150 times more sensitive than cell culture 
(Chapter 6). This suggests that very low numbers of C. burnetii cells were present in 
the original samples. 
 
Those spleen samples positive for antigen by IFA and negative for C> burnetii DNA  
by  qPCR  may  have  contained  persistent  (non-DNA)  antigen  or  non-viable  (DNA 
degraded) C. burnetii cells. This has been demonstrated previously with IFA detectable 
C. burnetii antigen in PCR negative samples
70. This may be due to the inability of the 
host to destroy the bacteria completely with the antigen of the C. burnetii remaining, 
although the cells were non-viable and without detectable DNA. These differences in 
the viability of the C. burnetii may be due to differences in the host’s ability to clear 
and degrade the bacteria. It is less likely to be due to differences in the bacteria (such as  
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Phase  variation  and  genotype)  as  they  were  from  the  same  outbreak,  although  this 
cannot  be  determined  currently.  These  bacteria  may  however  be  in  different  forms 
within the host, which could affect their ability to infect SCID mice. Testing of the 
remaining patients involved in the outbreak may help to give a clearer picture of these 
unusual results and determine how common it is for C. burnetii DNA, antigen and/or 
viable bacteria to persist in patients years after initial infection. 
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This study demonstrated a highly sensitive qPCR for the detection of C. burnetii DNA, 
it’s  usefulness  on  both environmental  and  clinical  samples,  the  optimal  method  for 
isolation of C. burnetii and the need for methods (such as PCR and animal inoculation) 
for cases of chronic bacteraemia (such as those that are seronegative  or those with 
persisting antigen). The use of the Com1 qPCR was shown to be very sensitive for use 
with water and milk samples. PCR inhibition was observed in some soil samples that 
could be overcome with a 1:10 dilution. Detection of C. burnetii in these sample types 
could be further improved by removing the larger solids with large pore filters or by 
concentrating the bacteria present by means of magnetic beads
64 or concentrating the 
DNA extracted by precipitation
126. In this study, aerosolised C. burnetii was detected in 
air by sampling via PBS. As most of the bacteria aerosolised were not detected in the 
air samples the method needs to be further optimised. Options for consideration include 
a  better  method  of  aerosolising  the  bacteria  (to  better  imitate  natural  aerosolised 
bacteria),  increasing  the  duration  of  sampling  or  the  use  of  a  real  impinger,  glass 
filters
100 or a vacuum
56 to sample air. With the methods described and an optimised 
aerosol  assay,  samples  taken  from  areas  at  risk  of  contamination  such  as  abattoirs, 
farms and sale yards could be tested for C. burnetii. This could be coupled with sponge 
wipes and vacuum samples as utilised in a recent study
56 to give a clearer picture of 
C. burnetii contamination in certain areas. That study showed positive areas included 
grocery  stores,  post  offices,  banks  and  hospitals.  There  is  likely  to  be  an 
underestimation of cases in Australia as there is a common misconception that animal 
contact is required for Q fever infections.  
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The testing of clinical samples was investigated to ensure that diagnostic tests for Q 
fever by PCR would detect small numbers of bacteria if present. It was found that more 
laborious methods such as the chloroform method of extraction were not necessary for 
the detection of C. burnetii DNA even when in the SCV form and in bone marrow 
samples. The silica column method of extraction and purification adequately removed 
potential PCR inhibitors from blood, plasma, serum and bone marrow specimens. The 
method would be highly useful for detecting C. burnetii in diagnostic samples early in 
the disease and also for samples where the bacteria would no longer be viable (e.g. 
frozen  samples).  This  assay  could  potentially  be  improved  with  an  increase  of  the 
digestion time from 10 minutes to 48 hours but at a large cost to turn around time for 
diagnostic reporting. 
 
The optimal method of isolation of C. burnetii was investigated as detection by PCR 
does not differentiate between viable and non-viable bacteria. The isolation of bacteria 
is essential for certain studies on C. burnetii. While the DH82 cell line grew the highest 
numbers of bacteria from most of the C. burnetii isolates tested, differences in bacterial 
yield between cell lines was minimal. The Vero cell line was the most sensitive for 
growth of the Arandale isolate while the DH82 cell line was the most sensitive for 
growth of the Henzerling isolate. These comparisons could be extended to evaluate 
other  cell  lines  and  for  comparison  with  the  cell  free  method  published  recently
79. 
When cell culture, PCR and SCID mouse inoculation were compared it was found that 
SCID  mouse  inoculation  (followed  by  PCR  analysis  of  the  spleen)  was  the  most 
sensitive method for detection of viable C. burnetii. SCID mouse inoculation should be 
used on PCR positive diagnostic samples and those likely to be PCR positive (such as 
heart valves from Q Fever endocarditis patients) to increase the likelihood of obtaining  
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C. burnetii isolates for further analysis. After an isolate has been obtained it can then be 
put into cell culture and maintained as such to reduce the use of animals and the cost 
and to produce large amounts of the bacteria for other studies such as genotyping and 
other genetic analyses. 
 
The increased sensitivity of SCID mice for C. burnetii isolation was demonstrated in 
the investigation of an unusual asymptomatic case of Q fever in this study. All cell 
cultures were negative but an isolate was obtained through SCID mouse inoculation. 
This asymptomatic case of chronic bacteraemia was demonstrated by ongoing PCR 
positive results despite the serum being continually seronegative. This demonstrates the 
importance of early vaccination as this person may have acquired the infection while 
working at an abattoir for three months before vaccination. Further investigation could 
be undertaken to determine if a genetic difference in the host had prevented the clearing 
of the bacteria and caused a lack in antibody response. 
 
A second C. burnetii specific qPCR targeting the IS1111A gene was described was also 
highly sensitive. However, as some studies have suggested that not all isolates contain 
this insert a duplex qPCR to both the Com1 and the IS1111A was developed. This 
duplex was highly specific and sensitive, detecting 1-10 copies per reaction for both 
targets. This assay could be combined with detection of an internal control (detecting 
human DNA for example) and/or other pathogenic targets such as those also causing 
flu-like non-specific symptoms so that many possibly causes of symptoms could be 
diagnosed simultaneously. 
 
Preliminary  genetic analysis of the C. burnetii isolated from the asymptomatic case 
(Poowong isolate) was undertaken. Genetic analysis was attempted by RFLP analysis.  
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However  separate  bands  could  not  be  visualised.  Southern  blotting  of  restriction 
endonuclease cut DNA was attempted with a hybridisation probe targeting the insertion 
sequence (data not shown). Both methods were unsuccessful. By conventional PCR 
using a method previously described
30 the Poowong isolate was found to belong to a 
different geno-group from the other six new Australian Q fever isolates analysed. The 
Poowong isolate was also positive for the adaA gene while the other new Australian 
isolates were not. The Poowong isolate had two differences in the sequence of the 
ankyrin gene compared to the Nine Mile and Henzerling isolates. A genetic difference 
in this isolate may contribute to the difference in the “disease” state. Further analysis is 
required  and  late  in  this  study  the  whole  genome  sequence  of  this  isolate  was 
commercially acquired. It’s analysis is still pending and beyond the scope of this thesis. 
 
Through  the  use  of  different  methods  of  detection  on  plasma,  serum  and  PBMC 
samples  from  patients  infected  in  an  outbreak  (Newport)  six  years  previously  the 
usefulness of the SCID mouse inoculation was again demonstrated. Eleven of these 
patients had a persistent serological response. All plasma and PBMC samples were 
negative by qPCR; cell culture demonstrated very weak positives in only two patients 
and SCID mice inoculation and analysis of the spleen demonstrated six positive by 
qPCR and six positive for antigen by IFA, yet only two patients were positive by both 
methods. This may be due to a difference in assay sensitivities and the presence of non-
viable cells. The remaining 41 patients should be tested to give a clearer picture of the 
pathogenesis  of  post-Q  fever  infection  and  the  possibility  of  persistent  non-viable 
antigen  or  low  numbers  of  viable  C. burnetii  in  the  patient.  These  results  further 
demonstrate  the  usefulness  of  SCID  mouse  inoculation  over  both  cell  culture  and 
qPCR. These mice are more sensitive for detection than qPCR and appear to be able to 
detect  non-viable  C. burnetii  antigen.  The  Com1  qPCR  results  of  the  SCID  mice  
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inoculated with the Newport patient samples (Chapter 9) compared to those inoculated 
with  dilutions  of  spleen  or  infected  embryonated  egg  sac  homogenate  (Chapter  6) 
suggest that these patient samples have a reduced virulence or infectivity demonstrated 
by a increased Ct (i.e. less DNA was detected). This may be due to the sample type 
itself, a loss in virulence during shipping on ice or possibly that these patient were 
infected with a low virulent strain of C. burnetii. To investigate the latter hypothesis the 
isolates obtained though SCID mouse inoculation need to be maintained in cell culture 
and further analysed. The results of this study demonstrate the importance of follow up 
testing on Q fever infections, especially if these patients have been receiving treatment. 
If they had been treated the treatment may need to be more rigorous or for an increased 
time. 
 
In conclusion this study has shown optimal methods for the detection of C. burnetii 
including qPCR and SCID mouse inoculation and has demonstrated the importance of 
these methods in cases that may have chronic bacteraemia. Analysis of more cases of Q 
fever by the methods optimised herein will hopefully shed more light on this bacterium, 
the differences in the geno-groups and the persistence of C. burnetii (even in the form 
of non-viable antigen) in the host.  
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A Ap pp pe en nd di ix x   
A.  Spearman-Kärber method for calculation of 50% end point 
The TCID50 ID50 LD50 and DD50 (detection dose) were calculated to give the 50% end 
point using the following formula: 
 
Log D50 = xp=1 + 0.5d-dp 
 
where xp=1 is the highest log dilution giving all positive responses, d is the log dilution 
factor (for ten fold dilutions this equals 1) and p is the sum of values of p for xp=1 and 
all higher dilutions
7. 
 
The ten-fold Arandale titration inoculated into Vero cells described in Chapter 5 is used 
in the following example (Table 38). 
 
Table 38 Example calculation of TCID50 
Log dilution  Number in group  Number positive  Proportion positive 
-9  6  6  1.00 
-10  6  4  0.67 
-11  6  0  0.00 
    Sum (p)  1.67 
xp=1 = -9 
log TCID50 = | -9 + 0.5 –1.67 |= | -10.17 | 
TCID50 = 1.48   10
+10 
The dilution where 50% is positive is given in this calculation. In the example this is 
-10.17, this was then changed to copy numbers by the standard curve such as Figure 25 
and Figure 26 in chapter 6.  
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